Annual Report • Jun 10, 2021
Annual Report
Open in ViewerOpens in native device viewer

Consolidated Interim Financial Statements as of March 31 2021 (Unaudited) The Phoenix Holdings Ltd.

| Report of the Board of Directors on the State of the |
|---|
| Corporation's Affairs |
| Consolidated Interim Financial Statements |
| Standalone Financial Data from the Consolidated Interim |
| Financial Statements Attributed to the Company |
| Report on the Effectiveness of Internal Control over Financial |
| Reporting and Disclosure |
| Statements Regarding Controls and Procedures in respect of |
| Disclosure in the Financial Statements of The Phoenix |
| Insurance Company Ltd. |

| Benjamin Gabbay - Chairman |
|---|
| Roger Abravanel |
| Ben Langworthy |
| Marilyn Victoria Hirsch |
| Zhak Cohen |
| Rachel Levine (External Director) |
| Zohar Tal (External Director) |
| Dr. Ehud Shapira (Independent Director) |
| Eliezer Yones |
Report of the Board of Directors on the State of the Corporation's Affairs as of March 31 2021


| 1. The Group's Structure, its Areas of Activity, and Developments Therein 3 | |
|---|---|
| 2. Description of the Business Environment…………………………………………………………………………………………10 | |
| 3. Developments in the Macroeconomic Environment………………………………………………………………………18 | |
| 4. The Board of Directors' Explanations for the State of the Corporation's Business 22 | |
| 5. Disclosure on Exposure to, and Management of, Market Risks………………………………………………….39 | |
| 6. Linkage balance……………………………………………………………………………………………………………………………………….41 | |
| 7. Corporate Governance Aspects……………………………………………………………………………………………………………44 | |
| 8. Disclosure Provisions Relating to the Corporation's Financial Reporting46 |
The Report of the Board of Directors of The Phoenix Holdings Ltd. (hereinafter, "The Phoenix Holdings" or the "Company" or the Corporation") as of March 31 2021, outlines the principal changes in the Company's operations in the period from January through March 2021 (hereinafter - the "Reporting Period").
The report was prepared in accordance with the Securities Regulations (Periodic and Immediate Reports), 1970. With regard to the insurance, pension, and provident fund operations of the Group, the Report was prepared pursuant to the Supervision of Insurance Business Regulations (Reporting), 1998, and in accordance with the directives issued by the Commissioner of the Capital Market, Insurance and Savings Authority (the "Supervisor" or the "Commissioner"). The report was prepared assuming that the reader also has at his/her disposal the Company's full 2020 periodic report (hereinafter - the "Periodic Report").
The Report of the Board of Directors is an integral part of the quarterly report, and the quarterly report should be read in its entirety, as a single unit (hereinafter - the "Financial Report" or the "Financial Statements").
The controlling shareholder of the Company is Belenus Lux S.à.r.l. (hereinafter - "Belenus"), which is held by Centerbridge Partners LP and Gallatin Point Capital LLC (hereinafter - the "Funds"). For further details regarding the holding stakes and structure, please see Section 1.1 under "Description of the Corporation's Business" in the Periodic Report.


123456789:;6789<=>[email protected]:=DB>E=?@;68@?F0
W-XYZX- [ --\ Y][Y ^-_ D=A95B?6:a:;DB8b?5BA6?:ABD6A7:>::86b6BAc@:@B<78C=D@:def/gg;7<<7:8Fh?:@56 A6D:A@D=i79B@7:8B@6c@56a:;DB8b6j69=@6>?6k6AB<?5BA6i=biB9l?c:AB@:@B<:defmnFo ;7<7:81Gcpggcmnn?5BA6?:/DFkF6B953Fq=A@56A;:A6c78@56=@=A6?:;6:@56?5BA6?D=A95B?6> B?DBA@:@56?5BA6i=biB9lDamp#66;amp#56;amp#59;amp#66;amp#98;amp#63;amp#54;amp#65;amp#107;amp#54;amp#58;amp#65;amp#64;amp#53;amp#54;amp#68;amp#61;amp#65;amp#68;amp#58;amp#63;amp#54;amp#58;amp#54;amp#106;amp#54;amp#65;amp#57;amp#55;amp#63;amp#55;amp#56;amp#67;amp#64;amp#53;amp#54;amp#58;amp#68;amp#64;amp#55;amp#58;amp#56;amp#63;amp#66;amp#114;amp#66;amp#65;6@: :`796A?B8>6;D<:b66?:@56a:;DB8bB8>?=i?7>7BA76?Fq:A=A@56A>6@B7<?cD<6B?6?66@56 a:;DB8bs?7;;6>7B@6A6D:A@?>B@6>t9@:i6A/pgpgB8>uBb-pgp/1v6d:?Fwpgpg.g/.//pGnx B8>pgp/.g/.gmmyy-cA6?D69@7k6<b3FV0
/FGFpFHI#J#'"''#)+N#RO+#!" z
\
-_
[ --\
{YY[X- [
Z :8uBA95p-pgp/c9:89=AA68@<br7@5@56BDDA:kB<:@56a:;DB8bs?|6A7:>79v6D:A@B?:}696;i6A G/pgpgc@56a:;DB8bs?~:BA>:}7A69@:A?>697>6>@:>7?@A7i=@6Bdef-gx;7<<7:8>7k7>68>1r5795 ]X- [X-\
X \_ --X \_[W px;7<<7:8.r5795rB?=?6>@:6j69=@6@56?5BA6i=biB9lD<B8.rB?>6>=9@6>A:;@56@:@B< >7?@A7i=@7:8B;:=8@B?:`@56>7?@A7i=@7:8>B@6Fh99:A>78C<bc@56B9@=B<B;:=8@>7?@A7i=@6>B? >7k7>68>7?defGog;7<<7:8B8>A6DA6?68@?def/F-yD6A?5BA6F0 /FGFGFHK+#!")+!!#TN)Q"'LK&!S) t8uBbpxpgp/c@56X-
[ --\ ]-ZZ- @:6;D<:b66?B8>:`796A?:@56a:;DB8bB8>7@??=i?7>7BA76?c6j6A97?Bi<678@:=D@:GcyGmcggg :A>78BAba:;DB8b?5BA6?:def/FggDBAkB<=66B95c?=iE69@@:B>E=?@;68@?cr7@5:=@9B?5 9:8?7>6AB@7:8Fq:A=A@56A>6@B7<?cD<6B?6?66d:@6y@:@56q78B897B<f@B@6;68@?F0 /FGF-FH\$QL#"#"(+K!))#R#&#+S!)&&#"(' W
!"#\$%!&'#"()*+', -./ ] [Z
W]
__
z
_ ?@Bl61B8>=D@:/gg:
W] _
z
.v6?7>6896`:Af687:A
0

Citizens Ltd. (hereinafter - "Ad 120") as part of the execution of the Company's multi-year strategic plan, whereby the Group will focus, among other things, on its core business and unlock the value of the Group's asset portfolio. As of the report date, the Company is acting to implement the aforesaid with the assistance of an investment bank with which the Company has entered into an agreement in this matter. As of the report publication date, The Phoenix Insurance had received several unbinding initial offers from potential acquirers. The Phoenix Insurance is considering the various offers and alternatives for executing the transaction. For further details, please see the Bank's immediate report dated January 28 2021 (Ref. No.: 2021-01-011200).
In May 2021, Gama Management and Clearing Ltd. (hereinafter - "Gama") published a draft prospectus for an initial public offering and sale offer (hereinafter: the "Draft Prospectus"). As of the report publication date, the Company indirectly holds - through The Phoenix Investments and Finances Ltd., a wholly-owned subsidiary of the Company (hereinafter - "The Phoenix Investments") - 49% of Gama's issued and paid-up share capital. According to the draft prospectus, the company intends, concurrently with the execution of the IPO, in accordance with the IPO prospectus, to acquire, through The Phoenix Investments, such that following the IPO and full hold more than 60% of Gama's issued and paid up share capital and voting rights, fully diluted, and shall be the controlling shareholder in Gama. To the extent that the issuance will indeed proceed and the Company will gain a holding stake of more than 50% over Gama, the Company is expected to record a one-off capital gain due to gaining control, ranging between NIS 230 million and NIS 280 million, depending on the IPO proceeds. As of the report publication date, the IPO is scheduled to take place in June 2021. However, it shall be clarified that the information stated in this section is forward-looking information and that there is no certainty that the IPO will indeed take place and what its terms and conditions will be.
On May 9 2021, KSM Sal Certificates Holdings Ltd. - a company indirectly controlled by the Company, jointly with YD More Investments Ltd. - filed a binding offer to acquire all shares of Psagot Mutual Funds Ltd., Psagot Securities Ltd. and Psagot Compass Investments Ltd. (hereinafter, collectively the "Acquired Companies") by Psagot Investment House Ltd. (hereinafter - "Psagot"). The offer reflected an enterprise value of approximately NIS 420 million for the Acquired Companies, on the basis of zero debt and zero cash as of December 31 2020. The offer expired on May 10 2021 at 5:00 PM under the terms and conditions of the offer. For further details, please see the Company's reports dated May 9 2021 and May 11 2021 (Ref. Nos.: 2021-01-080166 and 2021-01-082401, respectively).
In January 2021, the Board of The Phoenix Insurance ratified its decision+to transfer shares of Phoenix Excellence by way of dividend in kind. The distribution has not yet been executed since, as of the report publication date, the approval of the Israel Tax Authority has yet to be given. It should be noted that the approval of the Capital Market, Insurance and Savings Authority has already been obtained. For further details - including the Board of Directors' original explanations for approving the distribution - please see the Company's immediate report dated December 31 2019 (Ref. No.: 2019-01-126166). It should be noted that as part of the distribution of the dividend in kind and prior to its execution, in August 2020, the Company's Board of Directors approved the Company's commitment to supplement The Phoenix Excellence's shareholders equity to the amount stipulated in the Supervision of Financial Services Regulations (Provident Funds) (Minimum Equity Required from a Management Company of a Provident Fund or a Pension Fund), 2012, in lieu of The Phoenix Insurance's commitment.
As part of the implementation of its business strategy and its wish to expand its asset management activities in general and its pension and provident funds activities in particular, on February 28 2021, the Company completed the merger transaction - under which the Company acquired Halman-Aldubi Investment House Ltd. (hereinafter - "Halman-Aldubi"), by way of a reverse triple merger transaction - was completed. Upon completion of the transaction, Halman Aldubi became a privately-held company wholly-owned by the Company. The proceeds of the Halman Aldubi transaction totaled NIS 275 million.
On February 18 2021, the Company entered into an agreement with Halman Aldubi Provident and Pension Funds Ltd., a company wholly owned by Halman-Aldubi (hereinafter - "Halman Provident"), according to which the Company would extend Halman Provident a loan to finance the full early redemption of all bonds (Series A) issued by Halman Provident, in the amount of NIS 73.6 million (hereinafter, respectively: the "Bonds" and the "Early Redemption"); according to the agreement, the Company undertook to finance the full early repayment of a loan totaling NIS 15 million (hereinafter - the "Bank Loan Amount"), taken by Halman Provident from a local banking corporation. On March 8 2021, early redemption of the bonds was made and the bank loan to the local banking corporation was repaid.
1 The decision on the transfer of the Phoenix Excellence was initially made in December 2019. Due to the passage of time, and since the Israel Tax Authority's regulatory approval has yet to be granted, the Board of Directors of the Company discussed the issue again and approved the distribution.

On May 23 2021, the Phoenix Excellence's Board of Directors decided to merge Halman Provident with and into Phoenix Provident. According to the merger outline, the provident funds and the old pension funds managed by Halman Provident will be transferred to the management of Phoenix Provident. The merger between the companies - including the merger of the provident funds and the provident funds' investment tracks - is expected to be completed on September 30 2021, subject to obtaining the approvals required by law.
On February 22 2021, the Company entered into an agreement with Meitav Dash Provident Funds and Pension Ltd. (hereinafter - "Meitav Dash Provident"), according to which the Company will exercise its influence as Halman Aldubi's sole shareholder, such that Halman Provident will sign an agreement for the sale to Meitav Dash Provident of the new pension funds managed by Halman Provident for NIS 45 million, to be paid in one lump sum on completion date. On March 10 2021, Halman Provident signed the said agreement. The completion of the sale is subject to meeting accepted conditions precedent, and the last date for the completion of the Funds' sale agreement is scheduled for June 30 2021.2
For further details, please see the immediate reports from the following dates: December 8 2020, January 28 2021, February 3 2021, February 18 2021, February 23 2021, February 24 2021, and February 28 2021 Ref. Nos.: 2020-01-133119, 2021-01-011467, 2021-01-013942, 2021-01-020860, 2021-01-022078, 2021-01-021813 and 2021-01-023697, respectively.
In February 2021, the Company's Board of Directors approved the adoption of a voluntary reporting policy in English on the English-language MAYA website of the Tel Aviv Stock Exchange, beginning on the date of publication of the Company's annual Financial Statements for 2020. The adoption of the said policy is based, inter alia, on a notice published by the Israel Securities Authority on June 30 2020 - "Notice to Companies: Voluntary Publication of Translations of Reports into English." For further details, please see the Company's immediate report dated February 25 2021 (Ref. No. 2021-01-023287). The Company follows the said policy and on April 22 2021, published its 2020 Periodic Report in English for the first time.
a. On January 11 2021, Midroog announced it was reiterating the rating of Series 3 and 4 bonds at Aa3.il, with a stable outlook. On January 31 2021, Midroog announced it has rated the extension of up to NIS 350 million in Series 4 and 5 bonds issued by the Company at Aa3.il,
2 The last date for the completion of the Funds' sale agreement was originally scheduled for May 31 2021; the agreement was extended by the parties until June 30 2021.
012345246789:2799;<=9>?:>238>@824175AB78458588238C9DB4EFG51DD8@1428>8B9>25@428@ H4E:4>F//IJI/KL8?<M9IJI/./N.JJOPOQR4E@H4E:4FS/IJI/KL8?<M9<IJI/./N.J/IT-/R< UV W XY Z[\ ]- X^ _ .17``.01234524678 9:2799;a12>428@2388b28E519E9?c8>185O4E@N69E@51E2384D9:E29?:B29MdcSNJD17719E 42.
ZefW ZY-Z ]- X
]]1428>8B9>2@428@H4E:4>FS/ IJI/KL8?<M9<gIJI/./N.J/ITQSR<h
6238>@824175AB784585882381DD8@1428>8B9>2155:8@6Fn38o398E1bC4B1247L4151Ep9E H4E:4>FS/IJI/KL8?<M9<IJI/./N.J/SIQSR<
/<S<//
W-WW ]- XZ
_- fW XSIJI/ KL8?<M9<IJI/.J/.J/SQ-OR
ZW
_ W Z] ZW - Zeh
C34Ep851E238>15;. W _ j\
klW 455825A71461712185A?1E4E147B8>?9>D4E8A4E@5978EF>4219<=9>?:>238>@8241759E34Ep851E238 1E28>852>428:>8AB78458588M928-<`29238=1E4E147c2428D8E25459?4>3S/IJI/K38>81E4?28> .#"t"#t&w+t+}"+) ZX Y-Z I</
/<S</Sh\ n38o398E1bdE5:>4E8159E51@8>1Ep238155:4E89?4E@@1219E47n18>/4B12471E52>:D8E2A >89pE18@45>8p:7429>F4B1247:E@8>2389E9D1c978EFL8p1D8A1E9>@8>2952>8Ep238E125 4B12474E@1DB>981255978EF>4219<dE4>3IJI/A23894>@9?1>829>54BB>98@299E21E:8 8b4D1E1Ep238155:4E8B>98@:>8<n38>89pE1219E9?2381E52>:D8E2454E@@1219E47n18>/4B1247 1E52>:D8E2155:682292384BB>9479?238C9DD15519E8>9?238C4B12474>;82AdE5:>4E84E@ c41Ep5<h
n38155:4E84D9:E2158bB828@29684BB>9b1D4287FMdcOJJD17719E
-W
X - ZlW ]- lW WZ ././NA \
--ZX
_]
ZX_
] ZXlllW ]- e n38o398E1bdE5:>4E809>;52996241E238>8p:7429>F4BB>9475>8:1>8@?9>8b8:21Ep238155:4E8<h
h

As part of The Phoenix's preparations for the application of IFRS 17 (hereinafter - the "Standard") in the Financial Statements of the Company and The Phoenix Insurance as of the quarterly and annual periods beginning on January 1 2023, in February 2021, The Phoenix Insurance signed agreements with software and integration service providers for the purpose of applying the Standard. The purpose of the agreements is to implement and assimilate a system aimed at enabling the Company to meet the regulatory requirements for the Standard, including the requirements detailed in "Roadmap for the Adoption of International Reporting Standard (IFRS) 17, Insurance Contracts", published on June 7 2020 by the Capital Market, Insurance and Savings Authority.
In addition, The Phoenix Insurance entered into an agreement with EY Canada, in partnership with EY Israel, which includes expanding their auditing and consulting services. The contract was preapproved by The Phoenix Insurance's Audit Committee, which determined - after being presented with satisfactory references - that the said consultancy project meets the independence rules according to the Commissioner's position titled "Impairment of the Independence of an Independent Auditor due to the Provision of an Ancillary Service" published in January 2021. For further details, please see Note 2(ee)(1) to the Financial Statements as of December 31 2020.
In April 2021, the Commissioner approved the appointment of Mr. Eldad Fresher as Chairman of the OPM Investment Committee for Insurance, Provident and Pension Planholders and Policyholders, following the approval by The Phoenix Insurance's Board of Directors. Mr. Fresher will begin his term in early June 2021. Mr. Fresher will replace Mr. Jacob Rosen, who served as the Committee's chairman for the past nine years. The Phoenix's management thanks Mr. Rosen for his substantial contribution to The Phoenix's performance and the unprecedented investments and achievements made over the past few years.
For details regarding the extent of the coronavirus crisis's impact on the Company's various business activities, please see Note 1 to the Financial Statements as of December 31 2020.
During May 2021, following a military escalation in Israel, rockets were fired into the country over a period of 11 days. During this period, the Company continued to provide full service to its customers. To the best of the Company's knowledge, as of the report publication date, the event does not have a material effect on the Company's performance. In addition, we note that the State of Israel covers property damage, if any.

The Phoenix Insurance is subject to the Solvency II-based Economic Solvency Regime in accordance with the provisions of Circular 2020-1-15 of the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") - "Amendment to the Consolidated Circular concerning Implementation of a Solvency II-Based Economic Solvency Regime for Insurance Companies" (hereinafter - the "Economic Solvency Regime"), which was published on October 14 2020. The Economic Solvency Regime is a regulatory directive that regulates capital requirements and risk-management processes among insurance companies. The Economic Solvency Regime sets a standard model for calculating eligible capital and the regulatory solvency capital requirement, with the aim of bringing insurance companies to hold buffers to absorb losses arising from the materialization of unexpected risks to which they are exposed. The solvency ratio is the ratio between an insurance company's economic shareholders' equity recognized for solvency purposes and the required capital.
The Company opted for the alternative provided by the Economic Solvency Regime regarding the transitional provisions, whereby the economic capital may be increased by gradually deducting from the insurance reserves until 2032 (hereinafter - the "Deduction During the Transitional Period"). With regard to the Deduction During the Transitional Period, a letter was addressed to insurance companies managers titled "Principles for calculating Deduction During the Transitional Period in the Solvency II-based Economic Solvency Regime" (hereinafter - the "Letter of Principles"). Pursuant to the Letter of Principles, the Deduction During the Transitional Period shall be calculated by dividing insurance policies issued through December 31 2016 into homogeneous risk groups. The aforesaid deduction shall be calculated as the difference between insurance reserves (retention) as per the economic balance sheet, including the risk margin attributed thereto (net of the difference between the fair value and the carrying amount of designated bonds) and the insurance reserves (retention) as per the Financial Statements. This difference shall be deducted on a linear basis until December 31 2032. The deduction balance at each reporting date (hereinafter - the "Deduction Value During the Transitional Period") shall be proportionate to the expected increase in the solvency ratio calculated excluding expedients during the Transitional Period.

The Economic Solvency Ratio Report as of December 31 2020 was published at the same time as the Financial Statements, on May 27 2021, and was prepared and presented in accordance with the provisions of Chapter 1, Part 4, Section 5 of the Consolidated Circular, according to Circular 2020-1-17 (hereinafter - the "Disclosure Provisions"). In accordance with the Consolidated Circular, the economic solvency ratio report in respect of the December 31 and June 30 data of each year shall be included in the first periodic report published after the calculation date. Despite the above, on March 19 2020, the Commissioner published a letter, Ref. No. SH 2020-2031, stipulating that an insurance company is exempt from publishing an economic solvency ratio report as of June 30 2020 and from filing solvency reporting files in for that date.
On March 14 2021, a letter from the Commissioner was published, Ref. No. 2021-423, stating that the deadline for publication of the economic solvency ratio report as of December 31 2020, as well as the accompanying files reported to the Commissioner, shall be filed no later than June 30 2021. In addition, the letter states that an insurance company may refrain from publishing an economic solvency ratio report as of June 30 2021.
The meaning of the terms in this section is the same as in Appendix B to Chapter 2 in Part 2 of Section 5 of the Consolidated Circular - "Economic Solvency Regime".
| As of December 31 | |
|---|---|
| 2020 | 2019** |
| Audited* In NIS thousand |
|
| 6,661,640 | 7,455,885 |
| 6.109,203 | 4,630,620 |
| 192% | 162% |
| punikation hate of the Solvensy Tatto Tenvi T | ||
|---|---|---|
| Raising of equity instruments | 220,000 | |
| Shareholders equity for SCR | 12,770,842 | 12,306,505 |
| Surplus | 6,109,203 | 4,850,620 |
| Economic solvency ratio (in %) | 192% | 165% |
| 7.1.1 11 4 |
(*) "Audited" refers to an audit held in accordance International Standard on Assurance Engagement (ISAE) 3400 – "The Examination of Prospective Financial Information."
**The solvency ratio calculation as of December 31 2019 does not include the effect of retrospective application following a policy change regarding LAT in life and health insurance.
(1) The above audited solvency ratio includes a NIS 200 million dividend distribution performed between the calculation date and report publication date. See Section E below.
In March 2020, the Commissioner published an amendment to the provisions of the Consolidated Circular regarding the Liability Adequacy Testing (hereinafter - the "LAT Circular"). The amendment included changes in the way insurance liabilities are calculated as part of the Liability Adequacy Test (LAT), and determined that these changes would apply from the financial statements as of March 31 2020 as a change in accounting policies by way of retrospective application. In accordance with the Commissioner's Directives, the said amendment is not reflected in the calculation of the Deduction During the Transitional Period as of December 31 2019.

In March 2021, the Commissioner published a clarification in connection with this issue, stipulating that the calculation of the LAT Circular's effect on the Deduction During the Transitional Period as of December 31 2020 shall be carried out retrospectively, as follows: The Deduction During the Transitional Period will be calculated as of December 31 2019 using the same method as the one used to calculate the Economic Solvency Ratio Report for that date; the accounting-based insurance liabilities include the effect of the LAT Circular, and the economic-based insurance liabilities (best estimate plus risk margin) and added fair value of the designated bonds include the effect derived therefrom. The Deduction During the Transitional Period as of December 31 2020 shall be based on the Deduction During the Transitional Period that was calculated retrospectively and will be deducted as described above. The effect of the LAT circular's application, as explained above, is to increase the amount of the Deduction During the Transitional Period by approximately NIS 382 million as of as of December 31 2019. Were it not for the capital surplus circular as of December 31 2020, it would have been NIS 5,816 million and the solvency ratio - 186%, after the Deduction as stated in the Letter of Principles. For details regarding the economic solvency ratio without applying the transitional provisions for the Transitional Period, and without adjusting the stock scenario, and for details regarding the solvency ratio target and restrictions imposed on the Company with respect to dividend distribution, please see Section C below.
| As of December 31 | ||
|---|---|---|
| 2020 | 2019** | |
| Audited* | ||
| In NIS thousand | ||
| Minimum capital requirement (MCR) | 1,665,410 | 1,863,971 |
| Shareholders equity for MCR | 9,773,104 | 8,919,336 |
(*) "Audited" refers to an audit held in accordance International Standard on Assurance Engagement (ISAE) 3400 - "The Examination of Prospective Financial Information."
**The calculation does not include the effect of retrospective application following a policy change regarding LAT in life and health insurance.
Below is a link to the Economic Solvency Ratio Report on the company's website. https://investor-relations.fnx.co.il/about-us/solvency-report/
The Company's policy is to have a solid capital base to ensure its solvency and ability to meet its liabilities to policyholders, to preserve the Company's ability to continue its business
0123432567182802323609:;2<=><43?;>;27>@62<326680>;8<:?;>6AB8;C<D=0@536679E;12 2<10=320:>;F73>;D;@266;29528;C<DD3663<@;>AG
H@HIJKLM
NOP Q
QPQQ 6:4;@15023<20>R;20@?20>R;2>0@R;906;?<@S<:4;@15TTAG
B8;D3@3D7D;1<@<D316:4;@15023<20>R;2U20V3@R3@2<0117@228;20@6323<@0: =><4363<@6U366;202-WXYZ83:;28;D3@3D7D6:4;@15023<20>R;2Z328<7220V3@R3@2< 0117@228;=<4363<@6?7>3@R28;B>0@6323<@0:[;>3<?366;202-\XYU]6;22<>;018-WXY L ^M _Q- ` - ^-^ aG
bPQKLM
NOP -c Q
^c` >023<20>R;2>0@R;<d-X\Y/-e\YUZ3283@Z831828;C<D=0@56;;V62<9;?7>3@R0@?0228; ;@?
g11<>?3@R2<28;:;22;>=79:368;?9528;C<DD3663<@;>U3@H12<9;>h-eUi8;>;3@0d2;>/28; j*++kjl0@3@67>0@1;1<D=0@5680::9;;@232:;?2362>3972;0?343?;@?<@:53dUd<::
B8;d<::Z3@R0;?020<@28;C<D=0@5o6;1<@<D316:4;@15023<U10:17:02;?Z328<7220V3@R 3@2<0117@228;20@6323<@0:=><4363<@60@?28;6:4;@15023<20>R;26;29528;C<D=0@5o6 p<0>?
!"#\$%!&'#"()*+', -./- WH@f;1;D9;>W\h-qU28;p<0>?
-c ^NPI >;1;34;?U0@?28;>;d<>;28;2>0@6d;>806@<25;29;;@D0?;AT@43;Z<d28;09<4;U<@H12<9;>heh\h\UB8;[8<;@3r OP
- ^P
vI\_ ==:3109:;2<28;2>0@6d;>Aw=<@>;1;3=2<d O ^L NP -c ^KNP IcQ ^^I PIx =><4363<@6

| As of December 31 | |||
|---|---|---|---|
| 2020** | 2019** | ||
| Audited* | |||
| In NIS thousand | |||
| Shareholders' equity for SCR (NIS thousand) Solvency capital requirement (SCR) (in NIS thousand) |
9,931,007 | 9,161,522 | |
| (1) | 8,557,405 | 8,896,554 | |
| Economic solvency ratio (in %) | 116% | 103% | |
| Effect of material capital-related measures taken in the period between the calculation date and the publication date of the solvency ratio report: Raising of equity instruments Shareholders equity for SCR |
9,931,007 | 220,000 9,381,522 |
|
| Surplus | 1,373,602 | 484,967 | |
| Economic solvency ratio (in %) | 116% | 105% | |
| Capital surplus after capital-related actions in relation to the Board of Directors' target: Minimum solvency target, net of the transitional provisions |
105% | 105% | |
| Capital surplus over target*** | 945,731 | 40,140 |
(*) "Audited" refers to an audit held in accordance International Standard on Assurance Engagement (ISAE) 3400 - "The Examination of Prospective Financial Information."
** The capital surplus includes 35% of the original difference attributed to the purchase of the activity of provident funds and management companies amounting to approximately NIS 15 million as of December 31 2020 and 2019. The difference is not recognized for dividend distribution purposes.
***The solvency ratio calculation as of December 31 2019 does not include the effect of retrospective application following a proactive policy change regarding LAT in life and health insurance.
(1) The above audited solvency ratio includes a NIS 200 million dividend distribution performed between the calculation date and report publication date. See Section E below.
During the first quarter of 2021, The Phoenix Insurance distributed a dividend in the amount of NIS 200 million, in accordance with the audited results as of December 31 2019, and in accordance with the results of an estimate to calculate the Solvency II-based economic solvency ratio as of December 31 2020 (hereinafter, the "Estimate"). For further details regarding the Estimate, please see the Company's immediate report dated March 25 2021.
According to the audited results as of December 31 2020, following the dividend distribution, as stated above, the economic solvency ratio of The Phoenix Insurance is 192%, and the economic solvency ratio net of the transitional provisions for the Transitional Period and without adjusting the stock scenario is 116%.
The results exceed the capital target set by the Board of Directors, which is 105% and meet the 150%-170% target range, in which the Company seeks to be during and after the Transitional Period, given the Deduction during the Transitional Period and its gradual reduction; thus, the Company exceeds the requirements of the letter published by the Commissioner in October 2017 reqarding restrictions on dividend distribution, as stated above.
In addition, on March 24 2021, the Board of Directors of The Phoenix Insurance approved taking under consideration the issuance of an Additional Tier 1 capital instrument in the amount of approximately NIS 400 million; the issuance shall have a positive effect on The Phoenix Insurance's solvency ratio. For further details, please see Section 1.3.13 below.
2.1.5. Changes in the linked shekel risk-free yield curve affect the Company's economic solvency ratio, especially in the mid- to long-terms, affect the Company's economic solvency ratio.
The following table summarizes the positive (negative) risk-free linked interest ("spot") rates:4
| Range/years | Dec. 31 2020 | Mar. 31 2021 | Mav 23 2021 | ||
|---|---|---|---|---|---|
| Short 1-3 term |
Between 0.13% and (0.85)% |
Between (1.28)% and (1.50)% |
Between (1.37)% and (1.73)% |
||
| 4-10 | Between (0.94)% and | Between (1.34)% and | Between (1.57)% and | ||
| Mid-term | (0.58)% | (0.50)% | (0.65)% | ||
| Mid-long | 11-15 | Between (0.49)% and | Between (0.39)% and | Between (0.51)% and | |
| term | (0.23)% | (0.12)% | (0.06)% | ||
| Long | 16-25 | Between (0.18)% and | Between (0.08)% and | Between 0.03% and | |
| term | 0.23% | 0.31% | 0.52% |
The Company performed a sensitivity analysis for a corresponding decrease of 50 basis points along the risk-free linked shekel interest rate curve. The effect of such a scenario on the economic solvency ratio is a 13% decrease in the solvency ratio, taking into account the transitional provisions and 8% and excluding a transitional provision or adjusting a stock scenario. This scenario reflects on equity, including the quantitative restrictions that apply to equity, on the economic solvency ratio and capital required for solvency purposes. The sensitivity test only reflects direct effects on the economic solvency ratio, holding all other factors fixed, and do not include effects derived from changes arising from other risk factors. It should be noted that the sensitivity is not necessarily linear; i.e., sensitivity at other rates is not necessarily a simple extrapolation of the sensitivity test presented.
The calculation of the solvency ratio is based, among other things, on forecasts, assessments, and estimates of future events, the materialization of which is uncertain and is not under the Company's control, and which should be considered as "forward-looking information" as the term is defined in Section 32A to the Securities Law, 1968.
4 The risk-free linked interest rate curves were taken from Fair Spread Ltd. To calculate the solvency ratio, the Company takes into account other components in addition to the risk-free interest rate. For more information, please see the Solvency Ratio Report published on October 28 2020 (Ref. No.: 2019-01-126082).
For further details regarding material regulatory provisions published during the reporting period, please see Section 4.1.1 to the 2020 Report on the Corporation's Business.
Following are drafts of material regulatory provisions published during the reporting period and thereafter, which are not included in the 2020 Report on the Corporation's Business. For further details regarding additional drafts of material regulatory provisions published during the reporting period, please see Section 4.1 to the 2020 Report on the Company's Business.
Following is a summary description of trends, events and developments in the Group's macroeconomic environment, that have or are expected to have an effect on the Group.
During the reporting period, another outbreak of the coronavirus pandemic took place in Israel. In response, a third lockdown was imposed, which included distancing regulations; the vaccination drive continued and turned out to be a very swift. The combination of the lockdown and vaccination drive resulted in a decline in morbidity rates, which allowed for a gradual reopening of the economy, most of which was completed towards late February. Growth figures for 2020 turned out to be a pleasant surprise, reflecting a contraction of a mere 2.5%; with exports - which continued to expand in 2020 - standing out. On the other hand, there was a prominent decrease of about 9% in private consumption. The Bank of Israel revised its 2021 growth forecast to 6.3%. In February, the unemployment rate in Israel was 4.6% (excluding furloughed employees), a low rate considering that the economy was under partial lockdown.

The positive economic data in Israel along with the fast vaccination pace and current account surplus supported a sharp appreciation of the shekel against world currencies until on January 14 2021, the Bank of Israel took the unusual step of announcing an expanded foreign currency purchase plan for 2021; this measure allowed yields to be traded in the negative territory, supporting the shekel's devaluation. In contrast to the short-term interest rates - which, as aforesaid, remained very low - long-term interest rates rose sharply, similarly to the global trend, mainly on the back of the rise in commodity prices. The inflation environment in Israel remained negative, dropping by an annualized 0% in February. However, inflation expectations for the coming year have soared to approximately 1.3%. In March, elections were held in Israel for the fourth consecutive time, with no clear winner, which further exacerbated the uncertainty.
The Tel Aviv 125 index was up 6.12% during the period; the shekel weakened against the US dollar by 3.9%; the 10-year shekel yield rose from 0.8% to 1.2%; and the real yield remained a relatively stable 0.8%.
The first growth estimate in the first quarter described a contraction in GDP at an annualized 6.5%, against the background of the third closure and the effect of a decrease in car imports (which were brought forward to the end of 2020 due to tax considerations). The indications subsequent to the balance sheet date describe an almost complete return to activity in most industries. The percentage of furloughed employees fell to 2.9% in the second half of April, with the unemployment rate up slightly from 4.7% to 5.0%. The Central Bureau of Statistics' growth projections for 2021 were slightly revised downwards to reflect a 2.3% contraction. The Bank of Israel estimates that in 2021, growth will reach 6.3%. In its monetary decision, the Bank of Israel left the interest rate unchanged; however, it explained that it had no intention of withdrawing from its bond purchase plan ahead of schedule, before its end date in the fall, and would even consider extending it if necessary. The Governor of the Bank of Israel added that it had patience in terms of allowing inflation to reach the target range. Following a state deficit of 12% during the coronavirus year, the Bank of Israel predicts an 8% deficit in 2021; in addition, it suggested that following the coronavirus period, the economy will reach a higher debt level of 80%. The Bank of Israel's foreign exchange reserves reached USD 200 billion. The inflation environment in Israel continued to rise, with the CPI up by 0.3% in April and 0.8% annually. Inflation expectations continued to soar, in line with the global trend, rising a sharp 1.9% - higher than the average 10-year inflation expectations, which were up 1.7% (in OTC trading). The rise in the inflation environment is mainly attributed to global factors, including higher prices for raw materials and transport costs. Since the elections, no new government has been formed in Israel. During May, Israel launched a military operation called "The Guardian of the Walls", which lasted 11 days; during the operation, rockets were fired into central Israel. However, the disruptions to economic activity were negligible and the capital market continued to operate relatively similar to the global trend.
The TA 125 index rose by 6.5% subsequent to the balance sheet date; the shekel strengthened against the US dollar by 2.6%; the nominal 10-year shekel yield rose from 1.1% to 1.2%; and the real yield was up to -0.6%.
The coronavirus pandemic continued around the world; but for the first time since the onset of the pandemic, the daily number of infections began to decline. More and more countries began to vaccinate their residents. In Europe, significant mobility restrictions continued. Recent data show that in 2020, GDP in the eurozone contracted by 6.2% and 3.5% in the U.S. The U.S. economy is more aggressively supported by fiscal accommodation measures; since the balance sheet date, the White House has delivered an additional aid package of USD 1.9 trillion. Chief procurement officer surveys also provided positive indications, with the US Chief Procurement Officer Survey soaring to 60.8 points - its highest level since 2004.
The global inflation environment recorded a marked increase - mainly on the back of the continued rise in commodity prices - with the CRB commodity price index up by a further 10.2%. The price of oil soared by 22%. Inflation expectations also rose sharply, with the 10-year US inflation expectations rising from 1.8% to 2.4%. Rising inflation expectations continued to push yields upwards worldwide, with 10-year ones in the US rising from 0.9% to 1.7% and in Germany - from -0.6% to -0.3%.
In equity markets, rotation continued between growth stocks - which lost momentum, and value stocks - which gained momentum.
The S&P 500 was up 5.8%, the EURO-STOXX 50 rose 10.3% and the MSCI EM was up 2.0%. The euro devalued by 4% against the US dollar, reaching a rate of approximately USD 1.17 per EUR 1.
In most Western countries, the coronavirus pandemic subsided, especially in the US, amid progress in the vaccination drive and restrictions, but recorded a sharp rise in multiple emerging economies, most prominently - in India. The International Monetary Fund updated its growth forecast for the global economy in 2021 from 5.5% to 6.0%. In the US, GDP data for the first quarter showed a 6.4% expansion, following President Biden's sizable fiscal plan - which totals USD 2.3 trillion for ten years, primarily for infrastructure projects, but was met by opposition from Republicans, and is expected to be cut down substantially. Global economic recovery is facing bottlenecks due to transportation and access to raw materials, which is reflected in a surprising drop in the US Chief Procurement Officer Survey in April, which fell to 60.7. Commodity prices rose sharply, with the CRB index rising a further 9% and oil adding another 7.5% to the WTI price, reaching USD 64. Inflation expectations soared worldwide, most prominently for the short term rather than for the long term. Inflation in the US (CPI) for April soared to an annual change of 4.2%. Central bank governors in Europe and the US have made it clear that they, too, regard the outbreak of inflation as an event with "temporary" indications and that they do not intend to deviate from their intention to leave the
[
[
j [

0123435246235789:84650;10:0<612=3408>8:20?3@A12B3CDEF8G34184H89377?6>302<73642B622B3 I3>B651823G31<8150>343>9B3198J7>K32B340;B220?328K3;01>05
TU V W- - T--T T X
Y-W 5881652B313Z2?33201;5E460501;<81<34152B6201:7620819077K3B0;B34847652781;342B61
LB3.\/O364O037>012B3CD>48==3>28.@]-^61>01F34?61O/485328/\@._^@LB3D`Ha\CD 528
The Group's operations are affected by constant changes in regulations and regulatory reforms that are executed gradually. The Group operates in a complex, changing reality in which it must prepare for such regulatory changes.
In addition, as the controlling shareholder of institutional entities, the Group must also deal with proposed changes in the minimum capital requirements that apply to its institutional entities, which impose, among other things, restrictions on dividend distribution by institutional entities.
The Group's operations and results are significantly affected by the capital markets, including, among other things, the low-interest environment that has implications for its insurance liabilities and on the returns embodied in the Group's financial asset portfolios, and consequently - on the management fees and financial margins from investments as well.

Assets under management as of March 31 2021 Premiums, gross, contributions towards benefits and proceeds
in respect of investment contracts for 1-3/2021

(**) Including the assets of the Halman Aldubi investment house and excluding the assets of the IEC and IPC (including the assets of the IEC and IPC in the amount of NIS 46 billion; total assets under management - NIS 310 billion).

The Phoenix Holdings Ltd.

Total assets under management by provident funds, excluding guaranteed return provident fund tracks, pension funds, ETFs, mutual funds, and customers' investment portfolios are not included in the Company's consolidated Financial Statements. Proceeds in respect of investment contracts are not included in premiums; rather, they are charged directly to liabilities in respect of insurance contracts and investment contracts.
For further details on the premiums in the various segments, please see Note 3 to the Financial Statements.

Following are key data from the consolidated balance sheets (in NIS billion):
Total financial assets in respect of yield-dependent contracts and cash equivalents in respect of yield-dependent contracts as of March 31 2021, amounted to approximately NIS 82.3 billion, compared to approximately NIS 64.5 billion as of March 31 2020 and NIS 78 billion as of December 31 2020.
Liabilities in respect of insurance contracts and yield-dependent investment contracts amounted to approximately NIS 81.3 billion as of March 31 2021, compared to approximately NIS 63.9 billion as of March 31 2020 and NIS 76.9 billion as of December 31 2020.

In the first quarter, investment including pre-tax other comprehensive income) amounted to approximately NIS 3,915 million, compared with a loss of approximately NIS 8,779 million in the first quarter last year. It should be noted that a significant portion of the said investment gains or losses was carried to participating policies and had no direct effect on the Company's results. The Company's results are mainly impacted by investment income from its nostro portfolio, as reflected in Sections 4.4.3-4.4.4 below.
P
P
1234567893:;<8358=34585>?8372@>587?A=72B?C568?CC<2<@5C5236559D585;>EF<>>8?G7C<35HF I1J-0-C7HH7?2B?C><85AD734345B?8859>?2A72@:;<8358H<93F5<8KL?93?634572B85<9579A;53? B?HH5B37?2?6M<87<EH5C<2<@5C52365596?HH?D72@3458<HH75972672<2B7<HC<8N53972198<5H<2A<8?;2A 345D?8HA7234567893:;<8358=34585>?8372@>587?A=72345
Q?83455665B39?2345859;H39334595@C523H5M5H=H5<95955A53<7H972J5B37?29RK./RK0SE5H?DKP

45;2A58D87372@5<8272@97245<H34729;8<2B5<2A72>8?>583F<2AB<9;<H3F729;8<2B5<99;C59<85<H853;82?6T<HH 85C<7272@72M593C52372B?C57972BH;A5A72B<>73<HC<8N535665B39KQ;83458C?85=72M593C52372B?C572H765729;8<2B579 >8595235A253?6F75HAB85A735A3?>?H7BF4?HA589KJ55J5B37?2RKRK0<E?M5KP
2A58D87372@5<8272@972H765729;8<2B572BH;A59M<87<EH5C<2<@5C5236559<B3;<HHFB?HH5B35A253?6<T85<H853;82 <99;C>37?2KP
P

| pqqhwtnmui2a a |
bcdefghijgklkmnmiogpkimioqmifgprnfmiqhkpisgpijmitkutgknvpijspqhprnvmiqhkpisgpqqhwgqpkgprkgnhkiuxyz{prr kgwpmimiomi gqnwginmisuwgmqmisrhjgjmisptmnprwpk}gngxxgsnq2~hknfgkwukgmi gqnwginmisuwgmirmxgmiqhkpisgmq tkgqgingjignuxvmgrjskgjmngjnuturmsvfurjgkq2€gg€gsnmui12120pu g2a bcd'ijgklkmnmiogpkimioqmirmxgmiqhkpisgmisrhjgq pkmprgwpipogwginxggqpsnhprrvsurrgsngjbignuxpyzkgprkgnhki |
|||
|---|---|---|---|---|
| 121212023ƒ!&&!"#"(#)K"K"K&O)#)!V+#"+P)+VVL+)K"'MK#""!"JPL\PP#"( | ||||
| VVL+)!"TPJ+K\$#")\PK"L&#KN#&#+#)#"+V#P)+[\KP+P!VYZYRL!MTKP' | ||||
| "#++L!PP)T!"'#"([\KP+P&K)+OKPQ#"]^_M#&&#!"S` | ||||
!"#\$%!&'#"()*+', -./0 efgkgqhrnqminfgxmkqnhpkngksuwtpkgjnunfgsukkgqtuijmiohpkngkrpqnvgpklgkgpxxgsngjv sfpiogqmivmgrjshk|gqsfpiogqminfg|prhguxiui/wpk}gnprgpqqgnqpijsfpiogqmipqqhwtnmuiq2 efgqgsfpiogqnkmoogkgjpimiskgpqgmimiqhkpisgrmpmrmnmgqpwuhinmionupttkumwpngrv1 wmrrmuiminfghpkngkb-wmrrmuixkuwnfggxxgsnquxnfgsptmnprwpk}gnpijpnunprux0y
a
12332456741859:7;72<25=:66:><?@>41AB7:9;2
| 12332456741859:7;72<25=:66:><?@>41AB7:9;2 |
||||
| O | IKIKPKQ R!&&!S#"(TU'T+TU(TU'#"(+V!WXT"YZ)U+[U"!"[#+Y] ^ |
_abcdc_e | _abcdcde |
_`_cbcdcde | |
| f:<87545?CB7:C439:7?g:J82 A:7249@hk@O |
0lK0mO | hn0K.m@O | 0NKPmO | |
| hk@f:<87545:J82 |
opq | O r st |
hk@f:<87545:J82
+UW)T#"()\* !XUT+#"()(W"+ IKPK0KQ R!&&!S#"(#)T"T"T&Y)#)!+WT#"+)T"'T"()!"+U)[&+)!+&# #")[UT"T"'&!"(+UW)T#"())[)(W"+!U+#U)+[TU+U!cdc_!WXTU'+! +!UU)X!"'#"([TU+U&T)+YTU#"W#&&#!"]
!"#\$%!&'#"()*+', -./0 B7525=?4525j:?<1:5<45
against insurance and contingent claims reserves. It should be noted that a significant portion of the investment income was carried to participating policies and has no direct effect on the Company's results.

(*) Investment income is net of yields credited to policyholders. Please see Section 4.4.1.2
Compared with the corresponding quarter last year, the results in the first quarter were mainly affected, by the increase in income from nostro investments and an increase in underwriting earnings. Most of the increase in underwriting earnings arose from management fee income due to collection of variable management fees in the amount of NIS 199 million; this resulted from the rallies in financial markets in Israel and around the world, which brought about a year-on-year increase in the value of planholders' portfolios in The Phoenix Insurance, compared with no such collections in the same period last year - as a result of declines in financial markets in Israel and around the world following the spread of the corresponding quarter last year.
In addition, results in the first quarter improved due to changes in the risk-free interest rate curve and changes in the K factor, compared to last year, as reflected in the above chart.
For further details, please see Note 8 to the Financial Statements. For further details regarding sensitivity of the insurance liabilities to a change in the interest rates, please see Note 40 to the Annual Financial Statements.
4.5.4. The rate of redemptions out of the average reserve (in annual terms) was approximately 3.6% compared with 3.0% in the corresponding period last year. It should be noted that the general state

of the economy, transition from product to product, employment rates, the coronavirus crisis, employees' wages, and market competition all affect this rate.
Following are details concerning estimated net investment earnings attributed to policyholders of participating policies and management fees calculated according to the Insurance Commissioner's guidelines, based on insurance reserve balances and returns:
| 1-3/2021 | 1-3/2020 | 1-12/2020 | |
|---|---|---|---|
| In NIS million | |||
| Investment qains (losses) credited to policyholders net of management fees(*) |
2,845 | (7,351) | 3,333 |
| Management fees | 324 | 111 | 740 |
(*) Excluding investment income (losses) credited (debited) to policyholders in the health insurance segment.
Following are the nominal returns on participating policies issued from 1992 to 2003:
| Policies issued up to 2004 (Fund J) | ||||
|---|---|---|---|---|
| 1-3/2021 | 1-3/2020 | 1-12/2020 | ||
| Nominal returns before payment of management fees Nominal returns after payment of |
4.33% | (11.15%) | 6.61% | |
| management fees Real returns before payment of |
3.55% | (11.30%) | 4.99% | |
| management fees Real returns after payment of |
4.23% | (10.71%) | 7.25% | |
| management fees | 3.45% | (10.86%) | 5.61% |
Fluctuations in these returns are a function of capital market returns in Israel and abroad, changes in the consumer price index, and changes in the exchange rate of the shekel against major currencies.
Set forth below are the nominal returns on participating policies is ued from 2004 and thereafter:
| Policies issued from 2004 and thereafter | ||||||
|---|---|---|---|---|---|---|
| 1-3/2021 | 1-3/2020 | 1-12/2020 | ||||
| Nominal returns before payment of | ||||||
| management fees | 4.19% | (11.42%) | 7.03% | |||
| Nominal returns after payment of management fees |
3.93% | (11.65%) | 5.97% | |||
| Real returns before payment of | ||||||
| management fees | 4.09% | (10.98%) | 7.67% | |||
| Real returns after payment of management fees |
3.83% | (11.21%) | 6.61% |
The Group manages provident and advanced education funds through The Phoenix Excellence, a wholly owned subsidiary of The Phoenix Insurance, which manages benefits and severance pay funds, advanced education funds, a central benefits and severance pay fund, a yield-guaranteed provident fund, an investment provident fund, a child long-term investment provident fund for savings, a self-directed benefits provident fund, and a personally managed advanced education fund.
For further details on the decision passed by The Phoenix Insurance's Board of Directors regarding the transfer of the shares of Phoenix Excellence Pension and Provident Funds Ltd. by way of a dividend in kind to the Company in the reporting year, please see Section 1.3.6 above.
As part of the implementation of its strategy and its wish to expand its asset management activities, in provident and pension funds activities in particular, on February 28 2021, the merger transaction - under which the Company acquired Halman-Aldubi - was completed. For further details, please see Section 1.3.7 below.
The pre-tax comprehensive income in the first quarter of 2021 amounted to approximately NIS 12 million compared to approximately NIS 7 million in the same period last year.
The increase in profit is mainly due to the increase in capital market yields, which affected both the margin in guaranteed return provident funds and in the investment income from the management company's nostro portfolio. The effect is NIS 15 million in investment income compared with last year, which was partially offset by the increase in general and administrative expenses and in marketing and purchase expenses.
For key data as to the financial results of the provident funds subsegment, please see Note 3 to the Financial Statements.


(*) Including the assets of the Halman Aldubi investment house (excluding the assets of the IEC and IPC provident funds in the amount of NIS 46 billion).
Based on Ministry of Finance data, 5 aggregate contributions towards benefits in the provident funds subsegment in the first quarter totaled approximately NIS 13,564 million, compared to a total of approximately NIS 11,309 million in the same quarter last year, reflecting an increase of approximately 19.9%. According to the Ministry of Finance data, as of March 31 2021, total assets under management in the provident funds subsegment amounted to approximately NIS 608 billion, compared to approximately NIS 483 billion as of March 31 2020, an increase of approximately 25.8%, which stems mainly from positive net accumulation in the provident funds subsegment.
The Group's pension subsegment is conducted through the Phoenix Excellence, a wholly-owned subsidiary of The Phoenix Insurance.
For further details on the merger of the management companies of the provident funds, advanced education funds, and pension funds, and on the decision passed by The Phoenix Insurance's Board of Directors regarding the distribution of the shares of Phoenix Excellence Pension and Provident Funds Ltd. as dividend in kind to the Company in 2020, please see Section 1.3.6 above.
As part of the implementation of its strategy and its wish to expand its asset management activities in general and its pension funds activities in particular, on February 28 2021, the merger transaction - under which the Company acquired Halman-Aldubi - was completed. For further details, please see Section 1.3.7 below.
5 Based on Gemel Net data.
12345678988:929;5<=>8>?=8@35:A@9:2<9;5B5>:=2>:AC:5DE5>9FB@58:5:55G295-929;51=>8>?=8@ H9895E5>9:IJ
K;5B35/98LB32<=9=>M0.N.08E2A>[email protected]=@@=2>?2EB8357928B35/98L@2:: 28BB32L=E895@6GOH-E=@@=2=>9;5:8E5B53=27@8:96583IK;5=>?358:5=>B32<=9832:5E8=>@6<32E 8>=>?358:5=>9;5359A3>:=>9;5?8B=98@E83459FP;=?;8<<5?9579;5>2:932=>Q5:9E5>9=>?2E52<9;5 E8>8D5E5>9?2EB8>6?2EB835792@8:96583F=>9;58E2A>92GOHRE=@@=2IJ TU&!VW"+)#"X!"+Y#Z[+#!")+!]Y')Z"^#+)]"'+!+]&]))+)["'YW]"](W"+_S `!"+Y#Z[+#!")+!]Y')Z"^#+)a#" bcdW#&&#!"e f))+)["'YW]"](W"+a#"bcd W#&&#!"e S

hijO>?@A7=>D9;58::59:29;5k8@E8l@7AC==>Q5:9E5>9;2A:5IJ
J m8:572>n=>=:9362<1=>8>?57898Fo8DD35D895?2>93=CA9=2>:92P837:C5>5<=9:=>9;5>5P ?2EB35;5>:=Q5B5>:=2>7::AC:5DE5>9=>9;5<=3:9pA839539298@578BB32L=E895@6GOH00F-qo E=@@=2>F?2EB83579289298@28BB32L=E895@6GOH00FNrsE=@@=2=>9;5:8E5B53=27@8:96583F 35<@5?9=>D8>=>?358:52<[email protected]
l??237=>D92n=>=:9362<1=>8>?57898F8:2n83?;-0.N.0F9298@8::59:A753E8>8D5E5>9=>9;5 >5P?2EB35;5>:=Q5B5>:=2>7::AC:5DE5>98E2A>9579289298@2<8BB32L=E895@6GOHRq- C=@@=2>F?2EB8357928BB32L=E895@6GOH-r-C=@@=2>2>n83?;-0.N.NF8>=>?358:52<8BB32L=E895@6 -.I0tI
S
v83>=>D:2>=>Q5:9E5>9:8<<5?9:9;5B32<=98C=@=962<9;=::5DE5>9F:2E52
D/953E?835=>:A38>?5j835?;838?953=w57C68??3A8@2<:=D>=<=?8>935:53Q5:2Q53@2>DB53=27:I O>Q5:9E5>9583>=>D:8358<<5?957C6?8B=98@E83459<@A?9A89=2>:F8:P5@@8:?;8>D5:=>=>9535:93895: 8>79;538952<?;8>D5=>9;5O:385@=?2>:AE53B3=?5=>75LFP;=?;8<5?99;56=5@7:2E834598C@5 <=>8>?=8@8::59B2392@=2:;5@78D8=:9=>:A38>?58>7?2>9=>D5>9?@8=E:35:53Q5:IJ
J
!"#\$%!&'#"()*+', -./0 om8:572>x5>:=2>G597898I
SPWYV\Zab\PYZPZPPcPdWV]R0101/1/eP]U1J

KLMNOPQRSPTUTVWVRXPYTRVRXZYZZQ[PYTPY\TYWP]^TPWQTR]^-_1]T^QTWOPTSPWYV\Zab\PYZPZPPcPdWV]R0101/1/eP\]U1J KLLMfRd\QSVRXY\\dOYRXPZVRVRWPTPZWTYWPYRSPgdPZZhY\QP]^R]R.[YTiPWYe\PYZZPWZVRjkN]R\l1]T^QTWOPTSPWYV\Z]R dOYRXPZSQPW]dOYRXPZVRYZZQ[bWV]RZYRS]WOPTdOYRXPZab\PYZPZPPm]WPnW]WOPVRYRdVY\cWYWP[PRWZ1J KLLLMfRhPZW[PRWVRd][PVRd\QSPZVRd][P^T][VRhPZW[PRWZUVWOYTPY\TPWQTR]^[]TP]T\PZZWOYR-\_1]T^QTWOPT
o][bYTPSUVWOWOPd]TTPZb]RSVRXpQYTWPT\YZWlPYTaWOPTPZQ\WZ]^WOP^VTZWpQYTWPTUPTP b]ZVWVhP\lY^^PdWPSelWOPVRdTPYZPVRR]ZWT]VRhPZW[PRWVRd][PYRSeldOYRXPZVRWOPVRWPTPZW TYWPdQThPaUOVdOVRdTPYZPSWOPjkNTPZPThPelmfcq0[V\V]Rd][bYTPSUVWOYmfcrs[V\V]R VRdTPYZPVRWOPZY[PbPTV]S\YZWlPYT1tRWOP]WOPTOYRSaWOPmfcquv[V\V]RSPdTPYZPVRWOP QRSPTUTVWVRXPYTRVRXZUYZ[YVR\lSQPW]YSPdTPYZPVRWOPjkNTPZPThPVRWOPd]TTPZb]RSVRX pQYTWPT\YZWlPYTYZYTPZQ\W]^QbSYWVRXYdWQYTVY\YZZQ[bWV]RZYRS]WOPTP^^PdWZW]WY\VRXmfc /0q[V\V]RwWOPSPdTPYZPUYZSQPW]]^^ZPWWVRXa\YZWlPYTYZUP\aWOPTPZPThPVRTPZbPdW]^WOP bT]^VWP[e]SVPSVRWOPbTPZPRWhY\QP]^WOPdQTTPRW^PPZYRSd][[VZZV]RZ^]TYXPRdVPZ]URPS elWOPo][bYRlVRWOPY[]QRW]^YbbT]gV[YWP\lmfc0r[V\V]R1xVWOWOPPgdPbWV]R]^ZYVS P^^PdWaWOPSPd\VRPVRWOPQRSPTUTVWVRXTPZQ\WZVRWOP^VTZWpQYTWPTd][bYTPSW]WOPd]TTPZb]RSVRX pQYTWPT\YZWlPYTVZ[YVR\lSQPW]YRY[]ZWd][b\PWPOY\W]^WOP^]TPVXRWTYhP\VRZQTYRdPYdWVhVWl1 ]T^QTWOPTSPWYV\Zab\PYZPZPPm]WPnW]WOPVRYRdVY\cWYWP[PRWZ1yJ
!"#\$%!&'#"()*+', --./ fWZO]Q\SePR]WPSWOYWYWWOVZZWYXPaWOPo][bYRlOYZdPYZPSW][YTiPW]RX.WPT[dYTP VRZQTYRdPb]\VdVPZVRhVPU]^WOPXQYTYRWPPSTPWQTRVR]RX.WPT[dYTPVRZQTYRdPb\YRZaYRSWOP d][b\PgVWl]^WOPTP\YWPSTPVRZQTYRdPVRWOVZYTPY1
J
J
J


KLMNOPQRSPTUTVWVRXPYTRVRXZYZZQ[PYTPY\TYWP]^TPWQTR]^-_1`RaPZW[PRWVRb][PVRb\QSPZVRb][P^T][VRaPZW[PRWZUVWO YTPY\TPWQTR]^[]TP]T\PZZWOYR-_1c]T^QTWOPTSPWYV\Zde\PYZPZPPfPbWV]R.1.1010gP]U1J
NOPVRbTPYZPVRVRaPZW[PRWVRb][PVRWOP^VTZWhQYTWPTUYZSQPW]WOPTY\iVR^VRYRbVY[YTjPWZVR `ZTYP\YRSYT]QRSWOPU]T\Sb][eYTPSUVWOWOPSPb\VRPWOPTPVRVRWOPb]TTPZe]RSVRXhQYTWPT\YZW iPYTd[YVR\i]RWOPgYbj]^WOPZeTPYS]^WOPb]T]RYaVTQZ1J
NOPVRbTPYZPVRQRSPTUTVWVRXPYTRVRXZVRWOP^VTZWhQYTWPTb][eYTPSW]WOPb]TTPZe]RSVRXhQYTWPT\YZW iPYTVZSQPW]WOPSPbTPYZP]^WOPVRZQTYRbP\VYgV\VWVPZ^]TeTPaV]QZiPYTZ[YVR\iSQPW]WOPP^^PbW]^ UPYWOPTSY[YXPYRS]ZZPZVRWOP^\VXOWbYRbP\YWV]RZQgZPX[PRW^]\]UVRXWOPZeTPYS]^WOP b]T]RYaVTQZSQTVRXWOPZY[PePTV]S\YZWiPYT1J
k
J


4.7.3. Following are explanations for the pre-tax underwriting earnings in the various subsegments of property and casualty insurance for the first quarter of 2021 compared with the corresponding quarter last year (in NIS million):

The decrease in underwriting earnings in the compulsory motor insurance subsegment in the first quarter compared with the first quarter of last year is due to moderation in the release of insurance liabilities in respect of previous years and from a decrease in the reinsurance liabilities.
The increase in underwriting earnings in the motor property subsegment in the first quarter compared with the first quarter of last year is due to a decrease in the insurance liabilities in respect of previous years.
The increase in underwriting earnings in the property and other subsegment stems mainly from the impact of weather damage in the same quarter last year, mostly on the business subsegment and the effect of the flight cancellation subsegment following the spread of the coronavirus.

| Motor property | |||||||
|---|---|---|---|---|---|---|---|
| In NIS million | |||||||
| 1-3/2021 | 1-3/2020 | 1-12/2020 | |||||
| Gross loss ratio | 64.9% | 71.7% | 66.9% | ||||
| Retention loss ratio | 64.8% | 71.7% | 66.9% | ||||
| Gross combined ratio | 89.5% | 99.2% | 96.4% | ||||
| Retention combined ratio | 89.4% | 99.2% | 96.4% |
| Property and other subsegments | |||||||
|---|---|---|---|---|---|---|---|
| In NIS million | |||||||
| 1-3/2021 | 1-3/2020 | 1-12/2020 | |||||
| Gross loss ratio | 29.2% | 58.7% | 40.7% | ||||
| Retention loss ratio | 19.9% | 63.2% | 37.8% | ||||
| Gross combined ratio | 53.4% | 83.9% | 68.9% | ||||
| Retention combined ratio | 45.3% | 91.3% | 76.4% |
Most of the segment's activities are carried out through Excellence.

The decrease in earnings in the first quarter compared with the corresponding quarter last year stemmed mainly from the Company's recognition of a one-off earning of NIS 15 million in the market-making activity in the corresponding quarter last year. The increase in expenses is due to an increase in assets under management of the retail brokerage portfolio.
Following is an analysis of the main effects and changes on the results of the insurance agencies segment for the first quarter of 2021 compared to the corresponding quarter last year (in NIS million):

Most of the increase in profit is due to an increase in income from growth and an increase of NIS 29 million in sales and NIS 9 million from investment income.

In the first quarter, loss amounted to approximately NIS 25 million compared with a loss of approximately NIS 532 million in the corresponding quarter last year. This said change stems primarily from substantial losses in the capital market in the corresponding quarter last year due to the coronavirus crisis.
The consolidated cash flows from operating activities in the reporting period amounted to approximately NIS 1,382 million. The consolidated cash flows used for investing activities in the reporting period amounted to NIS 399 million and mainly included a total of NIS 51 million used for software development and purchase, a total of NIS 12 million used to purchase property, plan and equipment, and a total of NIS 337 million used to acquire companies consolidated for the first time. The consolidated cash flow provided by financing activities in the reporting period amounted to approximately NIS 419 million; the cash flows included, among other things, a total of NIS 348 million arising from the issuance of a financial liability, a total of NIS 70 million used to repay financial liabilities, and a total of NIS 117 million used to assume financial liabilities.
The Group's cash and cash-equivalent balances increased from a total of approximately NIS 12,010 million at the beginning of the reporting period to approximately NIS 13,412 million at the end of the reporting year.
During the reporting period, there were no material changes in exposure to market risks and management methods thereof in relation that which is described in the 2020 Periodic Report, except as follows:
In February 2021, the Company expanded Bonds (Series 5) by 222,616 thousand bonds of NIS 1 p.v. each, for a total of NIS 222,616 thousand. The bonds (principal and interest) are linked to the CPI, and carry a linked annual interest, as stated, of 0.44%, payable in two semi-annual installments, in April and October of each calendar year from 2021 to 2030. Following the expansion, there has been a change in the exposure to linked interest rates in relation to the data as of December 31 2020.
The following table summarizes the results of the sensitivity tests to the linked interest rate on comprehensive income before tax, as of March 31 2021. The results are presented in NIS million, and do not include The Phoenix Insurance:
| Profit (loss) from changes in the risk factor |
Profit (loss) from changes in the risk factor |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Type of instrument |
Absolute increase of 2% |
10% increas e |
50/0 increas e |
Fair value |
5% decreas e |
10% decreas e |
Absolute decrease of 20/0 |
||
| Government bonds |
37.8 | ||||||||
| Corporate bonds |
(1.8) | (0.1) | 31.9 | 0.1 | 2.0 | ||||
| Capital note to the insurance |
(49.1) | (1.6) | (0.8) | 420.8 | 0.8 | 1.6 | 58.0 | ||
| company Total assets |
(50.9) | (1.7) | (0.9) | 490.4 | 0.9 | 1.7 | 60.0 | ||
| The Phoenix bonds(*) |
75.6 | 3.2 | 1.6 | (810.3) | (1.6) | (3.2) | (87.7) | ||
| Total liabilities |
75.6 | 3.2 | 1.6 | (810.3) | (1.6) | (3.2) | (87.7) | ||
| Total | 24.7 | 1.4 | 0.7 | (319.9) | (0.7) | (1.4) | (27.7) |
(*) The value of The Phoenix's bonds under the model is 3.18% lower than their market value (836.8).
In February 2021, the Company expanded Bonds (Series 4) by 127,384 thousand bonds of NIS 1 p.v. each, for a total of NIS 127,384 thousand. The bonds (principal and interest) are not linked to the CPI, and carry a non-linked annual interest, as stated, of 1.38%, payable in four quarterly installments, in January, April, July and October of each calendar year from 2021 to 2028. Following the expansion, there has been a change in the exposure to non-linked shekel interest rates in relation to the data as of December 31 2020.
The following table summarizes the results of the sensitivity tests to the non-linked shekel interest rate on comprehensive income before tax, as of March 31 2021. The results are presented in NIS million, and do not include the insurance company:

| Profit (loss) from changes in the | risk factor | Profit (loss) from changes in the risk factor |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Type of instrument |
Absolute increase of 20/0 |
10% increas e |
5% increas e |
Fair value |
5% decreas e |
10% decreas e |
Absolute decrease of 20/0 |
||
| Government honds |
(0.2) | 4.5 | 0.2 | ||||||
| Corporate honds |
1.5 | 0.1 | |||||||
| Capital note to the insurance company |
(26.7) | (1.2) | (0.6) | 238.6 | 0.6 | 1.2 | 31.7 | ||
| Total assets | (26.9) | (1.2) | (0.6) | 244.5 | 0.6 | 1.2 | 31.9 | ||
| The Phoenix bonds(*) |
19.9 | 0.5 | 0.2 | (668.6) | (0.2) | (0.5) | (22.1) | ||
| Total liabilities |
19.9 | 0.5 | 0.2 | (668.6) | (0.2) | (0.5) | (22.1) | ||
| Total | (7.1) | (0.7) | (0.4) | (424.1) | 0.4 | 0.7 | 9.8 |
(*)
Fair value: Fair value was calculated using the discounted cash flow model, using the appropriate interest rate for the cash flow period. The discount rate was calculated based on the market interest rate for the cash flow period, plus the risk premium derived from the security's rating. Market interest rate data was taken from the Reuters' database, that feeds The Phoenix's risk management system, and risk premium data (credit spreads) were taken from Fair Spread.
Scenarios: Daily historical changes in the past ten years were tested for each of the relevant risk factors (such as exchange rates and shares). The maximum and minimum daily changes were calculated for each risk factor, excluding interest rate risk, for which the calculation was based on a 2% absolute increase/decrease during a single day. This scenario was selected after a study of the yield curve database found that in the past 10 years, no absolute change exceeding 2% was observed in any single day. These changes served as scenarios for potential changes in each of the risk factors. Scenario outcomes were calculated at the single asset level, so as to avoid distorting results by aggregating different instruments.
1-41
| NIS | No n- net mo |
ET Ns - lin kag e t |
i ins Isr ael ura nce |
||||
|---|---|---|---|---|---|---|---|
| No n-l ink ed |
CP I-li nke d |
cu rre ncy |
ary item s |
o var iou s |
co mp any |
To tal |
|
| Inta ible As set ng s |
- | - | - | 1, 300 040 , |
- | 998 579 , |
2, 298 619 , |
| De fer red tax set as s |
- | - | - | 57, 245 |
- | - | 57, 245 |
| De fer red isit ion sts ac qu co |
- | - | - | - | - | 1, 819 463 , |
1, 819 463 , |
| Pro ty, lan t & uip nt per p eq me |
- | - | - | 197 283 |
- | 719 468 |
916 751 |
| Inv in inv est nts est me ees |
81, 728 |
15, 651 |
6, 170 |
, 144 725 |
- | , 522 836 |
, 771 110 |
| Inv in t of ield -de den est nt p erty t co ntra cts me rop res pec y pen |
- | - | - | , - |
- | , 1, 853 064 |
, 1, 853 064 |
| Inv the est nt p erty me rop - o r |
- | - | - | - | - | , 2, 721 934 |
, 2, 721 934 |
| Re ins set ura nce as s |
- | - | - | - | - | , 2, 650 209 |
, 2, 650 209 |
| Cre for of s dit cha ritie pur se ecu s |
399 000 |
- | 53, 000 |
- | - | , - |
, 452 000 |
| Cu nt t ets rre ax ass |
, - |
17, 148 |
- | - | - | 9, 749 |
, 26, 897 |
| Re cei vab les d d ebi t ba lan an ces |
140 467 |
- | 3, 371 |
- | - | 408 464 |
552 302 |
| Pre miu llec tibl ms co e |
, - |
- | - | - | - | , 739 902 |
, 739 902 |
| He ld-f sal f d isp l gr ts o or- e a sse osa oup |
- | - | - | 44, 473 |
- | , - |
, 44, 473 |
| t of Fin ial inv est nts in ield -de den t co ntra cts anc me res pec pen y |
- | - | - | - | - | 69, 130 062 |
69, 130 062 |
| Fin ial inv fo r ho lde f bo nds ET Ns hor t E TN est nts anc me rs o , s s, |
, | , | |||||
| , ite ET Ns dep osi rtifi and d b ond t ce cat str uct com pos es ure s |
- | - | - | - | 23 1, 000 |
- | 23 1, 000 |
| , Ma rke tab le d ebt set as s |
31, 443 |
68, 830 |
385 | - | - | 7, 390 646 |
7, 49 1, 305 |
| No ark ble de bt a eta ts n-m sse |
612 892 |
196 307 |
- | - | - | , 13, 524 006 |
14, 333 205 |
| Sh are s |
, - |
, - |
- | 61, 228 |
- | , 2, 056 370 |
, 2, 117 598 |
| Oth er |
29, 267 |
- | 817 | 14, 396 |
- | , 3, 490 678 |
, 3, 535 158 |
| En ber ed h a nd h e iva len ts f hol der f bo nds cum cas cas qu or s o |
, | , | |||||
| , han ded fu nds hor cha ded fu nds osi tra t ex tra te exc ge- , s nge , co mp |
|||||||
| han ded fu nds dep osi rtifi and d b ond tra t ce cat str uct exc ge- es ure s |
|||||||
| , | - | - | - | - | - | - | - |
| Ca sh and sh iva len ts i f y ield -de den ct o t co ntra cts ca equ n re spe pen |
|||||||
| - | - | - | - | - | 11, 162 653 |
11, 162 653 |
|
| Oth ash d c ash uiv ale nts er c an eq |
374 449 |
- | 32, 585 |
- | - | , 1, 842 320 |
, 2, 249 354 |
| , | , | , | |||||
| To tal ets ass |
1, 669 246 , |
297 936 , |
96, 329 |
1, 819 390 , |
231 000 , |
121 040 403 , , |
125 154 304 , , |
| Lia bilit ies in t of ins d n ield ntra cts res pec ura nce co an on- y |
|||||||
| dep end inv ent est nt c ont ts me rac |
- | - | - | - | - | 23, 904 976 , |
23, 904 976 , |
| t of Lia bilit ies in ins ntra cts d y ield -de den t res pec ura nce co an pen |
|||||||
| inv est nt c ont ts me rac |
- | - | - | - | - | 81, 296 403 , |
81, 296 403 , |
| Lia bilit ies in t of de fer red tax res pec es |
- | - | - | 22, 311 |
- | 912 100 , |
934 41 1 , |
| Lia bilit for loy ben efit et y em p ee s, n |
22, 526 |
- | - | - | - | 54, 130 |
76, 656 |
| Lia bilit in r of ect t ta y esp cur ren xes |
- | 18, 688 |
- | - | - | 51, 916 |
70, 604 |
| Pay abl and dit bal es cre anc es |
489 240 |
300 | 2, 541 |
- | - | 2, 323 096 |
2, 815 177 |
| Lia bilit ies fo r bo nds ET Ns hor t E TN ite ET Ns and , s s, c om pos |
, | , | , | ||||
| , red bo nds stru ctu |
- | - | - | - | 228 000 |
- | 228 000 |
| Fin ial liab ilitie anc s |
1, 457 362 |
1, 118 319 |
59, 000 |
- | , - |
5, 113 299 |
, 7, 747 980 |
| Lia bilit ies cla ssi fied he ld f ale as or s |
, - |
, - |
- | 10, 458 |
- | , - |
, 10, 458 |
| liab ilit ies To tal To tal |
1, 969 128 , 299 882 |
1, 137 307 , 839 370 |
61, 541 787 |
32, 769 786 621 |
228 000 , 000 |
113 655 920 , , 384 483 |
117 084 665 , , 069 639 |
| exp os ure |
( ) , |
( ) , |
34, | 1, , |
3, | 7, , |
8, , |
| NIS | rei Fo |
No n- |
ET Ns |
i ins Isr ael |
|||
|---|---|---|---|---|---|---|---|
| gn cu rre |
net mo ary |
- lin kag e t |
ura nce |
||||
| No n-l ink ed |
CP I-li nke d |
ncy | item s |
o var iou s |
co mp any |
To tal |
|
| Inta ible As set |
- | - | - | 818 111 |
- | 977 930 |
1, 796 041 |
| ng s De fer red tax set as s |
- | - | - | , 28, 870 |
- | , - |
, 28, 870 |
| De fer red isit ion sts ac co |
768 459 |
768 459 |
|||||
| qu Pro lan t & |
- | - | - | - | - | 1, , |
1, , |
| uip ty, nt per p eq me |
- | - | - | 138 868 , |
- | 635 493 , |
774 361 , |
| Inv in inv est nts est me ees |
72, 478 |
15, 200 |
6, 170 |
150 145 , |
- | 49 1, 738 |
735 731 , |
| Inv in t of ield -de den est nt p erty t co ntra cts me rop res pec y pen |
- | - | - | - | - | 1, 631 541 , |
1, 631 541 , |
| Inv est nt p erty the me rop - o r |
- | - | - | - | - | 2, 613 378 , |
2, 613 378 , |
| Re ins set ura nce as s |
- | - | - | - | - | 2, 475 063 , |
2, 475 063 , |
| Cre dit for cha of s ritie pur se ecu s |
255 500 , |
- | 8, 500 |
- | - | - | 264 000 , |
| Cu nt t ets rre ax ass |
- | 11, 051 |
- | - | - | 150 235 , |
161 286 , |
| Re cei vab les d d ebi t ba lan an ces |
219 774 , |
- | - | - | - | 405 538 , |
625 312 , |
| Pre miu llec tibl ms co e |
- | - | - | - | - | 823 372 , |
823 372 , |
| Fin ial inv in t of ield -de den est nts t co ntra cts anc me res pec y pen |
- | - | - | - | - | 55, 157 099 , |
55, 157 099 , |
| Fin ial inv fo r ho lde f bo nds ET Ns hor t E TN est nts anc me rs o , s s, , |
|||||||
| ite ET Ns dep osi rtifi and d b ond t ce cat str uct com pos es ure s , |
- | - | - | - | 275 000 , |
- | 275 000 , |
| Ma rke tab le d ebt set as s |
16, 278 |
46, 205 |
87 | - | - | 458 764 7, , |
521 334 7, , |
| No ark eta ble de bt a ts n-m sse |
126 670 , |
138 816 , |
26, 000 |
- | - | 13, 213 841 , |
13, 505 327 , |
| Sh are s |
- | - | - | 51, 253 |
- | 1, 384 578 , |
1, 435 831 , |
| Oth er |
- | - | 15, 530 |
- | - | 2, 468 472 , |
2, 484 002 , |
| En ber ed h a nd h e iva len ts f hol der f bo nds cum cas cas qu or s o , |
|||||||
| fu fu han tra ded nds hor t ex cha tra ded nds osi te exc ge- , s nge , co mp |
|||||||
| han tra ded fu nds dep osi t ce rtifi cat and str uct d b ond exc ge- es ure s , |
|||||||
| - | - | - | - | - | - | - | |
| Ca sh and sh iva len ts i f y ield -de den ct o t co ntra cts ca equ n re spe pen |
|||||||
| - | - | - | - | - | 512 737 7, , |
512 737 7, , |
|
| Oth ash d c ash uiv ale nts er c an eq |
490 172 , |
- | 4, 000 |
- | - | 1, 209 087 , |
1, 703 259 , |
| To tal ets ass |
1, 187 042 , |
211 272 , |
54, 117 |
1, 187 247 , |
275 000 , |
100 377 325 , , |
103 292 003 , , |
| t of Lia bilit ies in ins ntra cts d n ield res pec ura nce co an on- y |
|||||||
| dep end inv ent est nt c ont ts me rac |
- | - | - | - | - | 23, 311 893 , |
23, 311 893 , |
| Lia bilit ies in t of ins d y ield -de den ntra cts t res pec ura nce co an pen |
|||||||
| inv est nt c ont ts me rac |
- | - | - | - | - | 63, 930 828 , |
63, 930 828 , |
| Lia bilit ies in t of de fer red tax res pec es |
- | - | - | 6, 043 |
389 742 , |
395 785 , |
|
| for efit Lia bilit loy ben et em p ee s, n y |
13, 504 |
- | - | - | - | 43, 265 |
56, 769 |
| Lia bilit in r of ect t ta y esp cur ren xes |
- | 10, 273 |
- | - | - | 10, 480 |
20, 753 |
| Pay abl and dit bal es cre anc es |
228 21 1 |
- | - | - | - | 2, 002 397 |
2, 230 608 |
| Lia bilit ies fo r bo nds ET Ns hor t E TN ite ET Ns and , s s, c om pos |
, | , | , | ||||
| , red bo nds stru ctu |
- | - | - | - | 272 000 |
- | 272 000 |
| Fin ial liab ilitie anc s |
989 604 |
587 804 |
21, 093 |
- | , - |
5, 298 894 |
, 6, 897 395 |
| Pro vis ion fo fo isit ion of inv ent est r pa ym r ac qu an ee |
, - |
, - |
- | - | , - |
, - |
|
| To tal liab ilit ies |
1, 231 319 , |
598 077 , |
21, 093 |
6, 043 |
272 000 , |
94, 987 499 , |
97, 116 031 , |
(44,277) (386,805) 33,024 1,181,204 3,000 6,175,972
5,389,826 6. Linkage base reports
1-42
Total exposure
1-43
| NIS | Fo rei gn cu rre ncy |
No n- net mo ary |
ET Ns - lin kag e t o va |
li ins Isr ae e co ura nc |
|||
|---|---|---|---|---|---|---|---|
| No n-l ink ed |
CP I-li nk ed |
ite ms |
rio us |
mp an y |
To tal |
||
| Inta ible As set ng s |
- | - | - | 1, 013 232 , |
- | 1, 003 43 6 , |
2, 016 668 , |
| De fer red ta ts x a sse |
- | - | - | 104 55 , |
- | - | 104 55 , |
| De fer red isit ion sts ac qu co |
- | - | - | - | - | 1, 712 630 |
1, 712 630 |
| Pro rty lan t & uip nt pe , p eq me |
- | - | - | 138 924 |
- | , 722 94 1 |
, 86 1, 865 |
| Inv in inv est nts est me ees |
81 32 0 |
31 9 |
170 | , 150 933 |
, 503 127 |
756 86 9 |
|
| of Inv est nt in r ect ield -de nde nt c ont ts |
, - |
15, - |
6, - |
, - |
- - |
, 1, 83 9, 57 6 |
, 1, 83 9, 57 6 |
| rty me pro pe esp pe rac y Inv the est nt |
- | - | - | - | - | 2, 728 710 |
2, 728 710 |
| rty me pro pe - o r Re ins set |
, 2, 53 1, 65 9 |
, 2, 53 1, 65 9 |
|||||
| ura nce as s Cre dit for rch of itie |
- 374 000 |
- | - 29 000 |
- | - | 40 000 |
|
| pu ase se cur s Cu |
, | - 22 6 |
, | - | - | - 196 |
3, 422 |
| nt t ets rre ax ass |
- 22 |
6, | - | - | - | 6, | |
| Re cei ble nd de bit ba lan va s a ces |
129 0 , |
- | - | - | - | 40 0, 572 |
52 9, 792 |
| Pre miu llec tib le ms co |
- | - | - | - | - | 65 1, 825 |
65 1, 825 |
| Fin cia l in s in f y ield -de nde tm ent ct o nt c ont ts an ves re spe pe rac |
- | - | - | - | - | 65 57 0, 44 7 , |
65 57 0, 44 7 , |
| Fin cia l in s fo r h old of bo nds ET Ns ho rt E TN tm ent an ves ers , s s, , |
|||||||
| ific ite ET Ns de it c ert ate nd str uct d b ond com pos pos s a ure s , |
- | - | - | - | 23 9, 000 |
- | 23 9, 000 |
| Ma rke tab le d ebt set as s |
12, 80 9 |
29 32 6 , |
2, 067 |
- | - | 8, 05 1, 26 6 |
8, 095 46 8 , |
| No ark ble de bt a eta ts n-m sse |
57 9, 900 |
195 392 , |
- | - | - | 13, 23 1, 897 |
14, 007 189 , |
| Sh are s |
- | - | - | 39 52 0 , |
- | 1, 860 47 3 , |
1, 89 9, 993 |
| Oth er |
21 59 7 , |
51 1 |
- | 25 29 7 , |
- | 3, 20 0, 064 |
3, 24 7, 46 9 |
| En be red sh and sh uiv ale fo r h old of bo nds nts cum ca ca eq ers , |
|||||||
| han ded fu nds ho xch ded fu nds osi -tra rt e tra te exc ge , s an ge , co mp |
|||||||
| han ded fu nds de it c ific nd d b ond -tra ert ate str uct exc ge pos s a ure s , |
- | - | - | - | - | - | |
| Ca sh and sh uiv ale in f y ield -de nde nts t o nt c ont ts ca eq res pec pe rac |
|||||||
| - | - | - | - | - | 10, 464 21 6 , |
10, 464 21 6 , |
|
| Oth h a nd h e iva len ts er cas cas qu |
55 7, 159 |
- | 26 59 6 , |
- | - | 962 148 , |
1, 545 903 , |
| To tal set as s |
75 005 1, 6, |
24 6, 774 |
63 833 , |
1, 423 010 , |
23 9, 000 |
115 435 183 , , |
805 119 163 , , |
| Lia bili ties in f in d n ield t o tra cts res pec sur an ce con an on -y |
|||||||
| de nde inv nt est nt c ont ts pe me rac |
- | - | - | - | - | 23 46 9, 887 , |
23 46 9, 887 , |
| f in Lia bili ties in t o tra cts d y ield -de nde nt res pec sur an ce con an pe |
|||||||
| inv est nt c ont ts me rac |
- | - | - | - | - | 76 856 913 , , |
76 856 913 , , |
| Lia bili ties in f d efe d t t o res pec rre axe s |
- | - | - | 50 56 7 , |
- | 847 23 7 , |
897 804 , |
| Lia bili for loy be nef its, ty t em p ee ne |
14, 035 |
- | - | - | - | 45 32 7 , |
59 362 , |
| of Lia bili ty in r ect nt t esp cu rre axe s |
- | 20 422 , |
- | - | - | 43 022 , |
63 444 , |
| Pa ble nd dit ba lan ya s a cre ces |
22 8, 49 8 |
- | - | - | - | 2, 224 353 , |
2, 452 85 1 , |
| Lia bili ties fo r b ond ET Ns ho rt E TN ite ET Ns d s, , s s, c om pos an |
|||||||
| d b ond str uct ure s |
- | - | - | - | 23 8, 000 |
- | 23 8, 000 |
| Fin cia l lia bili ties an |
1, 26 180 7, |
864 958 , |
45 50 0 , |
8, 000 |
- | 4, 858 076 , |
043 714 7, , |
| To tal lia bil itie s |
1, 50 9, 713 |
885 38 0 , |
45 50 0 , |
58 567 , |
23 8, 000 |
108 344 815 , , |
111 08 1, 975 , |
| To tal ex po su re |
24 6, 292 |
( 638 606 ) , |
18, 333 |
1, 364 443 , |
1, 000 |
7, 090 36 8 , |
8, 08 1, 830 |


Amendment No. 3 to the Securities Regulations (Periodic and Immediate Reports), 2009 (hereinafter - "ISOX"), which deals with internal controls over financial reporting and the disclosure thereof (hereinafter - the "Regulations"), was published in December 2009. The amendment enacts a number of changes aimed at improving the quality of financial reporting and disclosure by reporting corporations.
As from the publication date of the ISOX amendment, and as set out in the Company's previous Reports of the Board of Directors, the Company has acted and is acting on an ongoing basis to implement the required procedure in The Phoenix Group in accordance with the provisions of the ISOX amendment. In accordance with the provisions of the ISOX amendment, the Company opted to implement to the internal controls of all of its consolidated institutional entities the provisions of the circulars of the Commissioner of the Capital Market, Insurance and Savings applicable thereto - the Institutional Entities Circular 2009-9-10, "Management's Responsibility for Internal Controls over Financial Reporting"; Institutional Entities Circular 2010-9-6, "Management's Responsibility for Internal Controls over Financial Reporting - Amendment"; Circular 2010-9-7 "Internal Controls over Financial Reporting - Statements, Reports and Disclosures"; Circular 2012-9-5 "Internal Controls over Financial Reporting - Statements, Disclosures and Management's Responsibility for Internal Controls over Financial Reporting - Amendments"; and Circular 2015-9-15, "Internal Controls over Financial Reporting - Statements, Reports, Disclosures and Management's Responsibility for Internal Controls over Financial Reporting - Amendments" (hereinafter - "Management's Responsibility Circulars").
The processes relating to the activities of institutional entities are also addressed in the Insurance Commissioner's Circulars, please see Section 7.1.2. below.
Alongside the process described in Section 7.1.1 above, The Phoenix Group's institutional entities apply the provisions of Management's Responsibility Circulars pertaining to controls and procedures regarding disclosure and internal controls over financial reporting of an institutional entity, and implement the procedures required in connection therewith, as described below; this is done in accordance with the stages and dates set out in the abovementioned circulars and in collaboration with external consultants engaged for that purpose. As part of this process, the Group's institutional entities adopted the internal control model of COSO - the Committee of Sponsoring Organization of the Treadway Commission - which is a generally accepted framework for assessment of internal controls.
Managements of the institutional entities, together with their CEOs and CFOs, assessed the effectiveness of the controls and procedures concerning the said institutional entities' disclosure in their financial statements as of the end of the period covered in this report. Based on this assessment, the CEOs and CFOs of the institutional entities in The Phoenix Group concluded that, as of the end of this period, the controls and procedures as to the institutional entities' disclosure are sufficiently effective for recording, processing, summarizing, and reporting the information that the institutional entities are required to disclose in their quarterly report in accordance with the provisions of the law and the reporting provisions set by the Commissioner of the Capital Market, Insurance, and Savings and on the date set out in these provisions.
During the quarter ending March 31 2021, no changes took place in the internal control over financial reporting of the Group's institutional entities that had a material effect, or is expected to have a material effect, on the institutional entities' internal control over financial reporting. Furthermore, the Group's institutional entities are improving and streamlining processes and/or internal controls and/or customer service.
The reports and statements relating to the relevant processes are attached to the financial statements of The Phoenix Group's institutional entities, in accordance with the provisions of Management's Responsibility Circulars.
For further details regarding events subsequent to the balance sheet date, please see Note 9 to the Financial Statements.
| Series/issuance date | Bonds Series 3 | Bonds Series 4 | Bonds Series 5 |
|---|---|---|---|
| Rating agency | Midroog / Ma'alot | Midroog / Ma'alot | Midroog / Ma'alot |
| Rating as of the report date |
Aa3.il iIAA /- | Aa3.il iIAA /- | Aa3.il iIAA /- |
| Par value on issuance date |
272,191,000 ש"ח | NIS 391,384,000 | NIS 822,616,000 |
| Interest type | Non-linked | Non-linked | CPI-linked |
| Nominal interest | 2.22% | The Bank of Israel's variable quarterly interest rate plus a 1.28% spread |
0.44% |
| Effective interest rate on issuance date |
Approximates the nominal interest |
1.7% | 0.55% |
| Listed on the TASE | Yes | Yes | Yes |
| Principal payment dates | 5 equal annual installments of 16.66% on July 31 of each of the years 2022 through and 2026, one installment of 16.7% on July 31 2027. |
2 equal annual installments of 12% on July 31 of each of the years 2020 and 2021 and 4 equal annual installments of 19% on July 31 of each of the years 2025 through 2028. |
3 equal annual installments of 4% on July 1 of each of the years 2022 through 2024, one installment of 28% on May 1 2028, and 2 equal installments annual of 30% on May 1 of each of the years 2029 through 2030. |
| Interest payment dates | Semi-annual interest on January 31 and July 31 |
Quarterly interest on January 31, April 30, July 31, and October 31 |
Semi-annual interest on May 1 and November 1 |
| Nominal p.v. as of Mar. 31 2021 |
NIS 272 million | NIS 391 million | NIS 822 million |
| CPI-linked nominal p.v. as of Mar. 31 2021 |
NIS 272 million | NIS 391 million | NIS 822 million |
| Carrying amount of bonds' outstanding balances as of Mar. 31 2021 |
NIS 271 million | NIS 389 million | NIS 808 million |

| Series/issuance date | Bonds Series 3 | Bonds Series 4 | Bonds Series 5 |
|---|---|---|---|
| Carrying amount of interest payable as of Mar. 31 2021 |
NIS 0.9 million | NIS 0.8 million | NIS 1.48 million |
| Market value as of Mar. 31 2021 (*) |
NIS 284 million | NIS 393 million | NIS 837 million |
| Series' materiality | The series is material as this term is defined in Regulation 10(b)13(a) of the Securities Regulations (Periodic and Immediate Reports), 1970. |
The series is material as this term is defined in Regulation 10(b)13(a) of the Securities Regulations (Periodic and Immediate Reports), 1970. |
The series is material as this term is defined in Requlation 10(b)13(a) of the Securities Regulations (Periodic and Immediate Reports), 1970. |
(*) The market value includes interest accrued as of March 31 2021.
As part of the deed of trust of the Company's Series 3 bonds, the Company undertook not to place a general floating charge on its assets as long as Series 3 bonds are not repaid in full, unless it obtained the bondholders' consent in advance and placed on that date a lien of the same rank in favor of Series 3 bondholders. Furthermore, with respect to Series 3 bonds, the Company assumed restrictions on distribution of dividends and expansion of the bonds series; the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 2.5 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 50% for two consecutive quarters. For further details, please see the Shelf Offering Report dated January 22 2018.
As part of the deed of trust of the Company's Series 4 bonds, the Company undertook not to place a general floating charge on its assets as long as Series 4 bonds are not repaid in full, unless it has obtained the bondholders' consent in advance and placed on that date a lien of the same rank in favor of Series 4 bondholders. Furthermore, with respect to Series 4 bonds, the Company assumed restrictions on distribution of dividends and expansion of the bonds series; the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 2.9 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 50% for two consecutive quarters. For further details, please see the Shelf Offering Report dated May 7 2019.
As part of the deed of trust of the Company's Series 5 bonds, the Company undertook not to place a general floating charge on its assets as long as Series 5 bonds are not repaid in full, unless it has obtained the bondholders' consent in advance and placed on that date a lien of the same rank in favor of Series 5 bondholders.

23456748947:;<5647=>7?559@74<7=AB9CD=:567E98>FCGF==387D47=54<?5<9C=9CD<H<D7CD D<=54<B35<9CI567E98>FCGFJ=93CD74599K59?98>JG;<56L<CFC?<FJ?9H7CFC5=;6747BG<5= =6F4MNO
PQ
MM MMRMQSTUR
MM
QO
VNO W X- P MR M Q
MMYZ[QO
VNO U \CFDD<5<9C:F87?6FC<=8L94FD]3=5<C^5674F579L?6FC^7<C
P MMRMQ `\@abAB<JJ<9C:567FCC3FJ<C5747=54F57;<JJ<C?47F=7BG5674F57=75<C@7?5<9CAbc9L567d77D9L e43=5b294L345674D75F
k=9LBFJFC?7=6775DF57:567E98>FCG?98>J<7=;<56567L<CFC?<FJ?9H7CFC5=D7=?4<B7DFB9H7bfC W MR Q --Y
X MPZ[W X- P MNO
P - M M X WQ --Y
X MPSTlWmZX
MM
WQ
n RVNO MNO
PUj 294L345674D75F<J=o-M SpX- P M 787C5=F=9Ld7?78B74a0 hihib1
qrstusuvswxtyzt{rst|y}w~tyztws{ywxt{r}t{rstyu}xtu}}sus{tsuyssxt}~t ("+)!+#!"+#+#!"+!+!",j
j j j "#"j #"!+!'! #+!)j &"#!"j #\$+##j j
¡¢1
1
j
1 j
j
Condensed Consolidated Interim Financial Statements
Part 2


| Review Report of the Auditors 2-3 | |
|---|---|
| Condensed Consolidated Interim Statements of Financial Position 4-5 | |
| Condensed Consolidated Interim Income Statements5 | |
| Condensed Consolidated interim Statements of Comprehensive Income 6-7 | |
| Condensed Consolidated Interim Statements of Changes in Equity 8-10 | |
| Condensed Consolidated Interim Statements of Cash Flow11-13 | |
| Notes to the Condensed Consolidated Interim Financial Statements14-100 | |
| Appendix to the Condensed Consolidated Interim Financial Statements….101-104 |

Kost Forer Gabbay & Kasierer Tel.+972-3-6232525
Menachem Begin Road 144A, Tel Aviv 6492102
Fax +972-3-5622555 ey.com
We have reviewed the accompanying financial information of The Phoenix Holdings Ltd. and subsidiaries ("the Company"), the condensed consolidated statement of financial statement of financial position as of March 31 2021, the related condensed consolidated statements of profit or loss, comprehensive income, changes in equity and cash flows for the three months period then ended. The Company's Board of Directors and management are responsible for the preparation and presentation of interim financial information for this interim period in accordance with IAS 34, "Interim Financial Reporting", and are responsible for the disclosure requirements set by the Commissioner of the Capital Market, Insurance and Savings and in accordance with the Financial Services (Insurance) Supervision Law, 1981 and they are also responsible for preparing financial information for this interim period under Chapter D of the Securities Regulations (Periodic and Immediate Reports), 1970, insofar as these regulations apply to a corporation that consolidates insurance companies. Our responsibility is to express a conclusion regarding the financial information for this interim period based on our review.
We did not review the condensed interim financial information of certain subsidiaries, whose ass ets included in consolidation constitute approximately 1.8% of a total consolidated assets as of March 31 2021 and whose revenues included in consolidation constitute approximately 1.2% of total consolidated revenues for the three months period then ended. respectively. Furthermore, we did not review the condensed interim financial information of certain companies accounted for at equity, the investment in which, at equity, amounted to approximately NIS 240,732 thousand as of March 31 2021, and the Company's share of their earnings amounted to NIS 9,453 thousand for the three months period then ended. The condensed interim financial information of those companies was reviewed by other auditors, whose review reports have been furnished to us, and our conclusion, insofar as it relates to financial information in respect of those companies, is based on the review reports of the other auditors.
We conducted our review in accordance with Review Standard (Israel) 2410 of the Institute of Certified Public Accountants in Israel, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit performed pursuant to Israeli GAAP and, as a result, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review and the review reports of other auditors, nothing has come to our attention that causes us to believe that the accompanying interim financial information is not prepared, in all material respects, in accordance with IAS 34 and in accordance with the disclosure requirements prescribed by the Commissioner of the Capital Market, Insurance and Savings, pursuant to the Financial Services Supervision Law (Insurance), 1981.
In addition to that which is stated in the previous paragraph, based on our review and the review reports of other auditors, nothing has come to our attention that causes us to believe that the abovementioned financial information does not comply, in all material respects, with the disclosure provisions of Chapter D of the Israel Securities Regulations (Periodic and Immediate Reports), 1970, insofar as these regulations apply to a corporation consolidating insurance companies.
Without qualifying the above conclusion, we draw attention to Note 7 to the financial statements regarding exposure to contingent liabilities.
Tel Aviv, Kost Forer Gabbay & Kasierer May 26, 2020 Certified Public Accountants

| As of | ||||
|---|---|---|---|---|
| Mar. 31 2021 Mar. 31 2020 |
||||
| Dec. 31 2020 | ||||
| Unaudited | Audited | |||
| In NIS thousand | ||||
| Assets | ||||
| Intangible assets | 2,298,619 | 1,796,041 | 2,016,668 | |
| Deferred tax assets | 57,245 | 28,870 | 55,104 | |
| Deferred acquisition costs | 1,819,463 | 1,768,459 | 1,712,630 | |
| Property, plant & equipment | 916,751 | 774,361 | 861,865 | |
| Investments in associates | 771,110 | 735,731 | 756,869 | |
| Investment property in respect of yield-dependent contracts | 1,853,064 | 1,631,541 | 1,839,576 | |
| Investment property - other | 2,721,934 | 2,613,378 | 2,728,710 | |
| Reinsurance assets | 2,650,209 | 2,475,063 | 2,531,659 | |
| Credit for purchase of securities | 452,000 | 264,000 | 403,000 | |
| Current tax assets | 26,897 | 161,286 | 6,422 | |
| Receivables and debit balances | 552,302 | 625,312 | 529,792 | |
| Premiums collectible | 739,902 | 823,372 | 651,825 | |
| Held-for-sale assets of disposal group (please see Note 4) | 44,473 | - | - | |
| Financial investments in respect of yield-dependent contracts | 69,130,062 | 55,157,099 | 65,570,447 | |
| Financial investments for holders of deposit certificates and structured | ||||
| bonds | 231,000 | 275,000 | 239,000 | |
| Other financial investments: | ||||
| Marketable debt assets | 7,491,305 | 7,521,334 | 8,095,468 | |
| Non-marketable debt assets | 14,333,205 | 13,505,327 | 14,007,189 | |
| Shares | 2,117,598 | 1,435,831 | 1,899,993 | |
| Other | 3,535,158 | 2,484,002 | 3,247,469 | |
| Total other financial investments | 27,477,266 | 24,946,494 | 27,250,119 | |
| Cash and cash equivalents in respect of yield-dependent contracts | 11,162,653 | 7,512,737 | 10,464,216 | |
| Other cash and cash equivalents | 2,249,354 | 1,703,259 | 1,545,903 | |
| Total assets | 125,154,304 | 103,292,003 | 119,163,805 | |
| Total assets in respect of yield-dependent contracts | 82,335,416 | 64,491,785 | 78,034,084 |

| As of | |||||
|---|---|---|---|---|---|
| Mar. 31 2021 | Dec. 31 2020 | ||||
| Unaudited | Audited | ||||
| In NIS thousand | |||||
| Equity | |||||
| Share capital | 309,961 | 309,951 | 309,951 | ||
| Premium and capital reserves in respect of shares | 837,324 | 826,991 | 833,592 | ||
| Treasury shares | (26,411) | - | (26,411) | ||
| Capital reserves | 955,191 | 316,490 | 913,036 | ||
| Retained earnings | 5,875,712 | 4,602,739 | 5,939,754 | ||
| Total equity attributed to the Company's shareholders | 7,951,777 | 6,056,171 | 7,969,922 | ||
| Non-controlling interests | 117,862 | 119,801 | 111,908 | ||
| Total equity | 8,069,639 | 6,175,972 | 8,081,830 | ||
| Liabilities | |||||
| Liabilities in respect of insurance contracts and non-yield-dependent investment contracts |
23,904,976 | 23,311,893 | 23,469,887 | ||
| Liabilities in respect of insurance contracts and yield-dependent investment contracts |
81,296,403 | 63,930,828 | 76,856,913 | ||
| Liabilities in respect of deferred taxes | 934,411 | 395,785 | 897,804 | ||
| Liability for employee benefits, net | 76,656 | 56,769 | 59,362 | ||
| Liability in respect of current taxes | 70,604 | 20,753 | 63,444 | ||
| Payables and credit balances | 2,815,177 | 2,230,608 | 2,452,851 | ||
| Held-for-sale liabilities of disposal group (please see Note 4) | 10,458 | - | - | ||
| Liabilities in respect of structured products | 228,000 | 272,000 | 238,000 | ||
| Financial liabilities | 7,747,980 | 6,897,395 | 7,043,714 | ||
| Total liabilities | 117,084,665 | 97,116,031 | 111,081,975 | ||
| Total equity and liabilities | 125,154,304 | 103,292,003 | 119,163,805 |
The accompanying notes are an integral part of the Condensed Consolidated Interim Financial Statements.
Executive Vice President, CFO Chief Executive Officer Chairman of the Board of
Eli Schwartz Eyal Ben Simon Benjamin Gabbay
Directors
Date of approval of the financial statements - May 26 2021

| For the three months ended March 31 |
For the year ended December 31 |
||||
|---|---|---|---|---|---|
| 2021 2020 |
|||||
| Unaudited | 2020 Audited |
||||
| In NIS thousand | |||||
| Premiums earned, gross | 2,618,322 | 2,719,613 | 10,382,652 | ||
| Premiums earned by reinsurers | 310,944 | 346,381 | 1,328,978 | ||
| Premiums earned - retention | 2,307,378 | 2,373,232 | 9,053,674 | ||
| Gains (losses) on investments, net and finance income | 3,854,595 | (8,153,568) | 5,479,706 | ||
| Income from management fees | 486,873 | 274,397 | 1,357,189 | ||
| Income from fees and commissions | 167,627 | 140,371 | 556,051 | ||
| Income from other financial services | 41,000 | 46,000 | 159,000 | ||
| Other income | 12,906 | 25,952 | 131,846 | ||
| Total income | 6,870,379 | (5,293,616) | 16,737,466 | ||
| Payments and change in liabilities in respect of insurance contracts and investment contracts, gross |
5,805,929 | (5,583,282) | 12,529,564 | ||
| Reinsurers' share in payments and in changes in liabilities in respect of insurance contracts |
203,863 | 256,732 | 826,690 | ||
| Payments and change in liabilities in respect of insurance contracts and investment contracts - retention |
5,602,066 | (5,840,014) | 11,702,874 | ||
| Fees and commissions, marketing expenses and other purchase expenses |
380,423 | 458,538 | 1,750,103 | ||
| General and administrative expenses | 363,731 | 323,975 | 1,360,028 | ||
| Other expenses | 10,745 | 832 | 54,885 | ||
| Finance expenses | 41,545 | 26,360 | 146,509 | ||
| Total expenses | 6,398,510 | (5,030,309) | 15,014,399 | ||
| Share in profits of equity-accounted investees | 16,027 | 15,304 | 39,697 | ||
| Profit (loss) before income taxes | 487,896 | (248,003) | 1,762,764 | ||
| Taxes on income | 161,769 | (94,798) | 553,829 | ||
| Profit (loss) | 326,127 | (153,205) | 1,208,935 | ||
| Attributed to: | |||||
| Company's shareholders | 315,404 | (166,067) | 1,169,023 | ||
| Non-controlling interests | 10,723 | 12,862 | 39,912 | ||
| Profit (loss) | 326,127 | (153,205) | 1,208,935 | ||
| Earnings (loss) per share attributed to the Company's shareholders (in NIS): |
|||||
| Basic earnings (loss) per share | |||||
| Earnings (loss) per ordinary share of NIS 1 par value (NIS) | 1.24 | (0.65) | 4.57 | ||
| Diluted earnings (loss) per share | |||||
| Earnings (loss) per ordinary share of NIS 1 par value (NIS) | 1.23 | (0.65) | 4.57 |

| For the three months | For the year ended December |
|||
|---|---|---|---|---|
| ended March 31 | 31 | |||
| 2021 | 2020 | 2020 | ||
| Unaudited | Audited | |||
| Profit (loss) for the period | 326,127 | In NIS thousand (153,205) |
1,208,935 | |
| Other comprehensive income (loss): | ||||
| Amounts that will be or that have been reclassified to profit or loss | ||||
| when specific conditions are met | ||||
| Net change in fair value of financial assets classified as available for sale, | ||||
| carried to capital reserves | 253,176 | (806,319) | 455,703 | |
| Net change in fair value of financial assets classified as available for sale, | ||||
| carried to the income statement | (230,110) | (86,071) | (516,761) | |
| Gain on impairment of financial assets classified as available for sale, carried | ||||
| to the income statement | 35,908 | 260,323 | 324,220 | |
| Company's share in other comprehensive income (loss), net, of equity | ||||
| accounted companies | 1,057 | 5,185 | (3,412) | |
| Tax effect | (19,529) | 215,048 | (89,697) | |
| Total components of net other comprehensive income (loss) subsequently | ||||
| reclassified to profit or loss | 40,502 | (411,834) | 170,053 | |
| Amounts that shall not be subsequently reclassified to profit or | ||||
| loss | ||||
| Revaluation of property, plant and equipment | - | 1,621 | 17,314 | |
| Actuarial gain (loss) in respect of defined benefit plans | - | - | 497 | |
| Tax effect | - | (373) | (4,190) | |
| Total components of other comprehensive income, net, that shall not be | ||||
| subsequently reclassified to profit or loss | - | 1,248 | 13,621 | |
| Total other comprehensive income (loss), net | 40,502 | (410,586) | 183,674 | |
| Total comprehensive income (loss) for the period | 366,629 | (563,791) | 1,392,609 | |
| Attributed to: | ||||
| Company's shareholders | 355,906 | (576,653) | 1,352,697 | |
| Non-controlling interests | 10,723 | 12,862 | 39,912 | |
| Comprehensive income (loss) | 366,629 | (563,791) | 1,392,609 | |

| Attributed to Company's shareholders | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transacti ons with non control ling interests |
Capital reserve from transaction with controlling shareholder - bonus |
Capital reserve from share based pay-ment In NIS thousand |
Revalu ation reserve |
Principal from trans lation diffe rences |
Capital reserve in respect of available for-sale assets |
Total | Non controlling interests |
Total equity |
|
| Balance as of January 1 2021 (audited) |
309,951 | 833,592 | (26,411) | 5,939,754 | (43,622) | 11,000 | 44,943 | 114,614 | (23,338) | 809,439 | 7,969,922 | 111,908 | 8,081,830 |
| Net income | - | - | - | 315,404 | - | - | - | - | - | - | 315,404 | 10,723 | 326,127 |
| Other comprehensive income |
- | - | - | - | - | - | - | - | 1,057 | 39,445 | 40,502 | - | 40,502 |
| Total comprehensive | |||||||||||||
| income | - | - | - | 315,404 | - | - | - | - | 1,057 | 39,445 | 355,906 | 10,723 | 366,629 |
| Share-based payment Dividend paid to non |
3,635 | - | - | 2,314 | - | - | - | 5,949 | - | 5,949 | |||
| controlling interests Commencement of |
- | - | - | - | - | - | - | - | - | - | - | (5,177) | (5,177) |
| consolidation Exercise of employee |
- | - | - | - | - | - | - | - | - | - | - | 408 | 408 |
| options Transfer from revaluation reserve in respect of revaluation of property, plant and |
10 | 97 | - | - | - | - | (107) | - | - | - | - | - | - |
| equipment, at the | |||||||||||||
| depreciation amount Dividend |
- - |
- - |
- - |
554 (380,000) |
- - |
- - |
- - |
(554) - |
- - |
- - |
- (380,000) |
- - |
- (380,000) |
| Balance as of March | 5,875,71 | ||||||||||||
| 31 2021 (unaudited) | 309,961 | 837,324 | (26,411) | 2 | (43,622) | 11,000 | 47,150 | 114,060 | (22,281) | 848,884 | 7,951,777 | 117,862 | 8,069,639 |
The accompanying notes are an integral part of the condensed consolidated interim financial statements.

| Attributed to Company's shareholders | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Retained earnings |
Capital reserve from transa ctions with non controlling interests |
Capital reserve from transaction with controlling share holder - bonus |
Capital reserve from share based pay ment |
Reva luation reserve In NIS thousand |
Principal from trans lation diffe rences |
Capital reserve in respect of available for-sale assets |
Total | Non contro lling interests |
Total equity |
|
| Balance as of January 1 2020 (audited) |
309,951 | 830,437 | 4,768,261 | (43,622) | 11,000 | 40,047 | 103,463 | (19,926) | 635,974 | 6,635,585 | 106,939 | 6,742,524 |
| Net income | - | - | (166,067) | - | - | - | - | - | - | (166,067) | 12,862 | (153,205) |
| Other comprehensive income (loss) |
- | - | - | - | - | - | 1,248 | 5,185 | (417,019) | (410,586) | - | (410,586) |
| Total comprehensive income (loss) |
- | - | (166,067) | - | - | - | 1,248 | 5,185 | (417,019) | (576,653) | 12,862 | (563,791) |
| Share-based payment | - | (3,446) | - | - | - | 685 | - | - | - | (2,761) | - | (2,761) |
| Transfer from revaluation reserve in respect of revaluation of property, plant and equipment, at the depreciation amount |
- | - | 545 | - | - | - | (545) | - | - | - | - | - |
| Balance as of March 31 2020 (unaudited) |
309,951 | 826,991 | 4,602,739 | (43,622) | 11,000 | 40,732 | 104,166 | (14,741) | 218,955 | 6,056,171 | 119,801 | 6,175,972 |

| Attributed to Company's shareholders | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from trans actions with non control ling interests |
Capital reserve from transactio ns with controlling share holders |
Capital reserve from share based payment In NIS thousand |
Reva luation reserve |
Principal from translati on diffe rences |
Capital reserve in respect of available for-sale assets |
Total | Non control ling interests |
Total equity |
|
| Balance as of | |||||||||||||
| January 1 2020 | |||||||||||||
| (audited) Net income |
309,951 - |
830,437 - |
- - |
4,768,261 1,169,023 |
(43,622) - |
11,000 - |
40,047 - |
103,463 - |
(19,926) - |
635,974 - |
6,635,585 1,169,023 |
106,939 39,912 |
6,742,524 1,208,935 |
| Other comprehensive | |||||||||||||
| income (loss) | - | - | - | 290 | - | - | - | 13,331 | (3,412) | 173,465 | 183,674 | - | 183,674 |
| Total comprehensive | |||||||||||||
| income (loss) | - | - | - | 1,169,313 | - | - | - | 13,331 | (3,412) | 173,465 | 1,352,697 | 39,912 | 1,392,609 |
| Share-based | |||||||||||||
| payment | - | 3,155 | - | - | - | - | 4,896 | - | - | - | 8,051 | - | 8,051 |
| Dividend paid to | |||||||||||||
| non-controlling | |||||||||||||
| interests | - | - | - | - | - | - | - | - | - | - | - | (31,971) | (31,971) |
| Acquisition of | |||||||||||||
| treasury shares | - | - | (26,411) | - | - | - | - | - | - | - | (26,411) | - | (26,411) |
| Acquisition of non controlling interests |
|||||||||||||
| Commencement of | - | - | - | - | - | - | - | - | - | (3,000) | (3,000) | ||
| consolidation | - | - | - | - | - | - | - | - | - | - | - | 28 | 28 |
| Transfer from | |||||||||||||
| revaluation reserve | |||||||||||||
| in respect of | |||||||||||||
| revaluation of | |||||||||||||
| property, plant and | |||||||||||||
| equipment, at the | |||||||||||||
| depreciation amount | - | - | - | 2,180 | - | - | - | (2,180) | - | - | - | - | - |
| Balance as of | |||||||||||||
| December 31 2020 (audited) |
309,951 | 833,592 | (26,411) | 5,939,754 | (43,622) | 11,000 | 44,943 | 114,614 | (23,338) | 809,439 | 7,969,922 | 111,908 | 8,081,830 |

| For the three months ended March 31 | For the year ended December 31 |
|||
|---|---|---|---|---|
| 2021 | 2020 | 2020 | ||
| Unaudited | Audited | |||
| Appendix | In NIS thousand | |||
| Cash flows provided by (used in) | ||||
| operating activities Profit (loss) for the period Adjustments required to present |
326,127 | (153,205) | 1,208,935 | |
| cash flows from operating activities | (a) | 1,056,086 | 1,603,179 | 3,562,529 |
| Net cash provided by operating activities |
1,382,213 | 1,449,974 | 4,771,464 | |
| Cash flows from investing activities Purchase of property, plant and equipment Proceeds from disposal of property, |
(12,389) | (8,205) | (137,587) | |
| plant and equipment Investment in associates |
- (10,632) |
- (20,719) |
1,158 (44,845) |
|
| Dividend from associates Acquisition of companies |
11,918 | 4,842 | 13,089 | |
| consolidated for the first time Acquisition of minority interest in a |
(b) | (337,071) | (36,573) | (86,665) |
| consolidated company Repayment (receipt) of a loan from |
- | - | (3,000) | |
| an associate Proceeds from disposal of |
90 | (240) | (8,173) | |
| investment in associate Acquisition and capitalization of |
- | 18,445 | 19,746 | |
| intangible assets costs | (51,382) | (53,730) | (233,430) | |
| Net cash used in investing activities Cash flows from financing activities |
(399,466) | (96,180) | (479,707) | |
| Acquisition of Company shares Assumption of financial liabilities |
- 117,000 |
- - |
(26,411) 72,097 |
|
| Repayment of financial liabilities | (70,699) | (146,291) | (572,121) | |
| Repayment of lease liability principal | (12,505) | (9,655) | (41,646) | |
| Issuance of financial liability Dividend to non-controlling interests |
348,457 | 217,511 | 585,433 | |
| in a consolidated company Repayment of contingent liability in respect of a put option to non |
(5,177) | - | (31,971) | |
| controlling interests | (5,355) | - | - | |
| Liability for REPO | 47,420 | 456,493 | 388,837 | |
| Net cash from financing activities Increase in cash and cash |
419,141 | 518,058 | 374,218 | |
| equivalents Balance of cash and cash |
1,401,888 | 1,871,852 | 4,665,975 | |
| equivalents at beginning of period Balance of cash and cash |
(c) | 12,010,119 | 7,344,144 | 7,344,144 |
| equivalents at end of period | (c) | 13,412,007 | 9,215,996 | 12,010,119 |
| For the three months ended March 31 |
For the year ended December 31 |
|||
|---|---|---|---|---|
| 2021 | 2020 | 2020 | ||
| Unaudited | Audited | |||
| In NIS thousand | ||||
| Adjustments required to present cash flows from | ||||
| (a) | operating activities: | |||
| Items not involving cash flows | ||||
| Net (gains) losses on financial investments in respect of | ||||
| insurance contracts and yield-dependent investment | ||||
| contract | (3,433,370) | 7,830,247 | (4,356,557) | |
| Change in fair value of investment property in respect of | ||||
| yield-dependent contracts | - | 12,998 | (25,857) | |
| Net (gains) losses on other financial investments Marketable debt assets |
(113,589) | 29,555 | (166,427) | |
| Non-marketable debt assets | (196,537) | (116,265) | (581,800) | |
| Shares | (123,408) | 262,429 | 24,735 | |
| Other | 78,203 | 175,127 | (228,807) | |
| Depreciation and amortization | 76,835 | 71,703 | 300,140 | |
| Loss (gain) on disposal of property, plant and equipment | 5 | 6 | - | |
| Change in fair value of investment property | - | 7,701 | (53,004) | |
| Change in provision for impairment of property, plant | ||||
| and equipment | (2,229) | (11,616) | (7,957) | |
| Gain from remeasurement of investment in an investee | ||||
| consolidated for the first time | (483) | - | (67,268) | |
| Change in financial liabilities | 240,427 | 625,848 | 853,786 | |
| Income tax expenses | 161,769 | (94,798) | 553,829 | |
| Company's share in the results of associates, net | (16,027) | (15,304) | (39,697) | |
| Payroll expenses in respect of share-based payment | 2,314 | 685 | 4,896 | |
| Changes in other balance sheet line items, net: | ||||
| Change in liabilities in respect of non-yield-dependent | ||||
| insurance contracts | 435,089 | 119,703 | 277,697 | |
| Change in liabilities in respect of yield-dependent | ||||
| contracts | 4,439,490 | (7,160,049) | 5,766,036 | |
| Change in liabilities for bonds, ETFs | (10,000) | (10,000) | (44,000) | |
| Change in financial investments for holders of ETFs, | ||||
| certificates of deposit | 8,000 | 9,000 | 45,000 | |
| Change in deferred acquisition costs | (87,786) | (34,912) | 20,917 | |
| Change in reinsurance assets | (118,550) | (127,342) | (183,938) | |
| Change in liabilities for employee benefits, net | 12,263 | 4,216 | 7,306 | |
| Change in accounts receivable, debit balances and | ||||
| collectible premiums | (111,143) | (245,001) | 28,325 | |
| Change in payables and credit balances | (44,969) | 97,411 | 306,867 | |
| Change in credit for purchase of securities | (49,000) | 43,000 | (96,000) | |
| Revaluation of loans granted to associates | (1,098) | (528) | (1,938) | |
| Financial investments and investment property in respect | ||||
| of insurance contracts and yield-dependent investment | ||||
| contracts: Acquisition of real estate properties |
(13,488) | (90,474) | (259,654) | |
| Acquisitions of financial investments, net | (126,245) | 1,317,569 | 3,091,025 | |
| Financial investments and other investment property: | ||||
| Acquisitions of financial investments, net | 219,579 | (1,120,881) | (1,264,985) | |
| Acquisition of real estate properties | (13,302) | (73,723) | (128,350) | |
| Cash paid and received during the period for: | ||||
| Taxes paid | (335,118) | (45,075) | (354,687) | |
| Taxes received | 178,454 | 141,949 | 142,896 | |
| Total cash flows provided by operating activities | 1,056,086 | 1,603,179 | 3,562,529 | |

| For the three months ended March 31 |
For the year ended December 31 |
||||
|---|---|---|---|---|---|
| 2021 | 2020 | 2020 | |||
| Unaudited | Audited | ||||
| In NIS thousand | |||||
| (b) | Acquisition of companies consolidated for the first time Assets and liabilities of the consolidated companies as of acquisition date: |
||||
| Working capital (excluding cash and cash equivalents) Deferred acquisition costs |
19,959 (19,047) |
(3,000) - |
(4,288) - |
||
| Other financial investments | (32,421) | - | - | ||
| Property, plant and equipment, net | (35,863) | - | (10,710) | ||
| Goodwill arising from acquisition | (138,653) | (22,000) | (154,549) | ||
| Intangible assets | (188,317) | (11,573) | (83,796) | ||
| Deferred taxes | 9,136 | - | 22,012 | ||
| Minority interests | 408 | - | 28 | ||
| Accounts payable in respect of acquisition of consolidated | |||||
| companies | 271 | - | - | ||
| Disposal of investment in an associate | 2,777 | - | 78,677 | ||
| Financial liability | 34,161 | - | 12,309 | ||
| Loan from parent company | - | - | 46,911 | ||
| Liability for payment in respect of acquisition of an investee | 5,487 | - | 6,741 | ||
| Liabilities for employee benefits | 5,031 | - | - | ||
| (337,071) | (36,573) | (86,665) | |||
| (c) | Cash and cash equivalents | ||||
| Balance of cash and cash equivalents at beginning of period: | |||||
| Other cash and cash equivalents | 1,545,903 | 1,731,709 | 1,731,709 | ||
| Cash and cash equivalents in respect of yield-dependent | |||||
| contracts | 10,464,216 | 5,612,435 | 5,612,435 | ||
| 12,010,119 | 7,344,144 | 7,344,144 | |||
| Balance of cash and cash equivalents at end of period: | |||||
| Other cash and cash equivalents | 2,249,354 | 1,703,259 | 1,545,903 | ||
| Cash and cash equivalents in respect of yield-dependent | |||||
| contracts | 11,162,653 | 7,512,737 | 10,464,216 | ||
| 13,412,007 | 9,215,996 | 12,010,119 | |||
| (d) | Material non-cash activities | ||||
| Payable dividend | (380,000) | - | - | ||
| Recognition of right-of-use asset against a lease liability | (5,676) | (3,531) | (8,383) | ||
| Appreciation (impairment) of available-for-sale assets against | |||||
| a capital reserve | 58,974 | (417,019) | 263,162 | ||
| Appreciation (impairment) of deferred taxes in respect of | |||||
| available for sale assets against a capital reserve | (19,529) | (215,048) | (89,697) | ||
| (e) | Breakdown of amounts included in operating activities | ||||
| Interest paid | 716 | 4,343 | 1,611 | ||
| Interest received | 58,582 | 65,264 | 608,612 | ||
| Dividend received | 17,687 | 5,301 | 32,215 |

A. The Phoenix Holdings Ltd. (hereinafter - the "Company") is an Israeli resident company incorporated in Israel, whose official address is 53 Derech Hashalom St., Givatayim, Israel. These financial statements were prepared in condensed format as of March 31 2021 and for the three-month period then ended (hereinafter - the "Condensed Consolidated Interim Financial Statements"). These financial statements should be read in conjunction with the Company's annual financial statements as of December 31 2020 and for the year then ended and the accompanying notes (hereinafter - the "Consolidated Annual Financial Statements").
| The Company | - | The Phoenix Holdings Ltd. |
|---|---|---|
| The Phoenix Insurance |
- | The Phoenix Insurance Company Ltd., a wholly-owned subsidiary. |
| The Phoenix Investments |
- | The Phoenix Investments and Finances Ltd., a wholly-owned subsidiary of the Company. |
| Excellence | - | Excellence Investments Ltd., a subsidiary of The Phoenix Investments. |
| The Phoenix Excellence Pension and Provident Funds Ltd. |
- | The Phoenix Excellence Pension and Provident Funds Ltd., a wholly-owned subsidiary of The Phoenix Insurance (formerly - Excellence Gemel Ltd.). |
| Halman Aldubi | - | Halman Aldubi Investment House Ltd. is a wholly-owned subsidiary of the Company (for further details, please see Note 4). |
| Halman Aldubi Provident |
Halman Aldubi Provident and Pension Funds Ltd. is a wholly-owned subsidiary of Halman Aldubi. |
|
| The Phoenix Capital Raising |
- | The Phoenix Capital Raising (2009) Ltd., a wholly-owned subsidiary of The Phoenix Insurance. |
| Belenus Lux S.a.r.l |
- | The controlling shareholder, held indirectly by Centerbridge Partners LP and Gallatin Point Capital LLC (hereinafter - the "Funds"). The said control is jointly held with Leolin Lux S.a.r.l, a sister company of Belenus. |
| Ad 120 | - | Ad 120 Residence Centers for Senior Citizens Ltd. is a wholly-owned subsidiary of The Phoenix Insurance. |
| The Phoenix Agencies |
- | The Phoenix Insurance Agency 1989 Ltd. - a company wholly-owned by the Company. |
On December 30 2019, the Board of Directors of The Phoenix Insurance Ltd. approved the distribution of the shares of The Phoenix Excellence Pension and Provident Funds Ltd., constituting approximately 100% of the issued and paid-up share capital of The Phoenix Excellence as dividend in kind to the Company. The actual distribution of the dividend is subject to approval by the Israel Tax Authority and the Capital Market, Insurance and Savings Authority. As of the report publication date, the Capital Market, Insurance and Savings Authority has given approval to execute the distribution, but no such approval has been received as yet from the Israel Tax Authority. For further details, please see the immediate report of the Company dated December 31 2019 (Ref. No. 2019-01-126166).

On December 7 2020, the Company entered into a merger agreement with Halman Aldubi Investment House Ltd. (hereinafter: "Halman Aldubi). Under the merger agreement, a reverse triple merger was carried out, with Halman Aldubi becoming a privately-held company wholly owned by the Company. The consideration of the transaction is approximately NIS 275 million. On February 28 2021, upon meeting the conditions precedent, the merger was completed. For further details regarding the transaction, please see Note 4, "Business Combinations".
In January 2021, The Phoenix Insurance's Board of Directors decided to consider the possibility of selling its control stake, and up to 100%, of Ad 120, as part of the execution of the Company's multi-year strategic plan. As of the report date, the Company is acting to implement the aforesaid with the assistance of an investment bank with which the Company has entered into an agreement in this matter. As of the report publication date, The Phoenix Insurance had received several unbinding initial offers from potential acquirers. The Phoenix Insurance is considering the various offers and alternatives for executing the transaction. Accordingly, as of the report date, The Phoenix Insurance has created a tax reserve in the amount of approximately NIS 46 million in respect of its intended sale of Ad 120; however, at this stage, there is no certainty that the sale will indeed materialize and what its terms and conditions will be. For further details, please see Note 7 to the Annual Report and the immediate report dated January 28 2021 (Ref. No.: 2021-01-011200).
In May 2021, Gama Management and Clearing Ltd. (hereinafter - "Gama") published a draft prospectus for an initial public offering and sale offer (hereinafter - the "Draft Prospectus"). As of the report publication date, the Company indirectly holds, through The Phoenix Investments and Finances Ltd., 49% of Gama's issued and paid-up share capital. According to the draft prospectus, the company intends, concurrently with the execution of the IPO, in accordance with the IPO prospectus, to acquire, through The Phoenix Investments, such that following the IPO anf full dilution, it will hold approximately 60% of Gama's issued and paid up share capital and voting rights, fully diluted, and shall be the controlling shareholder in Gama. To the extent that the IPO will indeed go forward and the Company will gain a holding stake of more than 50% in Gama, the Company is expected to record a one-off capital gain due to gaining control, depending on the IPO proceeds. As of this date, the IPO is scheduled to take place during June 2021; however, it shall be clarified that there is no certainty that the IPO will indeed take place and what its terms and conditions will be.
On May 9 2021, KSM Sal Certificates Holdings Ltd. - a company indirectly controlled by the Company, jointly with YD More Investments Ltd. - filed a binding offer to acquire all shares of Psagot Mutual Funds Ltd., Psagot Securities Ltd. and Psagot Compass Investments Ltd. (hereinafter, collectively - the "Acquired Companies") by Psagot Investment House Ltd. (hereinafter - "Psagot"). The offer reflected an enterprise value of approximately NIS 420 million for the Acquired Companies, on the basis of zero debt and zero cash as of December 31 2020. The offer expired on May 10 2021, in accordance with the terms and conditions of the offer.

The Consolidated Interim Financial Statements have been prepared in accordance with generally accepted accounting principles for the preparation of interim financial statements as prescribed by IAS 34, "Interim Financial Reporting", as well as in accordance with the disclosure requirements set by the Commissioner of the Capital Market, Insurance and Savings in accordance with the Financial Services Supervision Law (Insurance), 1981. In addition, the financial statements were prepared in accordance with the disclosure provisions in Chapter D of the Securities Regulations (Periodic and Immediate Reports), 1970, insofar as these regulations apply to a corporation consolidating an insurance company.
In preparing the condensed financial statements in accordance with International Financial Reporting Standards (IFRS), the Company is required to exercise discretion in assessments, estimates and assumptions that affect the implementation of the policy and the amounts of assets and liabilities, income and expenses. It is clarified that the actual results may differ from those estimates. Management's discretion in applying the Group's accounting policies and the key assumptions used in assessments involving uncertainty is consistent with that which is applied in the preparation of the annual financial statements. For further information regarding changes in critical estimates and assumptions used to calculate the insurance reserves, please see Note 8.A.
The accounting policies applied in the preparation of the interim consolidated financial statements are consistent with those implemented in the preparation of the Consolidated Annual Financial Statements, with the exception of new standards that entered into force on January 1 2021, as detailed below:
Amendments to IFRS 4, IFRS 7, IFRS 9, IFRS 16 and IAS 39 due to the IBOR reform
In August 2020, the IASB issued amendments to IFRS 9, "Financial Instruments", IFRS 7, "Financial Instruments: Disclosures", IAS 39, "Financial Instruments: Recognition and Measurement", IFRS 4, "Insurance Contracts" and IFRS 16, "Leases" (Hereinafter - the "Amendments").
The amendments provide practical expedients that address the effects the replacement of Interbank Offered Rates ((IBORs) by Risk Free Interest Rates (RFRs) on accounting treatment in the financial statements.
According to one of the practical reliefs, the Company will account for contractual amendments or amendments to cash flows resulting directly from the implementation of the reform similarly to the accounting treatment for changes in variable interest rates. In other words, companies are required to recognize the changes in interest rates by adjusting the effective interest rate without changing the book value of the financial instrument. The use of this practical expedient depends on the fact that the transition from IBOR to RFR takes place on the basis of equal economic conditions.
In addition, the amendments allow the changes required by the IBOR reform to be made for hedging designation and documentation purposes without causing hedging relationships to discontinue when certain terms and conditions are met. The amendments also provided temporary practical expedient for the application of hedge accounting relating to the identification of the hedged risk as 'separately identifiable'.
The amendments added disclosure requirements regarding the effect of the expected reform on the Company's financial statements, including reference to the manner in which the Company manages the implementation of the interest rate reform, the risks to which it is exposed as a result of the expected reform and quantitative disclosures regarding financial instruments in IBOR interest rates that are expected to change.
At this stage - since the contractural amendments have yet to be agreed upon - the Company is unable to estimate the accounting implications, if any, of the transition from IBOR interest rates to RFR interest rates on financial instrument contracts that are expected to be in place on the transition date, including the effects of the above Amendments.

Amendment to IAS 8, "Accounting Policies, Changes in Accounting Estimates and Errors"
In February 2021, the IASB issued an amendment to IAS 8: "Accounting Policies, Changes in Accounting Estimates and Errors" (hereinafter - the "Amendment). The purpose of the amendment is to introduce a new definition of the term "accounting estimates".
Accounting estimates are defined as "financial amounts in the financial statements subject to measurement uncertainty." The Amendment clarifies what changes in accounting estimates are and how they differ from changes in accounting policies and corrections of errors.
The Amendment will be applied prospectively to annual periods beginning on January 1 2023 and shall apply to changes in accounting policies and accounting estimates that occur at the beginning of that period or thereafter. Early application is allowed.
Beginning in Q2 2020 - in light of the publication of the LAT circular regarding the allocation of assets other than at fair value when performing the liability adequacy test (LAT) - the Company allocated the results of Ad 120 to the life insurance and long-term savings and health insurance segment as well. The following table reconciles the abovementioned change, under the assumption that the Company would have designated Ad 120 to the life insurance and long-term savings and health segment:

| For the three months ended March 31 |
For the year ended December 31 |
|||
|---|---|---|---|---|
| Life insurance and long-term savings segment | 2020 | |||
| Unaudited | Audited | |||
| In NIS thousand | ||||
| Premiums earned, gross | 1,259,058 | 4,765,553 | ||
| Premiums earned by reinsurers | 23,634 | 99,195 | ||
| Premiums earned - retention | 1,235,424 | 4,666,358 | ||
| Investment income, net and finance income | (7,191,455) | 4,641,250 | ||
| Income from management fees | 202,822 | 1,106,546 | ||
| Income from fees and commissions | 9,334 | 39,119 | ||
| Other income | 11,263 | 22,936 | ||
| Total income | (5,732,613) | 10,476,209 | ||
| Payments and change in liabilities in respect of insurance contracts and investment contracts, gross |
(5,879,613) | 8,517,055 | ||
| Reinsurers' share in payments and in changes in liabilities in respect of insurance contracts |
1,655 | 49,450 | ||
| Payments and change in liabilities in respect of insurance contracts and investment contracts - retention |
(5,881,268) | 8,467,605 | ||
| Fees and commissions and other purchase expenses | 182,050 | 728,085 | ||
| General and administrative expenses | 130,303 | 548,029 | ||
| Other expenses | (6,814) | 26,303 | ||
| Finance expenses | (8,988) | 2,185 | ||
| Total expenses | (5,584,717) | 9,772,207 | ||
| Company's share in the net results of investees | 6,979 | 12,006 | ||
| Net income (loss) before taxes on income | (140,916) | 716,008 | ||
| Other comprehensive income (loss) before taxes on income |
(99,340) | 6,732 | ||
| Total comprehensive income (loss) before taxes on income |
(240,256) | 722,740 |

| For the three months ended March 31 |
For the year ended December 31 |
|
|---|---|---|
| 2020 | ||
| Health insurance segment | Unaudited | Audited |
| In NIS thousand | ||
| Premiums earned, gross | 763,861 | 2,781,698 |
| Premiums earned by reinsurers | 95,200 | 286,671 |
| Premiums earned - retention | 668,661 | 2,495,027 |
| Investment income, net and finance income | (665,410) | 473,843 |
| Income from fees and commissions | 9,468 | 44,170 |
| Other income | 7,508 | 12,736 |
| Total income | 20,228 | 3,025,776 |
| Payments and change in liabilities in respect of insurance contracts and investment contracts, gross |
(195,410) | 2,371,630 |
| Reinsurers' share in payments and in changes in liabilities in respect of insurance contracts |
88,141 | 234,439 |
| Payments and change in liabilities in respect of insurance contracts and investment contracts - retention |
(283,551) | 2,137,191 |
| Fees and commissions and other purchase expenses | 161,189 | 497,769 |
| General and administrative expenses | 40,223 | 157,523 |
| Finance expenses | (808) | (1,112) |
| Total expenses | (82,947) | 2,791,371 |
| Company's share in the net results of investees | - | 2,055 |
| Profit before taxes on income | 103,174 | 236,460 |
| Other comprehensive loss before taxes on income | (68,999) | (33,485) |
| Total comprehensive income before taxes on income | 34,175 | 202,975 |
| Consumer price index | Representative exchange rate of the US dollar |
||||
|---|---|---|---|---|---|
| Known CPI | In lieu CPI | ||||
| % | % | % | |||
| For the three months ended on: | |||||
| March 31 2021 | 0.1 | 0.8 | 3.7 | ||
| March 31 2020 | (0.5) | (0.1) | 3.1 | ||
| For the year ended December 31 2020 | (0.6) | (0.7) | (7) |

The Company operates in the following operating segments:
The life insurance and long-term savings segment includes the following subsegments: life insurance, related coverages and pension and provident funds management. The segment includes long-term savings (under various categories of insurance policies, pension funds and provident funds), as well insurance coverages in respect of various risks such as: death, disability, permanent health insurance, and more. In accordance with the Commissioner's directives, the long-term savings segment is broken down into life insurance, pension funds and provident funds. For information regarding the allocation of operating results of Ad 120 following the application of the circular regarding the procedure for allocating non-marketable assets, please see Notes 2.D above.
The health insurance segment includes the Group's health insurance activity. The segment includes longterm care, medical expenses, surgery and transplants, dental, travel and foreign workers insurance and more.
For information regarding the allocation of operating results of Ad 120 following the application of the circular regarding the procedure for allocating non-marketable assets, please see Notes 2.D above.
The property and casualty insurance segment includes the liability and property subsegments. In accordance with the Commissioner's directives, the property and casualty insurance segment is broken down into compulsory motor insurance, motor property, other property and other liability subsegments.
Compulsory motor insurance subsegment
The compulsory motor insurance subsegment focuses on coverage, the purchase of which by the vehicle owner or driver is mandatory, in respect of bodily injury caused as a result of the use of a motor vehicle (to the driver, passengers, or pedestrians).
The motor property subsegment focuses on coverage against property damage to the policyholder's vehicle and third-party property damage caused by the insured vehicle.
The liability subsegments provide coverage in respect of the policyholder's liability for any thirdparty damage he/she may cause. These subsegments include: third-party liability, employers' liability, professional liability and product liability.
Property subsegments other than motor and liability as well as other insurance subsegments.
The financial services segment includes Excellence's results. The segment includes investment management activity, including mutual funds, ETFs, brokerage services, underwriting services, market making in various securities and other services.
In addition, the results of this segment include the operations of The Phoenix's investment fund management.
The insurance agencies segment includes the activity of the pension arrangement agencies and other consolidated insurance agencies.

This segment includes operating segments that do not meet the quantitative threshold for reporting.
This activity includes part of the Group's HQ function that is not attributed to the operating segments and holding assets and liabilities against the Company's share capital in accordance with the Capital Regulations.

| For the three-month period ended March 31 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Life insurance and long term savings (a) |
Health (b) | Property and casualty insurance (c) |
Financial services |
Insurance agencies |
Other | Not attributed to operating segments |
Adjustments and offsets |
Total | |
| Unaudited | |||||||||
| In NIS thousand | |||||||||
| Premiums earned, gross | 1,261,813 | 660,630 | 695,879 | - | - | - | - | - | 2,618,322 |
| Premiums earned by reinsurers | 28,018 | 51,711 | 231,215 | - | - | - | - | - | 310,944 |
| Premiums earned - retention |
1,233,795 | 608,919 | 464,664 | - | - | - | - | - | 2,307,378 |
| Investment income, net and finance income | 3,389,444 | 326,165 | 94,187 | 56 | 4,395 | 801 | 43,928 | (4,381) | 3,854,595 |
| Income from management fees | 422,583 | - | - | 64,042 | 228 | 12,372 | 762 | (13,114) | 486,873 |
| Income from fees and commissions (d) | 8,569 | 12,355 | 54,179 | - | 125,314 | - | - | (32,790) | 167,627 |
| Income from financial services | - | - | - | 41,000 | - | - | - | - | 41,000 |
| Other income | 5,492 | 338 | - | 1,000 | 4,302 | 327 | 1,652 | (205) | 12,906 |
| Total income | 5,059,883 | 947,777 | 613,030 | 106,098 | 134,239 | 13,500 | 46,342 | (50,490) | 6,870,379 |
| Increase in insurance liabilities and payments in respect of insurance contracts |
4,497,410 | 844,488 | 464,031 | - | - | - | - | - | 5,805,929 |
| Reinsurers' share in payments and in changes in liabilities in | 10,751 | 54,693 | 138,419 | - | - | - | - | - | 203,863 |
| respect of insurance contracts | |||||||||
| Payments and change in liabilities in respect of insurance | |||||||||
| contracts and investment contracts - retention |
4,486,659 | 789,795 | 325,612 | - | - | - | - | - | 5,602,066 |
| Fees and commissions and other purchase expenses | 171,055 | 100,930 | 127,206 | 11,000 | - | - | - | (29,768) | 380,423 |
| General and administrative expenses | 144,227 | 37,738 | 31,255 | 61,468 | 80,189 | 13,711 | 9,869 | (14,726) | 363,731 |
| Other expenses | 4,325 | - | - | 3,000 | 3,231 | - | 304 | (115) | 10,745 |
| Finance expenses | 3,928 | 51 | 5,504 | 1,000 | 136 | 80 | 34,547 | (3,701) | 41,545 |
| Total expenses | 4,810,194 | 928,514 | 489,577 | 76,468 | 83,556 | 13,791 | 44,720 | (48,310) | 6,398,510 |
| Company's share in the net results of investees | 10,521 | 615 | (1,167) | 830 | 1,587 | 3,641 | - | - | 16,027 |
| Profit before taxes on income | 260,210 | 19,878 | 122,286 | 30,460 | 52,270 | 3,350 | 1,622 | (2,180) | 487,896 |
| Other comprehensive income (loss) before taxes on | |||||||||
| income | 30,043 | 3,108 | 55,236 | - | - | 587 | (28,943) | - | 60,031 |
| Total comprehensive income (loss) before taxes on | |||||||||
| income | 290,253 | 22,986 | 177,522 | 30,460 | 52,270 | 3,937 | (27,321) | (2,180) | 547,927 |
| As of March 31 2021 | |||||||||
| Unaudited | |||||||||
| In NIS thousand | |||||||||
| Liabilities, gross in respect of insurance contracts and yield dependent investment contracts |
75,600,323 | 5,696,080 | - | - | - | - | - | - | 81,296,403 |
| Liabilities, gross in respect of insurance contracts and non yield-dependent investment contracts |
13,069,298 | 4,372,914 | 6,462,764 | - | - | - | - | - | 23,904,976 |
(a) For additional data regarding the life insurance and long-term savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section D below.
(d) Arises from commission income received from agencies owned by the Group, mainly from activities in the life insurance and long-term savings segment.

| For the three-month period ended March 31 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Life insurance and long term savings |
Health | Property and casualty insurance |
Financial | Insurance | Not attributed to operating |
Adjust ments and |
|||
| (a) | (b) | (c) | services | agencies | Other | segments | offsets | Total | |
| Unaudited | |||||||||
| In NIS thousand | |||||||||
| Premiums earned, gross | 1,259,058 | 763,861 | 696,694 | - | - | - | - | - | 2,719,613 |
| Premiums earned by reinsurers | 23,634 | 95,200 | 227,547 | - | - | - | - | - | 346,381 |
| Premiums earned - retention |
1,235,424 | 668,661 | 469,147 | - | - | - | - | - | 2,373,232 |
| Losses on investments, net and finance income |
(7,199,881) | (656,984) | (73,853) | - | (4,866) | (322) | (217,001) | (661) | (8,153,568) |
| Income from management fees | 202,822 | - | - | 73,000 | 228 | 10,617 | 778 | (13,048) | 274,397 |
| Income from fees and commissions (d) |
9,334 | 9,468 | 54,109 | - | 97,881 | - | - | (30,421)(1) | 140,371 |
| Income from financial services | 46,000 | - | - | - | - | 46,000 | |||
| Other income | - | 18,771 | - | 5,000 | 2,613 | (7) | - | (425) | 25,952 |
| Total income | (5,752,301) | 39,916 | 449,403 | 124,000 | 95,856 | 10,288 | (216,223) | (44,555) | (5,293,616) |
| Payments and change in liabilities in respect of insurance contracts and | |||||||||
| investment contracts, gross | (5,879,613) | (195,410) | 491,741 | - | - | - | - | - | (5,583,282) |
| Reinsurers' share in payments and in changes in liabilities in respect of | |||||||||
| insurance contracts | 1,655 | 88,141 | 166,936 | - | - | - | - | - | 256,732 |
| Payments and change in liabilities in respect of insurance contracts and | |||||||||
| investment contracts - retention |
(5,881,268) | (283,551) | 324,805 | - | - | - | - | - | (5,840,014) |
| Fees and commissions and other purchase expenses |
181,295 | 161,944 | 132,548 | 11,000 | - | - | - | (28,249) | 458,538 |
| General and administrative expenses | 125,840 | 44,686 | 32,451 | 55,000 | 62,331 | 9,483 | 8,849 | (14,665) | 323,975 |
| Other expenses (income) | (6,814) | - | - | 3,000 | 2,714 | - | 1,932 | - | 832 |
| Finance expenses (income) | (7,776) | (2,020) | 5,042 | 1,000 | 364 | 86 | 30,151 | (487) | 26,360 |
| Total expenses | (5,588,723) | (78,941) | 494,846 | 70,000 | 65,409 | 9,569 | 40,932 | (43,401) | (5,030,309) |
| Company's share in the net results of investees | 6,979 | - | (463) | 513 | 3,772 | 4,503 | - | - | 15,304 |
| Net income (loss) before taxes on income | (156,599) | 118,857 | (45,906) | 54,513 | 34,219 | 5,222 | (257,155) | (1,154) | (248,003) |
| Other comprehensive income (loss) before taxes on income | (99,340) | (68,999) | (177,397) | - | - | 399 | (279,924) | - | (625,261) |
| Total comprehensive income (loss) before taxes on income | (255,939) | 49,858 | (223,303) | 54,513 | 34,219 | 5,621 | (537,079) | (1,154) | (873,264) |
| As of March 31 2020 | |||||||||
| Unaudited | |||||||||
| In NIS thousand | |||||||||
| Liabilities, gross in respect of insurance contracts and yield-dependent | |||||||||
| investment contracts | 59,845,046 | 4,085,782 | - | - | - | - | - | - | 63,930,828 |
| Liabilities, gross in respect of insurance contracts and non-yield | |||||||||
| dependent investment contracts | 12,896,492 | 4,051,357 | 6,364,044 | - | - | - | - | - | 23,311,893 |
(a) For additional data regarding the life insurance and long-term savings subsegments, please see Section b below.
(b) For additional data regarding the health insurance subsegments, please see Section c below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) Arises from commission income received from agencies owned by the Group, mainly from activities in the life insurance and long-term savings segment.

| For the year ended December 31 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Life insurance and long-term |
Property and casualty |
Financial | Insurance | Not attributed to operating |
Adjustments | ||||
| savings (a) | Health (b) | insurance (c) | services | agencies | Other | segments | and offsets | Total | |
| Audited | |||||||||
| In NIS thousand | |||||||||
| Premiums earned, gross | 4,765,553 | 2,781,698 | 2,835,401 | - | - | - | - | - | 10,382,652 |
| Premiums earned by reinsurers | 99,195 | 286,671 | 943,112 | - | - | - | - | - | 1,328,978 |
| Premiums earned - retention |
4,666,358 | 2,495,027 | 1,892,289 | - | - | - | - | - | 9,053,674 |
| Gains (losses) on investments, net and finance income | 4,632,824 | 482,269 | 130,873 | (91) | 37 | 127 | 239,167 | (5,500) | 5,479,706 |
| Income from management fees | 1,106,546 | - | - | 248,930 | 1,361 | 44,915 | 3,084 | (47,647) | 1,357,189 |
| Income from fees and commissions (d) | 39,119 | 44,170 | 214,717 | - | 389,025 | - | - | (130,980) | 556,051 |
| Income from financial services | - | - | - | 159,000 | - | - | - | - | 159,000 |
| Other income | 11,673 | 23,999 | - | 9,000 | 89,102 | 1,137 | 19 | (3,084) | 131,846 |
| Total income | 10,456,520 | 3,045,464 | 2,237,879 | 416,839 | 479,525 | 46,179 | 242,270 | (187,211) | 16,737,466 |
| Increase in insurance liabilities and payments in respect of | |||||||||
| insurance contracts | 8,517,055 | 2,371,630 | 1,640,879 | - | - | - | - | - | 12,529,564 |
| Reinsurers' share in payments and in changes in liabilities | |||||||||
| in respect of insurance contracts | 49,450 | 234,439 | 542,801 | - | - | - | - | - | 826,690 |
| Payments and change in liabilities in respect of insurance | |||||||||
| contracts and investment contracts - retention |
8,467,605 | 2,137,191 | 1,098,078 | - | - | - | - | - | 11,702,874 |
| Fees and commissions and other purchase expenses | 727,330 | 498,524 | 597,354 | 40,000 | - | - | - | (113,105) | 1,750,103 |
| General and administrative expenses | 543,566 | 161,986 | 144,083 | 222,078 | 237,974 | 39,466 | 66,210 | (55,335) | 1,360,028 |
| Other expenses | 26,303 | - | - | 12,000 | 9,123 | 409 | 7,505 | (455) | 54,885 |
| Finance expenses (income) | 3,397 | (2,324) | (8,021) | 5,000 | 3,314 | 402 | 147,191 | (2,450) | 146,509 |
| Total expenses | 9,768,201 | 2,795,377 | 1,831,494 | 279,078 | 250,411 | 40,277 | 220,906 | (171,345) | 15,014,399 |
| Company's share in the net results of investees | 12,006 | 2,055 | (3,592) | 3,159 | 8,670 | 17,399 | - | - | 39,697 |
| Net income (loss) before taxes on income | 700,325 | 252,143 | 402,793 | 140,920 | 237,784 | 23,301 | 21,364 | (15,866) | 1,762,764 |
| Other comprehensive income (loss) before taxes on | |||||||||
| income | 6,732 | (33,485) | 121,690 | - | (332) | 1,467 | 181,489 | - | 277,561 |
| Comprehensive income (loss) before taxes on income | 707,057 | 218,658 | 524,483 | 140,920 | 237,452 | 24,768 | 202,853 | (15,866) | 2,040,325 |
| As of December 31 2020 | |||||||||
| Audited | |||||||||
| In NIS thousand | |||||||||
| Liabilities, gross in respect of insurance contracts and yield | |||||||||
| dependent investment contracts | 71,540,354 | 5,316,559 | - | - | - | - | - | - | 76,856,913 |
| Liabilities, gross in respect of insurance contracts and non | |||||||||
| yield-dependent investment contracts | 13,047,252 | 4,237,911 | 6,184,724 | - | - | - | - | - | 23,469,887 |
(a) For additional data regarding the life insurance and long-term savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section D below.
(d) Arises from commission income received from agencies owned by the Group, mainly from activities in the life insurance and long-term savings segment.

| For the three-month period ended March 31 2021 | |||||||
|---|---|---|---|---|---|---|---|
| Provident | |||||||
| Life | fund | Pension fund | |||||
| insurance | management | management | Total | ||||
| Unaudited | |||||||
| In NIS thousand | |||||||
| Premiums earned, gross | 1,261,813 | - | - | 1,261,813 | |||
| Premiums earned by reinsurers | 28,018 | - | - | 28,018 | |||
| Premiums earned - retention | 1,233,795 | - | - | 1,233,795 | |||
| Investment income, net and finance | |||||||
| income | 3,372,939 | 15,033 | 1,472 | 3,389,444 | |||
| Income from management fees | 323,424 | 54,691 | 44,468 | 422,583 | |||
| Income from fees and commissions | 8,569 | - | - | 8,569 | |||
| Other income | 5,302 | - | 190 | 5,492 | |||
| Total income | 4,944,029 | 69,724 | 46,130 | 5,059,883 | |||
| Payments and change in liabilities in | |||||||
| respect of insurance contracts and | |||||||
| investment contracts, gross | 4,485,338 | 12,072 | - | 4,497,410 | |||
| Share of reinsurers in payments and | |||||||
| changes in liabilities in respect of | |||||||
| insurance contracts | 10,751 | - | - | 10,751 | |||
| Payments and change in liabilities in | |||||||
| respect of insurance contracts and | |||||||
| investment contracts - retention | 4,474,587 | 12,072 | - | 4,486,659 | |||
| Fees and commissions, marketing | |||||||
| expenses and other purchase expenses | 127,219 | 22,174 | 21,662 | 171,055 | |||
| General and administrative expenses | 98,463 | 23,482 | 22,282 | 144,227 | |||
| Other expenses | 4,049 | 183 | 93 | 4,325 | |||
| Finance expenses | 3,925 | 3 | - | 3,928 | |||
| Total expenses | 4,708,243 | 57,914 | 44,037 | 4,810,194 | |||
| Company's share in the net results of | |||||||
| investees | 10,521 | - | - | 10,521 | |||
| Net income before taxes on income | 246,307 | 11,810 | 2,093 | 260,210 | |||
| Other comprehensive income before | |||||||
| taxes on income | 30,043 | - | - | 30,043 | |||
| Total comprehensive income for the | |||||||
| period before taxes on income | 276,350 | 11,810 | 2,093 | 290,253 |

| For the three-month period ended March 31 2020 | ||||||
|---|---|---|---|---|---|---|
| Provident | ||||||
| Life | fund | Pension fund | ||||
| insurance | management | management | Total | |||
| Unaudited | ||||||
| In NIS thousand | ||||||
| Premiums earned, gross | 1,259,058 | - | - | 1,259,058 | ||
| Premiums earned by reinsurers | 23,634 | - | - | 23,634 | ||
| Premiums earned - retention | 1,235,424 | - | - | 1,235,424 | ||
| Gains (losses) on investments, net and | ||||||
| finance income | (7,198,634) | 522 | (1,769) | (7,199,881) | ||
| Income from management fees | 109,975 | 51,091 | 41,756 | 202,822 | ||
| Income from fees and commissions | 9,334 | - | - | 9,334 | ||
| Total income | (5,843,901) | 51,613 | 39,987 | (5,752,301) | ||
| Payments and change in liabilities in | ||||||
| respect of insurance contracts and | ||||||
| investment contracts, gross | (5,886,178) | 6,565 | - | (5,879,613) | ||
| Share of reinsurers in payments and | ||||||
| changes in liabilities in respect of | ||||||
| insurance contracts | 1,655 | - | - | 1,655 | ||
| Payments and change in liabilities in | ||||||
| respect of insurance contracts and | ||||||
| investment contracts - retention | (5,887,833) | 6,565 | - | (5,881,268) | ||
| Fees and commissions, marketing | ||||||
| expenses and other purchase expenses | 140,121 | 20,637 | 20,537 | 181,295 | ||
| General and administrative expenses | 85,847 | 17,379 | 22,614 | 125,840 | ||
| Other expenses (income) | (6,919) | 11 | 94 | (6,814) | ||
| Finance expenses (income) | (7,805) | 15 | 14 | (7,776) | ||
| Total expenses | (5,676,589) | 44,607 | 43,259 | (5,588,723) | ||
| The Company's share in the profits of | ||||||
| investees consolidated according to the | ||||||
| equity method, net of investees | 6,979 | - | - | 6,979 | ||
| Profit (loss) before income taxes | (160,333) | 7,006 | (3,272) | (156,599) | ||
| Other comprehensive loss before | ||||||
| taxes on income | (99,340) | - | - | (99,340) | ||
| Total comprehensive income (loss) | ||||||
| for the period before taxes on | ||||||
| income | (259,673) | 7,006 | (3,272) | (255,939) |

| For the year ended December 31 2020 | |||||||
|---|---|---|---|---|---|---|---|
| Provident | |||||||
| Life | fund | Pension fund | |||||
| insurance | management | management | Total | ||||
| Audited | |||||||
| In NIS thousand | |||||||
| Premiums earned, gross | 4,765,553 | - | - | 4,765,553 | |||
| Premiums earned by reinsurers | 99,195 | - | - | 99,195 | |||
| Premiums earned - retention | 4,666,358 | - | - | 4,666,358 | |||
| Investment income, net and finance | |||||||
| income | 4,592,667 | 37,459 | 2,698 | 4,632,824 | |||
| Income from management fees | 736,673 | 199,220 | 170,653 | 1,106,546 | |||
| Income from fees and commissions | 39,119 | - | - | 39,119 | |||
| Other income | 11,673 | - | - | 11,673 | |||
| Total income | 10,046,490 | 236,679 | 173,351 | 10,456,520 | |||
| Payments and change in liabilities in | |||||||
| respect of insurance contracts and | |||||||
| investment contracts, gross | 8,478,358 | 38,697 | - | 8,517,055 | |||
| Share of reinsurers in payments and | |||||||
| changes in liabilities in respect of | |||||||
| insurance contracts | 49,450 | - | - | 49,450 | |||
| Payments and change in liabilities in | |||||||
| respect of insurance contracts and | |||||||
| investment contracts - retention | 8,428,908 | 38,697 | - | 8,467,605 | |||
| Fees and commissions, marketing | |||||||
| expenses and other purchase expenses | 554,421 | 85,389 | 87,520 | 727,330 | |||
| General and administrative expenses | 378,758 | 80,118 | 84,690 | 543,566 | |||
| Other expenses | 20,762 | 733 | 4,808 | 26,303 | |||
| Finance expenses (income) | 3,393 | 21 | (17) | 3,397 | |||
| Total expenses | 9,386,242 | 204,958 | 177,001 | 9,768,201 | |||
| Company's share in the net results of | |||||||
| investees | 12,006 | - | - | 12,006 | |||
| Net income (loss) before income tax | 672,254 | 31,721 | (3,650) | 700,325 | |||
| Other comprehensive income before | |||||||
| taxes on income | 6,732 | - | - | 6,732 | |||
| Total comprehensive income (loss) | |||||||
| for the year before taxes on income | 678,986 | 31,721 | (3,650) | 707,057 |

| Policies including a savings component (including appendices) by policy issuance date |
Policies without a savings component |
|||||||
|---|---|---|---|---|---|---|---|---|
| Since 2004 | Life insurance sold as a single policy |
|||||||
| Until 1990 (1) |
Until 2003 | Non yield dependent |
Yield dependent |
Individual | Group | Total | ||
| Unaudited In NIS thousand |
||||||||
| Gross premiums Proceeds in respect of investment contracts |
16,354 | 276,482 | - | 793,075 | 142,326 | 33,576 | 1,261,813 | |
| credited directly to insurance reserves Financial margin |
- | - | - | 1,120,809 | - | - | 1,120,809 | |
| including management fees (2) Payments and change in liabilities in respect of |
124,289 | 244,523 (3) | - | 78,688 | - | - | 447,500 | |
| insurance contracts, gross Payments and change |
137,360 | 1,687,563 | - | 2,117,203 | 71,433 | 30,319 | 4,043,878 | |
| in liabilities for investment contracts Payments and change in liabilities for |
- | - | - | 441,460 | - | - | 441,460 | |
| guaranteed return provident fund tracks Total payments and change in liabilities from |
12,072 | |||||||
| life insurance and long term savings |
4,497,410 | |||||||
| Total comprehensive income from life insurance business |
94,979 | 143,235 | - | 8,565 | 23,759 | 5,812 | 276,350 | |
| Profit from pension and provident funds Total profit from life |
13,903 | |||||||
| insurance and long-term savings |
290,253 |
Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.

| Policies including a savings component (including appendices) by policy issuance date |
Policies without a savings component |
||||||
|---|---|---|---|---|---|---|---|
| Since 2004 | Life insurance sold as a single policy |
||||||
| Until 1990 (1) | Until 2003 | Non yield dependent |
Yield dependent |
Individual | Group | Total | |
| Audited | |||||||
| Gross premiums: Proceeds in respect of investment contracts credited |
19,518 | 295,589 | - | In NIS thousand 772,695 |
142,171 | 29,085 | 1,259,058 |
| directly to insurance reserves Financial margin |
- | - | - | 487,660 | - | - | 487,660 |
| including management fees (2) Payments and change in liabilities in |
(139,305) | 44,612 (3) | - | 65,175 | - | - | (29,518) |
| respect of insurance contracts, gross Payments and change in liabilities |
37,975 | (3,297,408) (6) | - | (1,783,126) (6) | 42,308 | 22,758 | (4,977,493) |
| for investment contracts Payments and change in liabilities |
- | - | - | (908,685) (6) | - | - | (908,685) |
| for guaranteed return provident fund tracks Total payments and change in liabilities from life insurance |
6,565 | ||||||
| and long-term savings Total comprehensive income (loss) from life insurance |
(5,879,613) | ||||||
| business | (101,451) (5) | (75,212) (4) | - | (78,763) | (4,839) | 592 | (259,673) |
| Profit from pension and provident funds Total loss on life insurance and long |
3,734 | ||||||
| term savings | (255,939) |
Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.

| Policies including a savings component (including appendices) by policy issuance date |
Policies without a savings component |
|||||||
|---|---|---|---|---|---|---|---|---|
| Since 2004 | Life insurance sold as a single policy |
|||||||
| Until 1990 (1) |
Until 2003 | Non yield dependent |
Yield dependent Unaudited |
Individual | Group | Total | ||
| In NIS thousand | ||||||||
| Gross premiums: Proceeds in respect of investment contracts |
73,020 | 1,133,432 | - | 2,870,641 | 563,776 | 124,684 | 4,765,553 | |
| credited directly to insurance reserves |
- | - | - | 1,945,751 | - | - | 1,945,751 | |
| Financial margin including management fees (2) Payments and change in |
185,503 | 466,855 (3) | - | 269,041 | - | - | 921,399 | |
| liabilities in respect of insurance contracts, gross Payments and change in |
439,848 | 2,783,738 | - | 4,457,267 | 261,625 | 112,290 | 8,054,768 | |
| liabilities for investment contracts Payments and change in liabilities for guaranteed |
- | - | - | 423,590 | - | - | 423,590 | |
| return provident fund tracks Total payments and change in liabilities from |
38,697 | |||||||
| life insurance and long term savings Total comprehensive income (loss) from life |
8,517,055 | |||||||
| insurance business (4) | 108,190 (5) | 560,657 (4)(5) | - | (74,902) | 71,566 | 13,475 | 678,986 | |
| Profit from pension and provident funds Total profit from life |
28,071 | |||||||
| insurance and long-term savings |
707,057 |
Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.

| Data for the period ended March 31 2021 | |||||
|---|---|---|---|---|---|
| Long-term care | Other (2) | ||||
| Individual | Group | Long-term | Short-term | Total | |
| Unaudited | |||||
| In NIS thousand | |||||
| Gross premiums | 64,897 | 239,633 | 372,814(1) | 3,995(1) | 681,339 |
| Payments and change in liabilities in respect of insurance contracts, gross |
103,997 | 505,115 | 228,792 | 6,584 | 844,488 |
| Total comprehensive income (loss) from health insurance business |
9,582 (4) | 393 | 14,417 | (1,406) | 22,986 |
(1) Of this, individual premiums in the amount of NIS 214,173 thousand and collective premiums in the amount of NIS 162,636 thousand. The decrease in individual premiums is mainly due to a decrease in travel insurance activity following the coronavirus crisis and ceasing to market health insurance policies for Israelis staying abroad permanently or for prolonged periods (relocation) beginning in the second quarter of 2020. In January 2021, the relocation insurance portfolio was transferred from the Company to the DavidShield Insurance Company Ltd.
| Data for the period ended March 31 2020 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Long-term care | Other (2) | |||||||
| Individual | Group | Long-term | Short-term | Total | ||||
| Unaudited | ||||||||
| In NIS thousand | ||||||||
| Gross premiums | 65,459 | 221,144 | 430,512(1) | 74,757(1) | 791,872 | |||
| Payments and change in liabilities in respect of insurance contracts, gross |
(64,736) | (368,987) (3) | 185,050 | 53,263 | (195,410) | |||
| Total comprehensive income (loss) from health insurance business |
50,245 (4) | (32,912) (3) | 39,747 | (7,222) | 49,858 |
(1) Of this, individual premiums in the amount of NIS 313,165 thousand and collective premiums in the amount of NIS 192,104 thousand.

| Data for the year ended December 31 2020 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Long-term care | Other (2) | |||||||
| Individual | Group | Long-term | Short-term | Total | ||||
| Audited | ||||||||
| In NIS thousand | ||||||||
| Gross premiums | 259,764 | 891,730 | 1,521,350(1) | 83,378(1) | 2,756,222 | |||
| Payments and change in liabilities in respect of insurance contracts, gross |
271,231 | 1,224,983 | 796,511 | 78,905 | 2,371,630 | |||
| Total comprehensive income (loss) from health insurance business |
41,730 | (33,016) | 228,886 | (18,942) | 218,658 |

| For the three-month period ended March 31 2021 | ||||||
|---|---|---|---|---|---|---|
| Compulsory motor insurance |
Motor property |
Property and other subsegments (*) |
Other liability subsegments (**) |
Total | ||
| Unaudited | ||||||
| In NIS thousand | ||||||
| Gross premiums | 185,928 | 329,441 | 228,546 | 163,678 | 907,593 | |
| Reinsurance premiums | 79,067 | 581 | 150,830 | 62,327 | 292,805 | |
| Premiums - retention | 106,861 | 328,860 | 77,716 | 101,351 | 614,788 | |
| Change in unearned premium balance, | ||||||
| retention | 32,037 | 73,440 | 19,068 | 25,579 | 150,124 | |
| Premiums earned - retention | 74,824 | 255,420 | 58,648 | 75,772 | 464,664 | |
| Investment income, net and finance income | 38,837 | 13,604 | 4,044 | 37,702 | 94,187 | |
| Income from fees and commissions | 18,922 | 16 | 28,686 | 6,555 | 54,179 | |
| Total income | 132,583 | 269,040 | 91,378 | 120,029 | 613,030 | |
| Payments and change in liabilities in respect of | ||||||
| insurance contracts, gross | 153,010 | 165,817 | 52,716 | 92,488 | 464,031 | |
| Reinsurers' share in payments and in changes | ||||||
| in liabilities in respect of insurance contracts | 68,792 | 314 | 41,040 | 28,273 | 138,419 | |
| Payments and change in liabilities for insurance | ||||||
| contracts - retention | 84,218 | 165,503 | 11,676 | 64,215 | 325,612 | |
| Fees and commissions, marketing expenses | ||||||
| and other purchase expenses | 15,410 | 51,855 | 36,724 | 23,217 | 127,206 | |
| General and administrative expenses | 7,208 | 10,968 | 6,848 | 6,231 | 31,255 | |
| Finance expenses | 2,653 | - | 276 | 2,575 | 5,504 | |
| Total expenses | 109,489 | 228,326 | 55,524 | 96,238 | 489,577 | |
| Company's share in the net results of | ||||||
| investees | (476) | (179) | (50) | (462) | (1,167) | |
| Net income before taxes on income | 22,618 | 40,535 | 35,804 | 23,329 | 122,286 | |
| Other comprehensive income before | ||||||
| taxes on income | 22,537 | 8,473 | 2,347 | 21,879 | 55,236 | |
| Total comprehensive income for the | ||||||
| period before taxes on income | 45,155 | 49,008 | 38,151 | 45,208 | 177,522 | |
| Liabilities in respect of insurance | ||||||
| contracts, gross, as of March 31 2021 | 2,819,358 | 796,742 | 703,203 | 2,143,461 | 6,462,764 | |
| Liabilities in respect of insurance | ||||||
| contracts - retention - as of March 31 2021 |
1,759,836 | 795,910 | 203,665 | 1,751,326 | 4,510,737 |
(*) Property and other insurance subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 82% of total premiums in these subsegments.
(**) Other liability insurance subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 82% of total premiums in these subsegments.

| For the three-month period ended March 31 2020 | |||||||
|---|---|---|---|---|---|---|---|
| Compulsory motor |
Motor | Property and other subsegments |
Other liability subsegments |
||||
| insurance | property | (*) Unaudited |
(**) | Total | |||
| In NIS thousand | |||||||
| Gross premiums | 182,069 | 312,102 | 235,604 | 156,783 | 886,558 | ||
| Reinsurance premiums | 91,498 | 34 | 151,731 | 42,567 | 285,830 | ||
| Premiums - retention | 90,571 | 312,068 | 83,873 | 114,216 | 600,728 | ||
| Change in unearned premium balance, | |||||||
| retention | 27,076 | 49,033 | 17,270 | 38,202 | 131,581 | ||
| Premiums earned - retention | 63,495 | 263,035 | 66,603 | 76,014 | 469,147 | ||
| Losses on investments, net and | |||||||
| finance income | (30,949) | (11,333) | (3,047) | (28,524) | (73,853) | ||
| Income from fees and commissions | 21,432 | - | 27,913 | 4,764 | 54,109 | ||
| Total income | 53,978 | 251,702 | 91,469 | 52,254 | 449,403 | ||
| Payments and change in liabilities in | |||||||
| respect of insurance contracts, gross | 118,824 | 188,630 | 108,415 | 75,872 | 491,741 | ||
| Reinsurers' share in payments and in | |||||||
| changes in liabilities in respect of | |||||||
| insurance contracts | 78,304 | (2) | 66,307 | 22,327 | 166,936 | ||
| Payments and change in liabilities for | |||||||
| insurance contracts - retention | 40,520 | 188,632 | 42,108 | 53,545 | 324,805 | ||
| Fees and commissions, marketing | |||||||
| expenses and other purchase | |||||||
| expenses | 12,174 | 60,131 | 39,338 | 20,905 | 132,548 | ||
| General and administrative expenses | 7,008 | 12,282 | 7,251 | 5,910 | 32,451 | ||
| Finance expenses | 2,496 | - | 246 | 2,300 | 5,042 | ||
| Total expenses | 62,198 | 261,045 | 88,943 | 82,660 | 494,846 | ||
| Company's share in the net | |||||||
| results of investees | (196) | (67) | (19) | (181) | (463) | ||
| Profit (loss) before income taxes | (8,416) | (9,410) | 2,507 | (30,587) | (45,906) | ||
| Other comprehensive loss before | |||||||
| taxes on income | (75,202) | (25,485) | (7,403) | (69,307) | (177,397) | ||
| Total comprehensive loss before | |||||||
| taxes on income for the period | (83,618) | (34,895) | (4,896) | (99,894) | (223,303) | ||
| Liabilities in respect of insurance | |||||||
| contracts, gross, as of March 31 | |||||||
| 2020 | 2,732,293 | 757,185 | 743,277 | 2,131,289 | 6,364,044 | ||
| Liabilities in respect of insurance | |||||||
| contracts - retention - as of | |||||||
| March 31 2020 | 1,826,246 | 757,185 | 232,231 | 1,763,031 | 4,578,693 |
(*) Property and other insurance subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 82% of total premiums in these subsegments.
(**) Other liability insurance subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 85% of total premiums in these subsegments.

| For the year ended December 31 2020 | ||||||
|---|---|---|---|---|---|---|
| Com pulsory motor |
Motor | Property and other subseg |
Other liability subseg |
|||
| insurance | property | ments (*) | ments (**) | Total | ||
| Audited | ||||||
| In NIS thousand | ||||||
| Gross premiums | 584,123 | 1,031,838 | 772,728 | 486,363 | 2,875,052 | |
| Reinsurance premiums | 288,266 | 135 | 527,646 | 164,581 | 980,628 | |
| Premiums - retention | 295,857 | 1,031,703 | 245,082 | 321,782 | 1,894,424 | |
| Change in unearned premium balance, retention | 19,988 | (15,965) | (6,996) | 5,108 | 2,135 | |
| Premiums earned - retention | 275,869 | 1,047,668 | 252,078 | 316,674 | 1,892,289 | |
| Investment income, net and finance income | 46,101 | 22,236 | 6,334 | 56,202 | 130,873 | |
| Income from fees and commissions | 86,229 | - | 111,679 | 16,809 | 214,717 | |
| Total income | 408,199 | 1,069,904 | 370,091 | 389,685 | 2,237,879 | |
| Payments and change in liabilities in respect of | ||||||
| insurance contracts, gross | 405,449 | 700,372 | 302,746 | 232,312 | 1,640,879 | |
| Reinsurers' share in payments and in changes in | ||||||
| liabilities in respect of insurance contracts | 271,132 | (7) | 207,374 | 64,302 | 542,801 | |
| Payments and change in liabilities for insurance | ||||||
| contracts - retention | 134,317 | 700,379 | 95,372 | 168,010 | 1,098,078 | |
| Fees and commissions, marketing expenses and | ||||||
| other purchase expenses | 66,377 | 255,818 | 176,843 | 98,316 | 597,354 | |
| General and administrative expenses | 30,616 | 54,182 | 32,096 | 27,189 | 144,083 | |
| Finance income | (3,964) | - | (411) | (3,646) | (8,021) | |
| Total expenses | 227,346 | 1,010,379 | 303,900 | 289,869 | 1,831,494 | |
| Company's share in the net results of investees | (1,519) | (519) | (157) | (1,397) | (3,592) | |
| Net income before income tax | 179,334 | 59,006 | 66,034 | 98,419 | 402,793 | |
| Other comprehensive income before taxes | ||||||
| on income | 51,449 | 17,583 | 5,334 | 47,324 | 121,690 | |
| Total comprehensive income for the year | 230,783 | 76,589 | 71,368 | 145,743 | 524,483 | |
| before taxes on income | ||||||
| Liabilities in respect of insurance contracts, | 2,731,581 | 717,570 | 677,415 | 2,058,158 | 6,184,724 | |
| gross, as of December 31 2020 | ||||||
| Liabilities in respect of insurance contracts - retention - as of December 31 2020 |
1,725,755 | 717,570 | 190,626 | 1,710,351 | 4,344,302 |
(*) Property and other insurance subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 81% of total premiums in these subsegments.
(**) Other liability insurance subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 84% of total premiums in these subsegments.

On December 7 2020, the Company entered into a merger agreement with Halman Aldubi Investment House Ltd. (hereinafter: "Halman Aldubi). Under the merger agreement, a reverse triple merger was carried out, with Halman Aldubi becoming a privately-held company wholly owned by the Company. The consideration of the transaction for Halman Aldubi is NIS 275 million. On February 28 2021, upon meeting the conditions precedent, the merger was completed. As of that date, the Company wholly-owns Halman Aldubi. The consolidation commencement date is March 31 2021.
Total assets under management by Halman Aldubi, net of the assets under management by the default pension fund sold to Meitav Dash (please see Section D below), as of March 31 2021, is approximately NIS 66 billion.
On February 18 2021, the Company entered into an agreement with Halman Aldubi Provident and Pension Funds Ltd., a company wholly-owned by Halman-Aldubi (hereinafter - "Halman Provident"), according to which the Company would extend Halman Provident a loan in the amount of approximately NIS 88,633 thousand. The loan principal will be repaid in six unequal annual installments on May 1 of each year. From 2022 to 2024 - 4% of the principal in each payment; in 2028 - 28% of the principal; and in 2029- 2030 - 30% of the principal in each payment. The loan (principal and interest) is linked to the consumer price index; the loan principal will bear a fixed interest rate of 0.45% (base interest rate). If Halman Provident does not meet the financial covenants specified in the loan agreement, the interest rate will increase by up to 0.5%. The loan to Halman Provident, for the purpose of financing the full early redemption of all bonds (Series A) issued by Halman Provident, in the amount of approximately NIS 73.6 million (hereinafter, respectively: the "Bonds" and the "Early Redemption"), as well as to finance the full early repayment of a loan totaling approximately NIS 15 million (hereinafter: the "Bank Loan Amount"), taken by Halman Provident from a local banking corporation. On March 8 2021, the early redemption of the bonds was executed and the Bank Loan Amount was transferred to the local banking corporation.
In addition, on March 25 2021, the Company entered into an agreement with Halman Aldubi to grant an additional loan in the amount of NIS 5 million. The loan principal will be repaid in one lump sum on March 31 2022. The principal will bear a fixed annual interest rate of Prime + 1%. The loan is intended to cover Halman Aldubi's credit line liabilities to a local bank.
On May 23 2021, the Board of Directors of Phoenix Excellence Pension and Provident Funds approved the merger of Halman Provident with and into The Phoenix Provident. According to the merger outline, the provident funds and the old pension funds managed by Halman Provident will be transferred to the management of Phoenix Provident. The merger between the companies - including the merger of the provident funds and the provident funds' investment tracks - is expected to be completed on September 30 2021, subject to obtaining the approvals required by law.
On February 22 2021, the Company entered into an agreement with Meitav Dash Provident Funds and Pension Ltd. (hereinafter: "Meitav Dash Provident"), according to which following the completion of the agreement with Halman Aldubi, as aforesaid, the Company will exercise its influence as Halman Aldubi's sole shareholder, such that Halman Provident will sign an agreement for the sale to Meitav Dash Provident of the new pension funds managed by Halman Provident for NIS 45 million, to be paid in one lump sum on the completion date. On March 10 2021, Halman Provident signed the said agreement. The completion of the sale is subject to meeting accepted conditions precedent, and the last date for the completion of the Funds' sale agreement is scheduled for June 30 2021.
Accordingly, in its financial statements as of March 31 2021, the Company classified the assets and liabilities in respect of the default pension activity as a held-for-sale assets and liabilities. Pursuant to a temporary measurement by an external appraiser, the total fair value of the held-for-sale assets and liabilities is approximately NIS 34 million.

The Company recognized the fair value of the assets acquired and the liabilities assumed as part of the business combination according to a provisional measurement. As of the date of approval of the financial statements, a final valuation has not yet been received by an external appraiser in relation to the fair value of the identified assets acquired and the liabilities assumed. A final adjustment of the consideration for the purchase as well as the fair value of the assets and liabilities purchased can be carried out up to 12 months from the acquisition date. At the final measurement date, the adjustments were made by way of a restating the comparison results previously reported according to the provisional measurement. The Company has opted to measure the non-controlling interests in the acquired company according to the proportionate share of the non-controlling interests in the fair value of the net identified assets of the acquiree.
The fair value of the identified assets and identifiable liabilities of Halman Aldubi at acquisition date is as follows:
| Fair value | |
|---|---|
| In NIS thousand | |
| Intangible assets | 205,760 |
| Deferred tax assets | 2,380 |
| Deferred acquisition costs | 19,047 |
| Property, plant & equipment | 34,901 |
| Investments in associates | (271) |
| Current tax assets | 1,952 |
| Receivables and debit balances | 18,056 |
| Financial investments | 32,421 |
| Cash and cash equivalents | 35,239 |
| Total assets | 349,485 |
| Liabilities in respect of deferred taxes | (55) |
| Liability for employee benefits, net | (5,018) |
| Liability in respect of current taxes | (2,637) |
| Payables and credit balances | (35,205) |
| Financial liabilities | (34,161) |
| Total liabilities | (77,076) |
| Assets, net in Halman's books of accounts | 272,409 |
| Non-controlling interests | 206 |
| Intangible assets arising from the acquisition, net of tax | 96,018 |
| Total acquisition cost, including loan to Halman Provident | 368,633 |

The total cost of the business combination amounted to NIS 369 million, and included a cash payment of NIS 275 million, a loan to Halman Provident in the amount of NIS 94 million and direct acquisition costs attributed to the transaction in the amount of approximately NIS 1 million, charged as an expense and included in the general and administrative expenses line item.
| In NIS thousand | |
|---|---|
| Total acquisition cost in cash | 275,000 |
| Loan to Halman Provident (*) | 93,633 |
| Total investment | 368,633 |
| Cash arising from the acquisition/used for the acquisition: | |
| Cash and cash equivalents in the acquiree as of the acquisition date | 35,239 |
| Cash paid as acquisition proceeds | (368,633) |
| Cash, net | (333,394) |
(*) For further details regarding the terms and conditions of the loans, please see Section B above.
As stated above, the consolidation commencement date is March 31 2021; therefore, the results of Halman Aldubi for the period ended March 31 2021 were not included in the Company's results.
Had the business combination taken place at the beginning of the year, the effect of the comprehensive income after tax and the income of Halman Aldubi on the after tax comprehensive income and income of the Group would have been immaterial.

| As of March 31 | As of December 31 |
||
|---|---|---|---|
| 2021 | 2020 | 2020 | |
| Unaudited | Audited | ||
| In NIS thousand | |||
| Investment property | 1,853,064 | 1,631,541 | 1,839,576 |
| Financial investments: | |||
| Marketable debt assets | 20,920,260 | 20,169,999 | 21,761,391 |
| Non-marketable debt assets | 7,513,185 | 7,145,477 | 7,119,613 |
| Shares | 19,514,158 | 13,790,691 | 18,045,043 |
| Other financial investments | 21,182,459 | 14,050,932 | 18,644,400 |
| Total financial investments | 69,130,062 | 55,157,099 | 65,570,447 |
| Cash and cash equivalents | 11,162,653 | 7,512,737 | 10,464,216 |
| Other | 189,637 | 190,408 | 159,845 |
| Total assets for yield-dependent contracts | 82,335,416 | 64,491,785 | 78,034,084 |
The following table presents an analysis of assets held against insurance contracts and investment contracts presented at fair value through profit and loss. The different levels were defined as follows:
Level 1 - fair value measured using quoted prices (unadjusted) in an active market for identical instruments.
Level 2 - fair value measured using observable inputs, either directly or indirectly, that are not included in Level 1 above.
Level 3 - fair value measured using inputs that are not based on observable market inputs.
For financial instruments periodically recognized at fair value, the Company estimates, at the end of each reporting period, whether transfers have been made between the various levels of the fair value hierarchy.
During the reporting periods there were no material transfers between Level 1 and Level 2.

The Company holds the financial instruments measured at fair value according to the following classifications:
| As of March 31 2021 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| In NIS thousand | ||||
| Financial investments: | ||||
| Marketable debt assets | 15,606,411 | 5,313,849 | - | 20,920,260 |
| Non-marketable debt assets | - | 5,780,945 | 1,732,240 | 7,513,185 |
| Shares | 17,616,224 | 667,087 | 1,230,847 | 19,514,158 |
| Other financial investments | 8,692,736 | 1,408,113 | 11,081,610 | 21,182,459 |
| Total | 41,915,371 | 13,169,994 | 14,044,697 | 69,130,062 |
| Level 1 | |||
|---|---|---|---|
| Level 2 | Level 3 | Total | |
| Unaudited | |||
| In NIS thousand | |||
| 16,170,342 | 3,999,657 | - | 20,169,999 |
| - | 6,149,514 | 995,963 | 7,145,477 |
| 12,575,472 | 220,261 | 994,958 | 13,790,691 |
| 4,705,344 | 837,343 | 8,508,245 | 14,050,932 |
| 33,451,158 | 11,206,775 | 10,499,166 | 55,157,099 |
(*) Reclassified.
| As of December 31 2020 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Audited | ||||
| In NIS thousand | ||||
| Financial investments: | ||||
| Marketable debt assets | 16,507,724 | 5,253,667 | - | 21,761,391 |
| Non-marketable debt assets | - | 5,427,432 | 1,692,181 | 7,119,613 |
| Shares | 16,277,954 | 518,085 | 1,249,004 | 18,045,043 |
| Other financial investments | 7,395,216 | 1,101,059 | 10,148,125 | 18,644,400 |
| Total | 40,180,894 | 12,300,243 | 13,089,310 | 65,570,447 |

Assets measured at fair value - Level 3
| Fair value measurement at the reporting date | |||||
|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss | |||||
| Non | Other | ||||
| Marke | marke | financial | |||
| table debt | table debt | invest | |||
| assets | assets | Shares | ments | Total | |
| Unaudited | |||||
| In NIS thousand | |||||
| 10,148,12 | 13,089,31 | ||||
| Balance as of January 1 2021 | - | 1,692,181 | 1,249,004 | 5 | 0 |
| Total gains recognized in profit and loss | |||||
| (*) | - | 30,563 | 49,908 | 663,592 | 744,063 |
| Purchases | - | 357,168 | 69,658 | 992,481 | 1,419,307 |
| Proceeds from interest and dividend | - | (14,068) | (7,306) | (154,689) | (176,063) |
| Redemptions / sales | - | (208,876) | (41,597) | (393,378) | (643,851) |
| Transfers from Level 3 (**) | - | (124,728) | (88,820) | (174,521) | (388,069) |
| Balance on March 31 2021 | - | 1,732,240 | 1,230,847 | 11,081,610 | 14,044,697 |
| (*) Of which: | |||||
| Total unrealized gains for the period | |||||
| included in profit and loss in respect of | |||||
| assets held as of March 31 2021 | - | 25,022 | 42,660 | 519,689 | 587,371 |
(**) Transfers from Level 3 stem mainly from securities whose rating changed and from securities issued for the first time.
| Fair value measurement at the reporting date | ||||||
|---|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss | ||||||
| Non | Other | |||||
| Marke | marke | financial | ||||
| table debt | table debt | invest | ||||
| assets | assets | Shares | ments | Total | ||
| Unaudited | ||||||
| In NIS thousand | ||||||
| Balance as of January 1 2020 | - | 599,815 | 945,002 | 8,082,717 | 9,627,534 | |
| Total gains (losses) recognized in profit | ||||||
| and loss (*) | - | (25,993) | 13,119 | 42,240 | 29,366 | |
| Purchases | - | 483,540 | 122,937 | 807,632 | 1,414,109 | |
| Proceeds from interest and dividend | - | (4,175) | (4,981) | (92,110) | (101,266) | |
| Redemptions / sales | - | (57,224) | (81,119) | (337,591) | (475,934) | |
| Transfers into Level 3 | - | - | - | 5,357 | 5,357 | |
| Balance on March 31 2020 | - | 995,963 | 994,958 | 8,508,245 | 10,499,166 | |
| (*) Of which: | ||||||
| Total unrealized gains (losses) for the | ||||||
| period included in profit and loss in | ||||||
| respect of assets held as of March 31 | ||||||
| 2020 | - | (26,098) | 5,201 | 63,982 | 43,085 |

Assets measured at fair value - Level 3 (cont.)
| Fair value measurement at the reporting date | |||||
|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss | |||||
| Marketable debt assets |
Non marketable debt assets |
Shares | Other financial investments |
Total | |
| Audited | |||||
| In NIS thousand | |||||
| Balance as of January 1 2020 | - | 599,815 | 945,002 | 8,082,717 | 9,627,534 |
| Total gains recognized in profit and loss (*) |
- | 87,999 | 149,858 | 1,072,694 | 1,310,551 |
| Purchases | - | 1,274,640 | 285,357 | 2,804,880 | 4,364,877 |
| Proceeds from interest and dividend |
- | (21,774) | (20,877) | (439,476) | (482,127) |
| Redemptions / sales | - | (373,618) | (51,059) | (1,390,789) | (1,815,466) |
| Transfers into Level 3 (**) | - | 125,119 | - | 18,099 | 143,218 |
| Transfers from Level 3 (**) | - | - | (59,277) | - | (59,277) |
| Balance on December 31 2020 |
- | 1,692,181 | 1,249,004 | 10,148,125 | 13,089,310 |
| (*) Of which: | |||||
| Total unrealized gains for the period included in profit and loss in respect of assets held as of December 31 2020 |
- | 54,547 | 119,291 | 606,432 | 780,270 |
(**) Transfers to Level 3 stem mainly from securities the rating of which was changed; transfers from Level 3 stem from a security issued for the first time.

Composition:
| As of March 31 2021 | ||
|---|---|---|
| Carrying amount |
Fair value | |
| Unaudited | ||
| In NIS thousand | ||
| Loans and receivables: | ||
| Designated bonds and treasury deposits (*) | 8,300,630 | 12,268,566 |
| Other non-convertible debt assets, excluding deposits with banks | 4,887,646 | 5,186,548 |
| Deposits with banks | 1,144,929 | 1,193,076 |
| Total non-marketable debt assets | 14,333,205 | 18,648,190 |
| Impairments carried to profit and loss (cumulative) | 62,066 |
(*) The fair value is calculated according to the contractual repayment date.
| As of March 31 2020 | ||
|---|---|---|
| Carrying amount |
Fair value | |
| Unaudited In NIS thousand |
||
| Loans and receivables: | ||
| Designated bonds and treasury deposits (*) | 8,251,293 | 11,661,134 |
| Other non-convertible debt assets, excluding deposits with banks | 4,618,967 | 4,665,090 |
| Deposits with banks | 635,067 | 674,364 |
| Total non-marketable debt assets | 13,505,327 | 17,000,588 |
| Impairments carried to profit and loss (cumulative) | 29,278 |
(*) The fair value is calculated according to the contractual repayment date.

| As of December 31 2020 | |||
|---|---|---|---|
| Carrying amount |
Fair value | ||
| Audited | |||
| Loans and receivables: | |||
| Designated bonds and treasury deposits (*) | 8,190,398 | 12,193,361 | |
| Other non-convertible debt assets, excluding deposits with banks | 4,708,119 | 5,039,280 | |
| Deposits with banks | 1,108,672 | 1,153,929 | |
| Total non-marketable debt assets | 14,007,189 | 18,386,570 | |
| Impairments carried to profit and loss (cumulative) | 60,343 |
(*) The fair value was calculated according to the contractual repayment date.
The tables below depict an analysis of the financial instruments presented at fair value. During the reporting periods there were no material transfers between Level 1 and Level 2.
| As of March 31 2021 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| In NIS thousand | ||||
| Marketable debt assets | 6,128,980 | 1,362,325 | - | 7,491,305 |
| Shares | 1,551,492 | 237,290 | 328,816 | 2,117,598 |
| Other | 848,678 | 500,340 | 2,186,140 | 3,535,158 |
| Total | 8,529,150 | 2,099,955 | 2,514,956 | 13,144,061 |
| As of March 31 2020 | |||||
|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | ||
| Unaudited | |||||
| In NIS thousand | |||||
| Marketable debt assets (*) | 6,427,288 | 1,094,046 | - | 7,521,334 | |
| Shares (*) | 1,114,880 | 53,332 | 267,619 | 1,435,831 | |
| Other | 468,558 | 413,738 | 1,601,706 | 2,484,002 | |
| Total | 8,010,726 | 1,561,116 | 1,869,325 | 11,441,167 | |
| (*) Reclassified. |

| As of December 31 2020 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Audited | ||||
| In NIS thousand | ||||
| Marketable debt assets | 6,732,438 | 1,363,030 | - | 8,095,468 |
| Shares | 1,414,649 | 155,336 | 330,008 | 1,899,993 |
| Other | 716,580 | 493,072 | 2,037,817 | 3,247,469 |
| Total | 8,863,667 | 2,011,438 | 2,367,825 | 13,242,930 |
| Financial assets at fair value through profit and loss and available-for-sale financial assets |
|||||
|---|---|---|---|---|---|
| Marketable debt assets |
Non marketable debt assets |
Shares | Other financial investments |
Total | |
| Unaudited | |||||
| In NIS thousand | |||||
| Balance as of January 1 2021 | - | - | 330,008 | 2,037,817 | 2,367,825 |
| Total profits recognized: | |||||
| In profit and loss (*) | - | - | 16,265 | 38,058 | 54,323 |
| In other comprehensive income | - | - | 6,674 | 67,686 | 74,360 |
| Purchases | - | - | 17,572 | 192,484 | 210,056 |
| Proceeds from interest and dividend |
- | - | (1,388) | (37,411) | (38,799) |
| Redemptions / sales | - | - | (18,071) | (54,288) | (72,359) |
| Transfers from Level 3 (**) | - | - | (22,244) | (58,206) | (80,450) |
| Balance on March 31 2021 | - | - | 328,816 | 2,186,140 | 2,514,956 |
| (*) Of which: | |||||
| Total unrealized gains (losses) for the period included in profit and loss in respect of assets held as of March 31 2021 |
- | - | (1,311) | 18,242 | 16,931 |
(**) Transfers from Level 3 stem from a securities issued for the first time.

| Financial assets at fair value through profit and loss and available-for-sale financial assets |
|||||
|---|---|---|---|---|---|
| Marke table debt assets |
Non marke table debt assets |
Shares | Other financial invest ments |
Total | |
| Unaudited | |||||
| In NIS thousand | |||||
| Balance as of January 1 2020 Gains (losses) recognized: |
- | - | 241,569 | 1,498,494 | 1,740,063 |
| In profit and loss (*) | - | - | 11,261 | (84,084) | (72,823) |
| In other comprehensive income | - | - | 3,552 | 29,545 | 33,097 |
| Purchases | - | - | 56,969 | 189,937 | 246,906 |
| Proceeds from interest and | |||||
| dividend | - | - | - | (9,164) | (9,164) |
| Redemptions / sales | - | - | (45,732) | (23,022) | (68,754) |
| Balance on March 31 2020 (*) Of which: |
- | - | 267,619 | 1,601,706 | 1,869,325 |
| Total unrealized losses for the period recognized in profit and loss in respect of assets held as of |
|||||
| March 31 2020 | - | - | (1,427) | (94,563) | (95,990) |
| Marke table debt assets |
Non marke table debt assets |
Shares Audited |
Other financial invest ments |
Total | |
|---|---|---|---|---|---|
| In NIS thousand | |||||
| Balance as of January 1 2020 | - | - | 241,569 | 1,498,494 | 1,740,063 |
| Total profits recognized: | |||||
| In profit and loss (*) | - | - | 15,954 | 65,621 | 81,575 |
| In other comprehensive income | - | - | 30,695 | 90,028 | 120,723 |
| Purchases | - | - | 98,720 | 619,384 | 718,104 |
| Proceeds from interest and | |||||
| dividend | - | - | (6,250) | (81,452) | (87,702) |
| Redemptions / sales | - | - | (33,570) | (163,976) | (197,546) |
| Transfers into Level 3 (**) | - | - | - | 9,718 | 9,718 |
| Transfers from Level 3 (**) | - | - | (17,110) | - | (17,110) |
| Balance on December 31 2020 | - | - | 330,008 | 2,037,817 | 2,367,825 |
| (*) Of which: | |||||
| Total unrealized gains (losses) for | |||||
| the period recognized in profit and | |||||
| loss in respect of assets held as of | |||||
| December 31 2020 | - | - | (6,574) | (13,350) | (19,924) |
(**) Securities issued for the first time and securities classified from investment in an associate

| As of March 31 2021 | ||
|---|---|---|
| Carrying amount |
Fair value | |
| Unaudited | ||
| In NIS thousand | ||
| Financial liabilities presented at amortized cost: | ||
| Short-term credit from banking corporations | 128,673 | 128,673 |
| Bonds (please see Note 8.G) | 1,467,650 | 1,513,765 |
| Subordinated bonds (1) | 3,376,344 | 3,631,801 |
| Deposits from tenants | 578,621 | 578,621 |
| Liability for REPO | 434,113 | 434,113 |
| Other (3) | 26,434 | 26,434 |
| 6,011,835 | 6,313,407 | |
| Financial liabilities presented at fair value through profit and loss | ||
| Derivatives (4) | 652,113 | 652,113 |
| Liability for short sale of marketable securities | 952,406 | 952,406 |
| Total financial liabilities presented at fair value through profit and loss | 1,604,519 | 1,604,519 |
| Lease liabilities (2) | 131,626 | - |
| Total financial liabilities | 7,747,980 |
(1) The bonds were issued for the purpose of complying with the capital requirements
(2) No fair value disclosure is required.
(3) Mainly provision in respect of an option to acquire an investee.
(4) Including financial liabilities in respect of yield-dependent contracts totaling approximately NIS 533 million.

| As of March 31 2020 | ||
|---|---|---|
| Carrying amount |
Fair value | |
| Unaudited | ||
| In NIS thousand | ||
| Financial liabilities presented at amortized cost: | ||
| Loans from non-bank entities | 4,020 | 4,020 |
| Short-term credit from banking corporations | 38,000 | 38,000 |
| Bonds (1) | 1,127,565 | 1,095,521 |
| Subordinated bonds (1)(2) | 3,370,823 | 3,479,761 |
| Repurchase commitment (REPO) (3) | 456,712 | 456,712 |
| Deposits from tenants | 617,059 | 617,059 |
| Other | 20,942 | 20,942 |
| Total financial liabilities presented at amortized cost | 5,635,121 | 5,712,015 |
| Financial liabilities presented at fair value through profit and loss | ||
| Derivatives (3) (4) | 821,219 | 821,219 |
| Short sale of securities | 319,423 | 319,423 |
| Total financial liabilities presented at fair value through profit and loss | 1,140,642 | 1,140,642 |
| Lease liabilities (5) | 121,632 | - |
| Total financial liabilities | 6,897,395 |
(1) The bonds were issued in order to comply with the capital requirements.
(2) In view of the effect of the coronavirus crisis, in March 2020 the Bank of Israel extended to authorized entities (pension funds, provident funds, mutual funds and insurance companies) a proposal to enter into a repurchase transaction (REPO) - for the sale and repurchase of government bonds and zero-coupon bonds. Accordingly, The Phoenix Insurance entered into a REPO transaction totaling approximately NIS 457 million (of which NIS 98 million in respect of yield-dependent contracts). Liabilities for derivatives increased as well, by approximately NIS 632 million, mainly due to the sharp declines in financial markets and due to changes in exchange rates.
(3) Including financial liabilities in respect of yield-dependent contracts totaling approximately NIS 582 million.
(4) No disclosure of fair value was required.

| As of December 31 2020 | ||
|---|---|---|
| Carrying amount |
Fair value | |
| Audited | ||
| In NIS thousand | ||
| Financial liabilities presented at amortized cost: | ||
| Loans from non-bank entities | 80,796 | 80,796 |
| Bonds | 1,118,538 | 1,146,475 |
| Subordinated bonds (1) | 3,374,460 | 3,675,933 |
| Liability for REPO | 389,315 | 389,315 |
| Deposits from tenants | 589,726 | 589,726 |
| Other (3) | 24,583 | 24,583 |
| Total financial liabilities presented at amortized cost | 5,577,419 | 5,906,829 |
| Financial liabilities presented at fair value through profit and loss | ||
| Derivatives (4) | 436,818 | 436,818 |
| Liability for short sale of marketable securities | 924,088 | 924,088 |
| Total financial liabilities presented at fair value through profit and loss | 1,360,906 | 1,360,906 |
| Lease liabilities (2) | 105,390 | - |
| Total financial liabilities | 7,043,714 | |
| (1) The bonds were issued in order to comply with the capital requirements. |
(2) No disclosure of fair value was required. (3) Mainly provision in respect of an option to acquire an investee.
(4) Including financial liabilities in 2020 in respect of yield-dependent contracts totaling approximately NIS 362 million.
| As of March 31 2021 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| In NIS thousand | ||||
| Liability for short sale of marketable securities |
952,406 | - | - | 952,406 |
| Derivatives | 165,869 | 482,181 | 4,063 | 652,113 |
| Financial liabilities presented at fair value |
1,118,275 | 482,181 | 4,063 | 1,604,519 |

| As of March 31 2020 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Audited | ||||
| In NIS thousand | ||||
| Liability for short sale of marketable securities |
319,423 | - | - | 319,423 |
| Derivatives | 185,309 | 635,910 | - | 821,219 |
| Financial liabilities presented at fair value | 504,732 | 635,910 | - | 1,140,642 |
| As of December 31 2020 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Audited | ||||
| In NIS thousand | ||||
| Liability for short sale of marketable securities |
924,088 | - | - | 924,088 |
| Derivatives | 148,018 | 283,617 | 5,183 | 436,818 |
| Financial liabilities presented at fair value | 1,072,106 | 283,617 | 5,183 | 1,360,906 |
The fair value of investments traded actively in regulated financial markets is determined based on market prices as of the reporting date. For investments where there is no active market, fair value is determined using valuation techniques. Such techniques include using transactions that were recently made at market terms, reference to the current market value of another instrument which is substantially the same, discounting of cash flows, or other valuation methods.
The fair value of non-marketable debt assets, which are measured at fair value through profit and loss, and the fair value of non-marketable financial debt assets, for which fair value information is provided solely for disclosure purposes, is determined by discounting the estimated future cash flows from those assets. The discount rates are based primarily on yields on government bonds and spreads of corporate bonds as measured on the TASE. The quoted prices and interest rates used for discounting purposes are determined by a company which won the tender, published by the Ministry of Finance, for the setting up and operating a database of quoted prices and interest rates for institutional entities.

The fair value of the investment in non-marketable shares was estimated using the discounted cash flow model (DCF). The estimate requires management to make certain assumptions regarding the model's data, including expected cash flows, discount rates, credit risk and volatility. The probabilities in respect of the estimates in the range can be measured reliably, and management uses them to determine and evaluate the fair value of these investments in nonmarketable shares.
c) Derivatives
The Company enters into transactions involving derivative financial instruments with multiple parties, especially financial institutions. The derivatives were valued using valuation models with observable market inputs are mainly interest rate swap contracts and foreign currency forwards. The most frequently used valuation techniques include prices of forwards and swap models using present value calculations. The models combine a number of inputs, including the credit rating of the parties to the financial transaction, spot/forward exchange rates, prices of forward contracts and interest rate curves. All derivative contracts are fully back against cash; therefore, there is no counterparty credit risk and non-performance risk of the Company itself in respect thereof.
A. It is management's policy to maintain a strong capital base in order to retain Company's ability to continue its activities such that it will be able to generate returns to its shareholders and support future business activities. The Phoenix Insurance, the Excellence Group, pension and provident funds management companies and other institutional entities consolidated in the financial statements are subject to capital requirements set by the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner").
In October 2020, The Phoenix Insurance's Board of Directors set a minimum economic solvency ratio target and target range based on Solvency II. The minimum economic solvency ratio target, taking into account the transitional provisions, is set at 135% while the minimum solvency ratio target without taking into account the provisions during the transitional period is set at 105%, set to reach 135% at the end of the transitional period according to The Phoenix Insurance's capital plan.
Furthermore, The Phoenix Insurance's Board of Directors approved an economic solvency ratio target range of 150%-170%, within which The Phoenix Insurance aspires to be during and at the end of the transitional period, taking into account the Deduction During the Transitional Period and its gradual reduction.
The Phoenix Insurance is subject to the Solvency II-based Economic Solvency Regime in accordance with implementation provisions as published in June 2017 and revised in October 2020 (hereinafter the "Economic Solvency Regime").
The economic solvency ratio is calculated as the ratio between the insurance company's recognized economic equity and the capital required for solvency purposes.
The recognized economic equity is determined as the sum of the core tier 1 capital derived from the economic balance sheet and debt instruments that include loss absorption mechanisms (Additional Tier 1 capital, Tier 2 capital instruments, Subordinated Tier 2 capital, Tier 2 capital and Tier 3 capital).

Economic balance sheet items are calculated based on economic value, with insurance liabilities calculated on the basis of a best estimate of all expected future cash flows from existing businesses, without conservatism margins, and plus a risk margin.
The solvency capital requirement (SCR) is designed to estimate the economic equity's exposure to a series of scenarios set out in the Economic Solvency Regime provisions, and which reflect insurance, market and credit risks as well as operational risks.
The Economic Solvency Regime includes, among other things, transitional provisions in connection with compliance with capital requirements, and which allow increasing the economic equity by deducting from the insurance reserves an amount calculated in accordance with the Economic Solvency Regime provisions (hereinafter: the "Deduction"). The Deduction will decrease gradually until 2032 (hereinafter: the "Transitional Period"). In addition to a reduced capital requirement, that will increase gradually until 2023, in respect of certain investment types.
In accordance with the Consolidated Circular, the Economic Solvency Ratio Report in respect of the December 31 and June 30 data of each year shall be included in the first periodic report published after the calculation date. Despite the above, on March 19 2020, the Commissioner published a letter, Ref. No. SH 2020-2031, stipulating that an insurance company is exempt from publishing an Economic Solvency Ratio Report as of June 30 2020 and from filing solvency reporting files in for that date.
On March 14 2021, a letter from the Commissioner was published, Ref. No. 2021-423, stating that the deadline for publication of the Economic Solvency Ratio Report as of December 31 2020, as well as the accompanying files reported to the Commissioner, shall be filed no later than June 30 2021. In addition, the letter states that an insurance company may refrain from publishing an Economic Solvency Ratio Report as of June 30 2021.
The Phoenix Insurance published its Solvency Ratio Report as of December 31 2020 along with the publication of the Financial Statements.
In accordance with the Solvency Ratio Report as of December 31 2020, The Phoenix Insurance has surplus capital, both when calculation is made having no regard to the transition provisions and when it is made taking into account the transition provisions. The calculation made by The Phoenix Insurance as described above, was reviewed by The Phoenix Insurance's independent auditors, in accordance with International Standard on Assurance Engagements (ISAE 3400) - the Examination of Prospective Financial Information. This standard is relevant to audits of solvency calculations and does not constitute part of the auditing standards that apply to financial statements.
It should be emphasized that the projections and assumptions on the basis of which the Economic Solvency Ratio Report was prepared are based mainly on past experience as arising from actuarial studies conducted from time to time. In view of the reforms in the capital market, insurance and savings, and the changes in the economic environment, past data do not necessarily reflect future results. The calculation is sometimes based on assumptions regarding future events, steps taken by management, and the pattern of the future development of the risk margin, that will not necessarily materialize or will materialize in a manner different than the assumptions used in the calculation. Furthermore, actual results may materially vary from the calculation, since the combined scenarios of events may materialize in a manner that is materially different than the assumptions made in the calculation.
In their special report, the independent auditors noted that they did not review the appropriateness of the Deduction During the Transitional Period as of December 31 2020, except for verifying that the Deduction amount does not exceed the expected discounted amount of the risk margin and the capital required for solvency in respect of life and health insurance risks arising from existing businesses during the Transitional Period in accordance with the pattern of future development of the required capital, which affects both the calculation of the expected capital release and the release of the expected risk margin as described in the provisions on calculation of risk margin. Furthermore, attention is drawn to what is stated in the Economic Solvency Ratio Report regarding the uncertainty derived from regulatory changes and exposure to contingent liabilities, the effect of which on the solvency ratio cannot be estimated.
For further details, please see Section 2.1 to the Report of the Board of Directors, and the Economic Solvency Ratio Report as of December 31 2020 published on The Phoenix Insurance's website.

According to the letter published by the Commissioner, in October 2017, (hereinafter - the "Letter") an insurance company shall be entitled to distribute a dividend only if, following the distribution, the company has a solvency ratio - according to the provisions of the Economic Solvency Regime - of at least 100%, calculated without taking into account the transitional provisions and subject to the economic solvency ratio target set by the Company's Board of Directors. The aforesaid ratio shall be calculated without the relief granted in respect of the original difference attributed to the acquisition of the provident funds and management companies. In addition, the letter set out provisions for reporting to the Commissioner.
On October 27 2020, The Phoenix Insurance's Board of Directors approval of the dividend distribution whereby, as from 2021, The Phoenix Insurance shall distribute an annual dividend at a rate of 30% to 50% of its distributable comprehensive income as per its audited annual consolidated financial statements for the relevant year, so long as The Phoenix Insurance meets the minimum economic solvency ratio targets in accordance with Solvency II. ---
The minimum economic solvency ratio target, taking into account the transitional provisions, is set at 135% while the minimum solvency ratio without taking into account the provisions during the transitional period is set at 105%,1 set to reach 135% at the end of the transitional period according to The Phoenix Insurance's capital plan.
It is hereby clarified that this policy should not be viewed as an undertaking by The Phoenix Insurance to distribute dividends, and that any actual distribution shall be individually subject to the Board of Directors' approval, at its sole discretion; the Board of Directors of The Phoenix Insurance may decide on actual distribution at different (higher or lower) rates, or not to distribute any dividend. Furthermore, the execution of any actual distribution shall be subject to compliance with the provisions of the law applicable to any dividend distribution, including, among other things, the provisions of the Companies Law, 1999, and to compliance with the financial covenants The Phoenix Insurance has undertaken or/or will undertake to comply with, to The Phoenix Insurance's having sufficient distributable profits on the relevant dates, to the condition that the distribution shall not adversely affect the terms of The Phoenix Insurance's bonds and/or its cash flows, and to the extent to which the The Phoenix Insurance needs cash to finance its activities, including future investments, as shall be from time to time, and/or its expected and/or planned future activities.
The Board of Directors of The Phoenix Insurance may review the dividend distribution policy from time to time and decide, at any given time, taking into account business considerations and the legal and regulatory provisions applicable to The Phoenix Insurance, to change the dividend distribution policy, including the rate of dividend to be distributed.
On March 24 2021, the Board of Directors of The Phoenix Insurance approved the distribution of a dividend in the amount of NIS 200 million, in accordance with the audited results as of December 31 2019, and in accordance with the results of an estimate to calculate the Solvency II-based economic solvency ratio as of December 31 2020. The dividend was paid in April 2021.
As stated, in accordance with the audited economic solvency ratio as of December 31 2020, the Company meets the requirements of the letter published by the Commissioner in October 2017 regarding the restrictions on dividend distribution, as stated above.
The solvency ratio as of December 31 2020 does not include the effect of the business activity of The Phoenix Insurance subsequent to December 31 2020 until the report publication date, changes in the mix and amounts of insurance investments and liabilities, exogenous effects - including changes in the risk-free interest rate curve, and regulatory changes affecting the business environment.
1 On December 30 2019, the Board of Directors of The Phoenix Insurance approved the transfer of Excellence Pension and Provident Funds to the Company as distribution of a dividend in kind. The transfer was approved by the Commissioner; however, the Israel Tax Authority's approval for the execution of the transfer has not yet been received, and therefore the transfer has not yet been made. In view of the above, on October 27 2020, The Phoenix Insurance's Board of Directors passed a resolution whereby the target is inapplicable to the transfer. Upon receipt of the Israel Tax Authority's approval, the execution of the abovementioned transfer shall be assessed subject to the provisions of the Solvency Circular and letter. It should also be noted that this transfer is expected to reduce The Phoenix Insurance's capital surplus.


In recent years, there has been a significant increase in the number of petitions to approve class actions filed against the Group and in the number of lawsuits recognized as class actions. This is part of an overall increase in petitions to approve lawsuits as class actions in general, including against companies engaged in the Group's areas of activity, which stems mainly from the enactment of the Class Actions Law, 2006. This trend substantially increases the Group's potential exposure to losses in the event of a ruling against the Group companies in class actions.
Petitions to approve lawsuits as class actions are filed through the hearing procedure mechanism set forth in the Class Action Law, 2006 (hereinafter: the "Class Actions Law"). The hearings procedure for petitions to approve lawsuits as class actions is divided into two main stages: The first stage is the approval petition (hereinafter: the "approval petition" or the "approval stage", respectively.) If the approval petition is rejected by the court, the hearing stage at the class action level ends. A ruling at the approval stage may be subject to a request for appeal to the appellate courts. In the second stage, if the approval petition is accepted, the class action will be heard (hereinafter: the "class action stage"). A judgment at the class action stage can be appealed to the appellate courts. Within the mechanism of the Class Actions Law, there are, inter alia, specific settlement agreements, both in the approval stage and in the class action stage, as well as arrangements with regard to the plaintiff's withdrawal of the approval petition or class action lawsuit.
In the State of Israel, filing class action lawsuits does not entail payment of a fee derived from the claim amount; therefore the amounts of such claims may be significantly higher than the actual exposure for that claim.
Petitions to approve lawsuits as class actions (including lawsuits approved as class actions and the approval of which is under appeal) are set out in Sections 13-1, 32-17, 34, 43-36, 47-45, 50, 52, 56, 57 to the following table; for such lawsuits, which, in management's opinion - that is based, inter alia, on legal opinions whereby the Group's defense claims are more likely than not to be accepted and the petitions to approve the lawsuit as class actions will be rejected - no provision was included in the financial statements, except for petitions to approve class actions in which the Group is willing to reach a settlement. For petitions to approve lawsuits as class actions (including lawsuits approved as class actions and the approval of which is under appeal), in which the Group's defense claims - in whole or in part - are more likely than not to be rejected, and in which the Group is willing to reach a compromise, provisions were included in the financial statements to cover the exposure as assessed by the Group or a provision in the amount for which the Group is willing to settle, as the case may be.
Management's assessment, which is based, inter alia, on legal opinions received, is included in the financial statements under adequate provisions, where such provisions were required, to cover the exposure as assessed by the Group or the amount for which the Group is willing to settle, as the case may be.
Many of the petitions to approve lawsuits as class actions have been filed against the Group on various matters related to insurance contracts and the Group's ordinary course of business, for which the Group has allocated insurance reserves.
In petitions to approve lawsuits as class actions as set out in Sections 16-14, 33, 35, 44, 48, 49, 51, 55-53, 66-58 in the table below, at this preliminary stage, the chances of the petitions to approve lawsuits as class actions cannot be assessed and therefore no provision is included in respect thereof in the Financial Statements.

Following is more information about the petitions to approve lawsuits as class actions:
| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 1. | January 2008 Tel Aviv District Court The Phoenix Insurance and other insurance companies Approximately NIS 1.67 billion of all defendants, with about NIS 277 million attributed to The Phoenix Insurance.4 |
Unlawful collection of payments known as "sub-annuals" for life insurance policies, in an amount that exceeds the permitted one. |
In May 2018, the Supreme Court granted the defendants' motion for leave to appeal and dismissed the plaintiffs' appeal, such that the District Court's judgment was quashed and the motion for approval of the claim as a class action was denied. On July 2 2019, the Supreme Court upheld the plaintiffs' request for a further hearing (before a seven judge panel) on the question set forth in the Judgment regarding the regulator's position filed with the court regarding its instructions, and on the question of de minimis defense in a monetary class action. On February 2 2020, the Attorney General submitted his position in the additional hearing, according to which he supports the stipulations made in the Judgment as to the weight that should be given to the regulator's position in relation to its guidelines; the Attorney General also stated that in his view there is no room to interfere with the Judgment's adoption of the Capital Market Authority's interpretive position. An additional hearing was held on July 26 2020, and the parties await a judgment. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.
4 The amounts were assessed by the plaintiffs in the class action statement of claim. It should be noted that the amounts in the motion to approve the claim as a class action were different and higher; those amounts also referred to the claim of collecting handling fees on policies and interest on annual premium, which is paid in installments, at a rate higher than the rate permitted by law, which, as stated, has been rejected.

| A. Class actions - petitions to approve lawsuits as class actions and lawsuits approved as class actions |
(cont.) | |
|---|---|---|
| ---------------------------------------------------------------------------------------------------------------- | --------- | -- |
| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 2. | February 2010 Central District Court The Phoenix Insurance (and other insurance companies in a parallel case, in light of filing a consolidated class action statement of claim) Approximately NIS 1.47 billion of all defendants (includling the defendants in the corresponding case), of which approximately NIS 238 million is attributed to The Phoenix Insurance.4 |
The cause of the lawsuit, as approved by the District Court (in the corresponding case) was breach of insurance policies due to unlawful collection of handling fees in a manner that reduced the saving amount accrued in favor of the policyholder for a period starting seven years before the claim was filed. |
In November 2016, the District Court - in a parallel case filed against several other insurance companies - partially approved motions to approve the claims as class actions. The class action - both in the corresponding case and in the case heard against The Phoenix Insurance - continues to be heard jointly by the District Court. At the same time, the parties conduct a mediation process. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.
4 The amounts are the amounts assessed by the plaintiffs in the consolidated class action statement of claim filed in March 2019 against the insurance companies sued in the corresponding case and against The Phoenix. It should be noted that the amounts in the motion for approval of the claim as a class action were different and higher.

| A. Class actions - petitions to approve lawsuits as class actions and lawsuits approved as class actions (cont.) |
|---|
| --------------------------------------------------------------------------------------------------------------------------- |
| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 3. | April 2010 Central District Court The Phoenix Insurance and other insurance companies NIS 225.2 million from all the defendants. |
Non-refund of premium for the relative portion of the month in which the insurance ended (due to cancellation by the policyholder) and/or refund of premium (where the premium is refunded) at nominal values (without linkage differences and interest). |
In June 2015, the district court partially affirmed the petition to approve the claim as a class action lawsuit. In September 2016, the parties filed with the District Court an application for approval of a settlement agreement, at amounts that are immaterial to The Phoenix Insurance, which includes: the appointment of an examining party who will review the collection amounts in respect of which the claim was approved as a class action; consent to a contribution of 80% of the amount of the refund to be determined by the examining party; provisions regarding future conduct in cases of cancellation of policies that are the subject matter of the lawsuit and a recommendation regarding the payment of compensation to the plaintiffs, legal fees, etc. The settlement agreement is subject to the Court's approval. In June 2017, the Court appointed a reviewer to review the settlement agreement; the reviewer filed the review on The Phoenix Insurance in December 2020. The settlement agreement has not yet been approved by the court. |
| 4. | May 2013 Tel Aviv District Court The Phoenix Insurance Approximately NIS 220 million or alternatively NIS 90 million.4 |
Non-payment of interest in respect of insurance benefits from the date of the insurance event, or alternatively from the end of 30 days from the date on which the claim was filed and until actual payment date. |
On February 28 2021, the District Court handed down a partial judgment, according to which it has approved the class action, in respect of any entitled party (policyholder, beneficiary or third party), who - during the period starting three years prior to the filing of the lawsuit and ending on judgment date - received insurance benefits from The Phoenix Insurance (not in accordance with a judgment rendered in his case) without being duly paid interest thereon. It was also established that, for the purpose of implementing the judgment, calculation and manner of restitution, an expert will be appointed and that the class plaintiffs will be awarded legal expenses and legal fees. On May 18 2021, The Phoenix Insurance filed an appeal with the Supreme Court against the judgment handed down by the District Court as well as a motion to stay the execution of the judgment. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.
4 The amounts are those amounts that were estimated by the plaintiff in the class action statement of claim - NIS 220 million (if it was ruled that interest should be calculated from the date of occurrence of the insurance event) and NIS 90 million (if it is ruled that interest should be calculated starting 30 days from the delivery date of the claim). It should be noted that the amounts in the motion for approval of the class action lawsuit were different and higher and also related to the linkage claim, which was rejected as described above.

| A. Class actions - petitions to approve lawsuits as class actions and lawsuits approved as class actions |
(cont.) |
|---|---|
| ---------------------------------------------------------------------------------------------------------------- | --------- |
| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 5. | July 2014 Central District Court The Phoenix Pension and Gemel Ltd. (currently: Phoenix Excellence Pension and Provident Funds Ltd.) and management companies of other pension funds. NIS 48 million from all defendants. |
Acting in bad faith when using the right - under the pension fund's rules and regulations - to increase management fees paid by pensioners from the accrual to the maximum amount allowed, as from the date they become pensioners. |
The parties are awaiting the court's decision on the application for approval of the claim as a class action. |
| 6. | June 2015 Beer Sheva District Court The Phoenix Insurance Approximately NIS 125 million. |
The cause of action, as approved by the District Court, is a violation of the provisions of the policy regarding special compensation (reimbursement) for performing surgery in a private hospital funded by "additional insurance services" (SHABAN) and the questions common to the group members are: what is the value of the commitment form on behalf of a health maintenance organization in respect of a privately-owned hospital (Form 17), according to which the amount to be reimbursed to the policyholder is calculated; how The Phoenix Insurance in effect calculated the amount reimbursed to policyholders who underwent surgeries as part of SHABAN; and whether The Phoenix Insurance violated the provisions of the policy, and did not reimburse the full amount to the policyholders. |
In December 2019, the District Court approved the petition to approve the claim as a class action lawsuit. The group on whose behalf the class action will be conducted will include all policyholders who were insured under a health insurance policy with The Phoenix Insurance, which included a reimbursement arrangement for performing surgery at a private hospital funded by SHABAN, based on a commitment form/Form 17, and in respect of whom an insurance event occurred from June 25 2012 through June 25 2015. The parties are in a mediation procedure. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| A. Class actions - petitions to approve lawsuits as class actions and lawsuits approved as class actions (cont.) |
|
|---|---|
| --------------------------------------------------------------------------------------------------------------------------- | -- |
| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 7. | September 2015 | The claim is that the defendants pay agents fees and commissions calculated as a percentage of the |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| Tel Aviv District Court | management fees charged by them, thus allegedly violating their fiduciary duties, and that, as a result, the management fees that planholders are charged are higher than the appropriate rate. |
||
| The Phoenix Pension and management companies of |
|||
| additional pension funds | |||
| Approximately NIS 300 million per | |||
| year since 2008 of all the defendants. |
|||
| 8. | December 2015 | Alleged unlawful collection of "sub-annuals" in life insurance at a rate that is higher than the permitted one. |
On May 27 2020, the court issued a ruling rejecting the motion for approval of the claim as a class action, on the grounds that the plaintiffs do not have a cause of action. |
| Tel Aviv District Court | |||
| The Phoenix Insurance and another insurance company |
In September 2020, the plaintiff filed an appeal with the Supreme Court. An appeal hearing is scheduled for March 7 2022. |
||
| Approximately NIS 100 million from all defendants, of which NIS 50 million is attributed to The Phoenix Insurance. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 9. | February 2016 Central District Court The Phoenix Insurance NIS 100 million. |
The plaintiffs argue that The Phoenix Insurance does not link the payments it must pay policyholders under life insurance policies (which it issued until July 19 1984) due to an insurance event or due to the redemption of the policy, to the correct basic CPI in accordance with the linkage terms and conditions set out in the policies; i.e., the latest CPI published before the first day of the month in which the insurance term begins; the plaintiffs argue that this has a significant effect on the benefits to which the policyholders will be entitled. |
The parties are in a mediation procedure. |
| 10. | February 2016 Tel Aviv Regional Labor Court (the hearing was transferred from the Central District Court due to substantive jurisdiction) The Phoenix Pension and Gemel Ltd. (currently: Phoenix Excellence Pension and Provident Funds Ltd.) and management companies of additional pension funds. Approximately NIS 1 billion of all the defendants. |
The plaintiffs argue that the defendants are acting inappropriately by charging management fees in respect of disability and survivors benefits, and do not disclose that fact, and that the rate of management fees collected from such benefit recipients is the maximum permitted rate, taking advantage of the fact that benefit recipients cannot transfer their funds and/or entitlement to such benefits elsewhere. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| 11. | September 2016 Tel Aviv District Court The Phoenix Insurance and other insurance companies NIS 4.45 billion from all defendants, of which NIS 943 million is attributed to The Phoenix Insurance. |
Collection of premiums on health insurance policies, for unnecessary coverages that the policyholders do not need, and alleged sale of health insurance policies despite being aware that they include coverages that the policyholders have no need for, since they have supplementary health insurance from the health maintenance organization they are a member of. In addition, according to the defendants, they also tied services since customers were unable to purchase a reduced-coverage policy that will include only coverages that are not included in the supplementary health insurance of their health maintenance organizations, thus creating "overlapping insurance". |
In October 2020, the District Court ruled that the motion for approval of the claim as a class action was denied. In November 2020, the plaintiffs filed an appeal to the Supreme Court. An appeal hearing is scheduled for December 6 2021. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
The motions to approve the lawsuits as class actions that appear in Sections 12-16 below were submitted on the grounds of unlawful collection of investment management expenses which are not sanctioned by the policies or bylaws.
| 12. | September 2016 Central District Court The Phoenix Insurance NIS 14.7 million. |
Collecting investment management expenses in the individual saving policy Excellence Invest in addition to collecting management fees, without a provision in the policy expressly permitting to do so. |
In May 2019, the District Court approved the petition to approve the claim as a class action lawsuit filed against The Phoenix Insurance and three other insurance companies (hereinafter: the "Defendants"), for breaching the provisions of the insurance policy due to unlawful collection of investment management expenses. The class on whose behalf the class action lawsuit against The Phoenix Insurance will be conducted includes all policyholders of the individual savings policy Excellence Invest issued by The Phoenix Insurance at present and in the seven years prior to the date of submission of the motion for approval as class action. The remedies claimed are the reimbursement of the investment management expenses that were overcharged in addition to interest differentials; and an order directing the defendants to stop collecting such fees. |
|---|---|---|---|
| In September 2019, The Phoenix Insurance (along with the other defendants) filed a motion for leave to appeal to the Supreme Court against the decision approving the class action lawsuit. |
|||
| At the request of the Supreme Court, on August 13 2020, the Attorney General submitted his position on the proceedings and announced his attendance. According to the position, the Attorney General is of the opinion that the court should accept the motion for leave to appeal and the appeal itself and order the rejection of the motions for approval as class actions, for the reasons set out in the position. |
|||
| A hearing on the request for leave to appeal took place on February 11 2021, and the parties are awaiting the decision of the Supreme Court. |
|||
| At this point, the hearing on the class action in the District Court was postponed. | |||
| It should be noted that requests for approval of class actions regarding investment management expenses are also pending against Excellence Gemel (please see Section 13 in the table below), The Phoenix Insurance (see Section 14 in the table below) and Halman Aldubi Provident and Pension Funds Ltd. (see Sections 15 and 16 in the table below). |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 13. | November 2016 Jerusalem Regional Labor Court Excellence Nessuah Gemel Ltd. (currently: Phoenix Excellence Pension and Provident Funds Ltd.) Approximately NIS 215 million. |
The plaintiffs argue that under the rules and regulations of the Excellence Gemel provident fund, which were in effect until January 1 2016, and according to the rules and regulations of the Excellence Advanced Education fund, Excellence Gemel may not collect investment management expenses from planholders, since collection of such expenses had to stipulated clearly and expressly in the rules and regulations of the funds. |
The parties filed a motion for a hearing arrangement with the court, according to which the hearings to approve the claim as a class action will be postponed until a decision has been made in connection with the motion for leave to appeal against the May 2019 District Court decision to approve as petitions to approve lawsuits as class actions filed for similar causes of action against The Phoenix Insurance, among others (see Section 12 above, in the table). |
| 14. | June 2019 Tel Aviv Regional Labor Court The Phoenix Insurance Approximately NIS 351 million. |
According to the plaintiff, The Phoenix Insurance charges policyholders of insurance policies which combine a life insurance component and a pension saving component (executive insurance) for investment management expenses without such charges being included in the terms and conditions of the policy. |
The Phoenix Insurance has not yet submitted its response to the motion to approve the claim as a class action, and on October 2019, it submitted a motion for stay of proceedings until a decision is made in connection with the motion for leave to appeal against the May 2019 District Court decision to approve as class actions claims filed for similar causes of action (see Section 12 above, in the table). A final decision has yet to be made in connection with the stay of proceedings motion. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| A. Class actions - petitions to approve lawsuits as class actions and lawsuits approved as class actions |
(cont.) |
|---|---|
| ---------------------------------------------------------------------------------------------------------------- | --------- |
| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 15. | June 2019 Jerusalem Regional Labor Court Halman Aldubi Provident and Pension Funds Ltd. NIS 17.5 million. |
The statement of claim alleges that IBI Provident and Study Fund Management Company Ltd. (which was merged with Halman Aldubi on July 1 2018) charged the plaintiff and the other planholders of the study fund under its management, investment management expenses, in addition to the fund management fees, contrary to the fund's bylaws. |
Halman Aldubi has not yet submitted its response to the petition for approval of the claim as a class action lawsuit; in September 2019, it submitted a motion for a stay of proceedings until a final decision has been made on ten petitions to approve claims as class action lawsuits which are being heard in Labor Court (including against Excellence Nessuah (see Section 13 above in the table) regarding the collection of management expenses in provident funds and advanced education funds. |
| A final decision has yet to be made in connection with the stay of proceedings motion. |
|||
| 16. | July 2019 Jerusalem Regional Labor Court Halman Aldubi Provident and Pension Funds Ltd. No estimate was provided, but it was noted that the damage to all class members exceeds NIS 3 million. |
According to the statement of claim, Halman Aldubi charged the plaintiff and the other planholders of the Halman-Aldubi comprehensive pension fund (the "Fund") investment management expenses, in addition to the management fees charged by the Fund, contrary to the Fund's bylaws; the practice continued until May 2017, at which time the Fund's bylaws were changed so as to include the specific provision for charging direct investment management expenses. |
Halman Aldubi has not yet submitted its response to the petition for approval of the claim as a class action lawsuit; in September 2019, it submitted a motion for a stay of proceedings until a final decision has been made on ten petitions for approval of claims as class action lawsuits which are being heard in Labor Court (including against Excellence Nessuah (see Section 13 above in the table) regarding the collection of management expenses in provident funds and advanced education funds. A final decision has yet to be made in connection with the stay of proceedings motion. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 17. | January 2017 Central District Court The Phoenix Insurance and other insurance companies At least approximately NIS 12.25 million in respect of each of the defendants. |
According to the plaintiffs, insurance companies overcharge insurance premiums since they do not disclose to policyholders a "practice" in the motor insurance subsegment that allows updating the age of the young driver insured under the policy and/or the years of driving experience when moving into another age bracket and/or years of driving experience bracket which can potentially result in a reduction of the insurance premium. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| It should be noted that the plaintiffs refer in their claim to a decision approving a motion for approval of a claim as a class action dealing with the same issue and filed against another insurance company, in which the said practice had allegedly been proven. |
|||
| 18. | April 2017 Tel Aviv Regional Labor Court (the hearing was transferred from the Tel Aviv Central District due to substantive jurisdiction) Shekel Insurance Agency (2008) Ltd. (hereinafter: "Shekel"), Agam Liderim (Israel) Insurance Agency (2003) Ltd. (hereinafter: " Agam Liderim"), second-tier companies of The Phoenix Holdings, and other insurance agencies. Approximately NIS 357 million of all defendants, of which NIS 47.81 million is attributed to Agam Liderim and NIS 89.64 million to Shekel. |
According to the plaintiffs, until the regulator intervened and legislative changes were made in connection with this issue, managers of pension arrangements in general and the defendants in particular, provided employers with operating services involving preparing and managing pension insurance for employees without the employers paying any consideration in respect thereof to the pension arrangement managers, and that all costs pertaining to the operating services are paid by the employees through management fees they pay for the products marketed to them by the managers of the pension arrangement. |
In August 2020, the court issued a ruling rejecting the motion for approval of the claim as a class action. On October 5 2020, the plaintiffs filed an appeal with the National Labor Court. An appeal hearing is scheduled for June 9 2021. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 19. | June 2017 Central District Court The Phoenix Insurance The amount of the claim was not estimated. |
The lawsuit concerns improper and unlawful actions of The Phoenix Insurance in the process of marketing and selling the service contracts it sells as part of comprehensive motor insurance. According to the claim, The Phoenix Insurance markets, either directly or through agents acting on its behalf, comprehensive insurance plans that include service contracts, as an inherent and integral part thereof; these marketing activities are carried out without presenting customers with the price of the service contracts during the marketing process, without allowing them to give up the service contracts in exchange for a lower price that will reflect the cost of the service removed, while tying the purchase of a package of service contracts to the insurance plan, failing to provide reliable information, failing to match the insurance to the needs of the insurance applicant, etc. |
The parties are awaiting the court's decision on the application for approval of the claim as a class action. It should be noted that in July 2018, the Capital Market, Insurance and Savings Authority published an amendment to the circular on the introduction of service contracts and the methods employed to market them. The objective of the circular amendment was to prescribe additional provisions regarding the marketing of service contracts. |
| 20. | June 2017 Central District Court (sitting as an Administrative Court). The National Insurance Institute (hereinafter: the "National Insurance Institute") The Phoenix Insurance and additional insurance companies (hereinafter, jointly: the "Official Respondents") The amount of the claim was not estimated. |
According to the plaintiffs, the National Insurance Institute collects national insurance contributions and health insurance contributions illegally from the tax-exempt income of class members as defined below, in addition to collecting the minimum rate of health insurance contributions from class members' disability pension. According to the plaintiffs, the National Insurance Institute overcharges class members for these contributions through the pension fund, the employer or any other third party. The plaintiffs point out that the Official Respondents are entities through which the insurance premiums were collected from the plaintiffs, and clarify that any employer and any entity paying an early pension and any entity paying a PHI benefit in Israel may be in a similar position to that of the Official Respondents. According to the plaintiffs, it is impossible to add all the parties as respondents and the court is asked to consider the Official Respondents that were added and which are related to the plaintiffs' case as class action defendants. The plaintiffs also stated that no operative remedy is requested in the case of the Official Respondents in the framework of the above claim. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 21. | August 2017 Tel Aviv Regional Labor Court (the hearing was transferred from the Central District Court due to substantive jurisdiction) Excellence Gemel & Hishtalmut Ltd. (currently: Phoenix Excellence Pension and Provident Funds Ltd.) The claim amount was not estimated but it was stated as approximately NIS 1 million or more than NIS 2.5 million. |
Increasing management fees without sending prior notice as required by law. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. It should be noted that in May 2021, the National Court rejected the request for leave to appeal of Excellence Gemel in relation to the Regional Court's decision to reject its claim for the statute of limitations on the petition to approve the claim as a class action. It shall be clarified that the decision of the National Court did not directly address the substance of the statute of limitations argument and determined that the latter claim will be decided as part of the proceedings, without prejudice to the parties' arguments. |
| 22. | July 2017 Jerusalem District Court PassportCard Israel General Insurance Agency (2014) (hereinafter: "PassportCard") and The Phoenix Insurance The claim amount was not estimated, but it was stated that it exceeds NIS 2.5 million of all the defendants. |
The plaintiff claims that as part of travel insurance it provides PassportCard effectively records confidential medical conversations held between its policyholders and physicians, listens to these conversations and transfers them to The Phoenix Insurance, while breaching policyholders' privacy without their consent and while conducting wiretapping. In addition, the plaintiff claims that the defendants retain the recorded conversations, maintain an illegal database and even use the recordings. |
In October 2019, the court issued a judgment rejecting the motion for approval of the claim as a class action lawsuit. On January 6 2020 the plaintiff filed an appeal against the judgment to the Supreme Court. An appeal hearing is scheduled for June 16, 2021. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 23. | September 2017 Jerusalem District Court The Phoenix Insurance and other insurance companies The claim amount was not estimated, but it was stated that it was in the tens of millions of shekels or more. |
According to the plaintiffs, the defendants breach the provisions of Section 5(b) of the Adjudication of Interest and Linkage Differentials Law, 1961 (hereinafter: the "Interest and Linkage Differentials Law"), by implementing a policy whereby they do not add any linkage differences and/or interest and/or linked interest to amounts ruled against them by a judicial authority, in cases where the defendants pay such amounts to class members at a later date than the date set for such payment. |
On March 4 2021, the parties submitted to the court a motion for approval of a settlement agreement for an amount that is immaterial to The Phoenix Insurance, under which The Phoenix Insurance will amend the settlement deeds as outlined in the settlement agreement; the parties also recommended the payment of compensation to the class action plaintiff and legal fees for his/her attorneys. The settlement agreement has not yet been approved by the court. |
| 24. | January 2018 Central District Court The Phoenix Insurance and other insurance companies Approximately NIS 82.2 million per year from all the defendants, of which approximately NIS 22.3 million per year is attributed to The Phoenix Insurance. |
According to the plaintiff, The Phoenix Insurance unlawfully refrains from paying its policyholders and third parties the VAT component applicable to the cost of damages when the damages have not been effectively repaired. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 25. | February 2018 Tel Aviv District Court The Phoenix Insurance The Group's aggregate damage was not estimated, but it was stated that it can be assumed to exceed NIS 2.5 million. |
According to the plaintiffs, The Phoenix Insurance misleads those who purchased health insurance and/or those for whom health insurance was purchased, where such insurance is in effect only, or also, during the policyholder's time in mandatory military service, career military service or reserve military service and/or when the policyholder is a policeman and/or a member of the security forces of the State of Israel; the plaintiffs claim that The Phoenix Insurance sells to the class members in general and IDF soldiers in particular an insurance product that is almost impossible to use due to various reasons as specified in the lawsuit. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. In November 2020, the position of the Capital Market, Insurance and Savings Authority was submitted, which supports the position of The Phoenix Insurance. |
| 26. | February 2018 Jerusalem District Court The Phoenix Insurance The amount of the claim was not estimated. |
According to the plaintiffs, The Phoenix Insurance continues to charge life insurance premiums from its deceased policyholders. |
On January 25 2021, the parties submitted a motion for approval of a settlement agreement for an amount that is immaterial to The Phoenix Insurance, under which The Phoenix Insurance committed to reimburse insurance premiums to the class members, as outlined in the settlement agreement; the parties also recommended the payment of compensation to the class action plaintiff and legal fees for his/her attorneys. The settlement agreement has yet to be approved by the court. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 27. | February 2018 Tel Aviv District Court Excellence Nessuah Gemel Ltd. (currently: Phoenix Excellence Pension and Provident Funds Ltd.) and additional companies NIS 21 million from all defendants, of which NIS 6 million is attributed to Excellence Gemel. |
According to the plaintiffs, the claim deals with the unlawful collection of handling fees /collection fees/operating fees/fees and commissions/early repayment fees or any other payment (whatever its name may be) collected by the defendants from planholders thereof to whom they extended loans. |
Excellence Gemel has not yet submitted its response to the petition for approval of the claim as a class action lawsuit. The parties are negotiating. It should be noted that similar motions for approval of claims as class actions filed against The Phoenix Pension and The Phoenix Insurance were concluded with a settlement agreement. |
| 28. | March 2018 Tel Aviv Regional Labor Court The Phoenix Pension Ltd. (currently: Phoenix Excellence Pension and Provident Funds Ltd.) and additional companies The amount of the claim was not estimated. |
According to the plaintiffs, the claim deals with collection of insurance premiums in respect of survivors' insurance (life insurance coverage) from policyholders who have no survivors; which results with the policyholders paying insurance premiums without receiving anything in return. |
The parties are awaiting the court's decision on the petition for approval of the claim as a class action lawsuit. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 29. | May 2018 Haifa Regional Labor Court The Phoenix Pension and Gemel Ltd. (currently: Phoenix Excellence Pension and Provident Funds Ltd.)4 NIS 200 million. |
According to the plaintiffs, contrary to that which is stated in its rules and regulations, The Phoenix Pension has refrained from paying or from paying in full the partial contributions towards benefits to anyone who does not receive a full disability pension. In any case, The Phoenix Pension refrained from reporting to policyholders - either in pay slips or in annual statements - about the payments it made, to the extent that it did, indeed, make such payments. |
The parties are in a mediation procedure. |
| 30. | June 2018 Jerusalem District Court The Phoenix Insurance and another insurance company The amount of the claim was not estimated. |
According to the plaintiff, the claim deals with the defendants' unjustified refusal to recognize a surgical procedure that had medical justification as an insurance event according to the health policies issued, by claiming that it is a "preventive surgical procedure". |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. In February 2021, the position of the Capital Market, Insurance and Savings Authority was submitted. The Phoenix Insurance is preparing a response to the position. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.
4 The petition for approval of the claim as a class action lawsuit was originally filed against The Phoenix Insurance. The plaintiffs filed an amended petition for approval of the claim as a class action lawsuit, in which they changed the identity of the defendant and also added to their previous allegations and to the definition of the class they seek to represent.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 31. | September 2018 Tel Aviv Regional Labor Court The Phoenix Insurance The amount of the claim was not estimated. |
According to the plaintiff, The Phoenix Insurance breached its good faith and fiduciary duties towards its policyholders by automatically depositing the additional contributions it received following the expansion order that required an increase in contributions towards benefits for all Israeli workers, for policyholders in managers insurance policies taken out before June 1 2001 (with guaranteed annuity conversion factors) in new policies referred to by the plaintiff as "contribution policies", without carrying out a pension marketing procedure that includes a justification document, and also by determining the management fees in the policy unilaterally at the maximum rate permitted by law. |
On April 18 2021, the parties filed with the court an agreed motion to approve the plaintiff's withdrawal of the petition to approve the claim as a class action. The withdrawal motion has not yet been approved by the court. |
| 32. | December 2018 Tel Aviv District Court The Phoenix Insurance, other insurance companies and banks NIS 280 million from all defendants. |
According to he plaintiffs, the claim deals with unlawful overcharging of insurance premiums for unnecessary building insurance policies issued to building owners (who took out a mortgage loan and were required to insure the building with a building policy in favor of the lending bank), despite the fact that at the time of issuance of such policies, there was already and insurance policy covering that building, regardless of whether that policy was taken out with the same insurance company or with another insurance company. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| 33. | March 2019 Central District Court The Phoenix Insurance Approximately NIS 2.6 million. |
According to the plaintiff, the claim deals with The Phoenix Insurance's practice to delay the repayment of the relative portion of insurance premiums upon cancellation of compulsory motor and property insurance policies rather than paying it within the period set by law; the plaintiff also claims that The Phoenix Insurance repays the said amount without adding linked interest. The plaintiff also claims that The Phoenix Insurance refrains from repaying full linkage when refunding the relative portion of the insurance premiums. |
The parties are in a mediation procedure. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 34. | May 2019 Tel Aviv District Court The Phoenix Insurance Approximately NIS 766.8 million. |
According to the plaintiff, the claim deals with The Phoenix Insurance's not paying policyholders in participating life insurance policies which include an Rm formula their full share of the profits and full payments to which they are entitled under the insurance contracts; the plaintiff also claims that The Phoenix Insurance does not fulfill its reporting and disclosure obligations towards policyholders regarding their policies and rights. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. It should be noted that the plaintiff stated that a similar motion for approval of a claim as class action, which was filed against another insurance company, had recently been approved. |
| 35. | July 2019 Tel Aviv District Court The Phoenix Insurance and other insurance companies Approximately NIS 264.5 million from all the defendants, of which approximately NIS 67.5 million is attributed to The Phoenix Insurance. |
The plaintiffs claim that the defendants do not pay their policyholders interest as required by law in respect of insurance benefits for the period starting 30 days after the date of delivery of the claim until the date of actual payment. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. It should be noted that according to the plaintiffs, this claim is based on the same cause of action as the class action described in Section 4 above in the table; however, it was nevertheless decided to file this claim for the sake of caution only, given the doubt as to whether the class of plaintiffs seeking the approval of this motion is included in the previous class action. In light of this, at the request of The Phoenix Insurance, in July 2020 the proceedings in this claim were delayed until a judgment will have been rendered in the previous claim. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| A. Class actions - petitions to approve lawsuits as class actions and lawsuits approved as class actions |
(cont.) | |
|---|---|---|
| ------------------------------------------------------------------------------------------------------------------- | -- | --------- |
| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 36. | May 2019 Nazareth Magistrate Court The Phoenix Insurance The amount of the claim was not estimated. |
According to the plaintiff, this claim deals with The Phoenix Insurance's failure to pay in full insurance benefits under the insurance policy in respect of damage caused to a vehicle, on the grounds that the ownership class of the vehicle is "leasing - sale of a new vehicle with 0 km or formerly" even though the ownership of the vehicle is not and/or never was of such ownership class, and the permanent owner of the vehicle's license as "Owner 00" was the first purchaser, who is not the leasing company. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| 37. | August 2019 Central District Court The Phoenix Insurance and other insurance companies The claim amount was not estimated, but it was stated that it was NIS 1 million or more. |
The claim is that in insurance polices covering mechanical engineering equipment the defendants determine the value of the equipment for the purpose of determining the premium according to the value of new equipment, disregarding the age of the equipment; however, in the event of total loss of equipment the defendants pay the policyholders insurance benefits in accordance with the equipment's actual value upon the occurrence of the insurance event, taking into consideration the age of the equipment. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 38. | August 2019 Central District Court The Phoenix Insurance and other insurance companies The claim amount was not estimated, but it was stated that it was in the tens of millions of shekels or more. |
The plaintiffs claim that in case of vehicle theft or total loss as a result of an accident, the defendants refuse to reimburse policyholders for the proportionate share of the insurance premiums (the premium) paid for service contracts (road recovery services, windscreen repair, towing, etc.) in respect of the period subsequent to the theft or total loss, despite the fact that the service contract is cancelled and the risk it covers no longer exists. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. A pre-trial hearing is scheduled for July 19 2021. In February 2020, the position of the Capital Market, Insurance and Savings Authority was submitted, which is not in line with the plaintiffs' position. |
| 39. | December 2019 Central District Court PassportCard Israel General Insurance Agency (2014) (hereinafter: "PassportCard") and The Phoenix Insurance The amount of the claim was not estimated. |
According to the plaintiff, the defendants sell travel insurance without informing their customers - at the time of issuing the insurance policy - about the fact that the "search and rescue" component can be excluded if it is not required by the customers; the plaintiff also claims that the defendants do not inform customers about price changes they make in insurance policies' components; furthermore, the defendants do not inform customers in a clear manner about the right to reimbursement of a proportionate share of the insurance premiums in the event that the actual trip is shorter than planned, and in the event that the insurance period is shortened for any reason whatsoever (inlcuding due to cancellation of the insurance policy). The plaintiff also claims that even when the defendants reimburse insurance premiums to policyholders who shortened their travel period and at the same time also shortened the insurance period for any reason whatsoever, they do not reimburse the full insurance premium for the shortened insurance period, contrary to law and the insurance policy. |
The parties are in a mediation procedure. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 40. | January 2020 Central District Court The Phoenix Insurance, other insurance companies and a road recovery and towing services company. |
The plaintiff claims that, in cases where vehicles' windscreens broke, the defendants had provided and still provide alternative windscreens, which do not meet Israeli standards and are not manufactured by the same maker as the car; by doing so, the defendants allegedly breach their obligations under the insurance policies and coverage contracts. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| The claim amount was not estimated but it was stated that it significantly exceeds NIS 2.5 million. |
|||
| 41. | February 2020 Central District Court The Phoenix Insurance The claim amount was not estimated, but it was stated that it is in the millions of shekels or more. |
The plaintiff claims that starting in early 2016 or thereabouts, The Phoenix Insurance ceased to fulfill its obligation in health insurance policies marketed prior to February 1 2016, in which it undertook to provide insurance coverage, at no additional cost, to all children born to the principal policyholder (starting with the fourth child), until they reach the age of 21. |
The parties are in a mediation procedure. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| A. Class actions - petitions to approve lawsuits as class actions and lawsuits approved as class actions (cont.) |
|---|
| ------------------------------------------------------------------------------------------------------------------------------ |
| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 42. | February 2020 Tel Aviv Regional Labor Court The Phoenix Insurance No less than NIS 25 million. |
The claim is that The Phoenix Insurance refuses to pay its life insurance policyholders the benefit they are entitled to in respect of the first month after the end of the insurance period (the first month of their retirement). |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| 43. | February 2020 Central District Court PassportCard Israel General Insurance Agency (2014) (hereinafter: "PassportCard") and The Phoenix Insurance NIS 6.125 million. |
The claim is that the defendants violate the provisions of the travel insurance policy, since when an insurance event occurs to a policyholder and insurance benefits are claimed in respect of expenses of a person who travelled with the policyholder or accompanied him/her on their trip, the defendants deduct from the insurance benefits double the deductible - one for the policyholder and the other for another person covered by the insurance, i.e. the policyholder or person who travelled with the policyholder or the person who accompanied him/her. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| The plaintiff also claims that the defendants violate various provisions of insurance circulars regarding the claim filing form, the data included therein, receiving a copy thereof; the plaintiff further claims that the defendants refrain from informing policyholders who file claims of their right to obtain a copy of the decision made regarding their claim and/or appeal against the decision to various parties, nor do they inform policyholders of the period of time they have to do so. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| o. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 44. | February 2020 Tel Aviv Regional Labor Court (the hearing was transferred from the Tel Aviv District Court) Halman Aldubi Provident and Pension Funds Ltd. NIS 335 million (or alternatively, NIS 58 million or NIS 36 million). |
The claim is that Halman Aldubi allegedly violated its duty to the plaintiff and to all beneficiaries in the provident funds of Halman Aldubi, of deceased planholders, and any planholder of the Halman Aldubi provident funds with whom contact was lost, to locate and inform the said beneficiaries, as well as the planholders with whom contact was lost, that they are entitled to funds in the Halman Aldubi funds, on the dates set forth to that effect in the Supervision of Financial Services Regulations (Provident Funds) (Locating Planholders and Beneficiaries), 2012, in the period beginning on January 1 2013 until the date of the ruling in the lawsuit. |
Halman Aldubi has not yet filed its response to the amended approval petition filed by the plaintiff. A hearing on the petition to approve the lawsuit as a class action is scheduled for February 3 2022. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
The petitions to approve claims as class actions listed in Sections 45-47 below were filed following the coronavirus pandemic which broke out in March 2020. The petitions were submitted in the fields of motor, home and business (employers' liability and third parties) insurance; the plaintiffs argue in these motions that insurance companies in general and The Phoenix Insurance in particular should reimburse policyholders for premiums paid during the period in which restrictions were in place due to the coronavirus pandemic in view of the reduced insurance risk in these fields during that period.
| 45. | April 2020 Tel Aviv District Court The Phoenix Insurance, other insurance companies and the managing corporation of the Compulsory Motor Insurance Pool (the "Pool") Ltd. Approximately NIS 1.2 billion of all the defendants, of which NIS 145 million is attributed to The Phoenix Insurance or, alternatively, NIS 719 million of all the defendants, of which NIS 113 million is attributed to The Phoenix Insurance. |
The subject matter of the lawsuit is that the defendants unjustly profited,4 allegedly, by failing to reduce car insurance premiums (for compulsory and/or comprehensive and/or third party policies) during the mobility restrictions imposed due to the coronavirus pandemic. This was done, argued the plantiffs, despite a decrease in mileage travelled and the level of risk to which the defendants are exposed. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. |
|---|---|---|---|
| ----- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------- |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.
4 The petition to approve the claim as a class action includes two petitions to approve claims as class actions filed against The Phoenix Insurance and other defendants, which were merged into a single claim in February 2021 by the Tel Aviv District Court (see Note 42(a) (1) in Sections 42 and 44 of the class actions table in the Company's financial statements as of December 31 2020, published on March 25 2021 (Ref. No. 2021-01-044709).

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 46. | April 2020 Tel Aviv District Court The Phoenix Insurance and other insurance companies Approximately NIS 886 million of all the defendants, approximately NIS 107 million is attributed to The Phoenix Insurance. |
The argument is that the defendants must reimburse premiums they overcharged policyholders in motor and home insurance, due to a decrease in the risk they are exposed to as a result of the restrictions imposed following the coronavirus pandemic, which led to a decline in trips and a decline in bodily harm and damage to property. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. On February 2021, the court ruled that the petition to approve the claim as a class action in relation to motor insurance was dismissed and will continue to be heard in relation to home insurance. On April 25 2021, the plaintiff filed an appeal with the Supreme Court against the decision regarding the dismissal of the petition to approve the claim as a class action regarding car insurance. |
| 47. | April 2020 Haifa District Court The Phoenix Insurance and other insurance companies Approximately NIS 81 million of all the defendants, of which approximately NIS 13 million is attributed to The Phoenix Insurance. |
The plaintiff claims that the defendants overcharged insurance premiums in their employer liability insurance and third-party insurance (as part of business insurance policies), despite the drop in the number of employees, suppliers, customers, etc. who attend businesses due to the coronavirus pandemic and the restrictions imposed as a result thereof, which constitutes is a material decrease in the risk to which the defendants are exposed. |
An appeal hearing is scheduled for May 22 2022. The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 48. | May 2020 Tel Aviv District Court Phoenix Excellence Pension and Provident Funds Ltd. and other management companies The claim amount was not estimated, but it was stated that it is estimated, at a minimum, in the hundreds of millions of shekels. |
According to the plaintiffs, the claim deals with the defendants' classifying some of the contributions transferred to an advanced education fund on behalf of their customers as taxable provisions, even though they are not taxable. |
Phoenix Excellence filed its response to the petition for approval of the claim as a class action lawsuit as well as a motion for leave to file a third-party notice against the State - the Israel Tax Authority. A decision is yet to be issued on the request. A pre-trial hearing is scheduled for July 11 2021. |
| 49. | May 2020 Tel Aviv District Court Halman Aldubi Provident and Pension Funds Ltd. and other management companies and additional management companies The claim amount was not estimated, but it was stated that it is estimated, at a minimum, in the hundreds of millions of shekels. |
According to the plaintiffs, the claim deals with the defendants' classifying some of the contributions transferred to an advanced education fund on behalf of their customers as taxable provisions, even though they are not taxable. |
Halman Aldubi filed its response to the petition for approval of the claim as a class action lawsuit as well as a motion for leave to file a third-party notice against the State - the Israel Tax Authority. A decision is yet to be issued on the request. A pre-trial hearing is scheduled for July 11 2021. It should be noted that a similar petition to approve a claim as class action was filed against Phoenix Excellence (see Section 48 above in the table). |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 50. | June 2020 Tel Aviv District Court PassportCard Israel General Insurance Agency (2014) (hereinafter: "PassportCard") and The Phoenix Insurance At least NIS 10 million. |
According to the plaintiff, the claim deals with non-payment of insurance benefits in respect of cancellation of a trip due to a pandemic (the coronavirus pandemic) under travel insurance that the plaintiff purchased through PassportCard. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. |
| 51. | June 2020 Tel Aviv Regional Labor Court The Phoenix Insurance The amount of the claim was not estimated. |
According to the claim, after a policyholder passes away, The Phoenix Insurance links the funds accrued in the policy to the consumer price index, instead of linking them to the investment track selected by the policyholder, as it previously did. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. A hearing is scheduled for November 15 2021. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| A. Class actions - petitions to approve lawsuits as class actions and lawsuits approved as class actions |
(cont.) |
|---|---|
| ---------------------------------------------------------------------------------------------------------------- | --------- |
| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 52. | June 2020 Central District Court The Phoenix Insurance and another insurance company Approximately NIS 10.5 million for each defendant. |
According to the claim, the defendants overcharge customers in loan agreements they enter into with their customers; overcharging takes place due to a one-way linkage mechanism, which is in place under those agreements, whereby if the CPI increases above the base CPI, the defendants collect the linkage differences due to the increase; however, if the CPI decreases below the base index, they do not credit their customers for the said decrease. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| 53. | July 2020 Haifa Magistrate Court PassportCard Israel General Insurance Agency (2014) (hereinafter: "PassportCard") and The Phoenix Insurance NIS 1.84 million. |
According to the claim, when travel insurance benefits are paid late, the defendants do not pay interest in respect of the delay; the plaintiff also claims that the defendants usually pay the insurance benefits according to the exchange rate on the day of the insurance event rather than the exchange rate on repayment date. In addition, it was argued that the disclosure duty regarding the deductible and the limitation of the insurer's liability with regard to the "winter sports" component is violated as part of a representation made prior to entering into the insurance contract. |
The Phoenix Insurance has not yet submitted its response to the motion to approve the claim as a class action, and on January 10 2021, it submitted a motion for stay of proceedings until a final decision has been made in connection with the class action outlined in Section 4 above in the table. A decision has not yet been issued in connection with the stay of proceedings motion and a hearing was scheduled for October 11 2021. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 54. | July 2020 Central District Court The Phoenix Insurance and other insurance companies About 1.9 billion of all defendants, with the share of each of the defendants being in accordance with its market segment; according to the plaintiffs, The Phoenix's share is approximately 19%. |
According to the claim, the defendants must charge reduced insurance premiums in cases of insurance policies with exclusions due to an existing medical condition compared to policies in which no such exclusion is present, since exclusions mitigate the defendants' insurance risk. |
The Phoenix Insurance submitted its response to the petition for approval of the claim as a class action lawsuit. A pre-trial hearing is scheduled for July 1 2021. |
| .55 | September 2020 Tel Aviv District Court (the hearing was transferred from the Tel Aviv Regional Labor Court) Phoenix Excellence Pension and Provident Funds Ltd. No estimate was provided for the claim amount. |
The subject matter of the lawsuit, according to the plaintiff, is the following: provision of incorrect statements and/or incorrect calculations of the linkage differences credited to planholders; incorrect calculations and presentation of real profits; incorrect recording of deposits, causing the profits in respect thereof to be taxed unlawfully; causing pecuniary damage to planholders due to failure to monitor employers inadequate contributions and failure to require them to complete such contributions, whether by sending appropriate notices to employers and planholders or by making up the difference by the fund itself; and recording deposit dates that are different than the actual ones. |
Excellence Gemel has not yet submitted its response to the petition for approval of the claim as a class action lawsuit. On March 3 2021, at the request of Excellence Gemel, the Court transferred the petition for approval of the claim as a class action lawsuit to the Tel Aviv District Court and the panel which heard a similar petition for approval of the claim as a class action lawsuit that was filed against Excellence Gemel (see Section 48 above in the table). |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 56. | September 2020 Tel Aviv District Court The Phoenix Insurance NIS 92.7 million. |
According to the claim, The Phoenix Insurance does not pay policyholders insured under a long-term care policies the full amount due to them under their policies, since it offsets these amounts against proceeds received from the National Insurance Institute; it is also claimed that The Phoenix Insurance does not indemnify policyholders for certain medical treatments. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| 57. | September 2020 Central District Court The Phoenix Insurance and another insurance company NIS 84 million from all the defendants, of which NIS 67.2 million is attributed to The Phoenix Insurance (a total of NIS 16.8 million in respect of critical illness insurance and a total of NIS 50.4 million in respect of permanent health insurance). |
According to the claim, the defendants acted in violation of the provisions of critical illness insurance policies when they continued to charge policyholders the full amount of the monthly premium even after the first insurance event had occurred. It was also alleged against The Phoenix Insurance that contrary to its obligations, it charges its policyholders a monthly PHI insurance premium, even after the period of insurance coverage has ended. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A pre-trial hearing is scheduled for October 28 2021. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 58. | October 2020 Tel Aviv District Court The Phoenix Insurance It is noted that the amount of the claim cannot be estimated accurately for all groups as defined in the claim; however, it is noted that the amount of the claim in relation to the cosmetic surgery cause of action is NIS 7.53 million. |
According to the plaintiff, The Phoenix Insurance does not link the liability limits in its health insurance policies to the Consumer Price Index, thereby preventing policyholders from obtaining full recovery of their damages; the plaintiff also claims that The Phoenix Insurance does not provide insurance coverage to policyholders, claiming that the procedure in question is a cosmetic surgery, thereby breaching the provisions of the insurance contract; the plaintiff further claims that The Phoenix Insurance does not provide fair disclosure of the definition of cosmetic surgery and of the fact that it is excluded from the policy. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A hearing date has not yet been scheduled. |
| 59. | November 2020 Tel Aviv District Court PassportCard Israel General Insurance Agency (2014) (hereinafter: "PassportCard") and The Phoenix Insurance The amount of the claim was not estimated. |
According to the plaintiff, in the event of a flight cancellation, The Phoenix Insurance conditions the payment of insurance benefits upon a onerous condition whereby the policyholder is required to present an official confirmation on the flight cancellation from the airline; the plaintiff claims that insurance benefits are not paid due to a concealed, unlawful reason, whereby the policy only covers the cancellation of scheduled flights. By doing so, The Phoenix Insurance allegedly sold a product that has no value and does not cover the flight cancellation risk. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A pre-trial hearing is scheduled for July 18 2021. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 60. | December 2020 Haifa Magistrate Court The Phoenix Insurance NIS 1.75 million |
According to the plaintiff, who is insured in a health insurance policy comprising of a list of surgical procedures, The Phoenix Insurance does not pay insurance benefits in respect of invasive surgical procedure involving a further medical procedure to policyholders who took out the insurance before 2014. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A pre-trial hearing is scheduled for September 14 2021. |
| 61. | December 2020 Central District Court The Phoenix Insurance The aggregate claim amount was not estimated but it was stated that it exceeds NIS 2.5 million. |
According to the plaintiff, The Phoenix Insurance allegedly does not indemnify its policyholders in motor insurance policies relating to vehicles other than private and commercial cars weighing up to 3.5 tons (such as trucks, taxis, etc.), in respect of the damage caused to their vehicle due to the insurance event - which, the plaintiff claims, is in breach of the policy and the law. It is further claimed that The Phoenix Insurance does not provide its policyholders with an appraiser's report, which includes an estimate of the impairment to the vehicle's value due to the insurance event nor its manner of calculation. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A pre-trial hearing is scheduled for October 14 2021. |
A. Class actions - petitions to approve lawsuits as class actions and lawsuits approved as class actions (cont.)
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 62. | February 2021 Central District Court The Phoenix Insurance No estimate was provided for the claim amount, but it was stated that the damage exceeds NIS 2.5 million. |
According to the plaintiff, the claim deals with the increasing of insurance premiums by more than 75% than the agreed premiums in life, long-term care, and PHI insurance policies taken out as part of a special deal for members of the Israel Bar Association (and potentially in other insurance policies) in 2016, without informing policyholders, obtaining their consent and providing them with any explanations. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A pre-trial hearing is scheduled for October 14 2021. |
| 63. | March 2021 Tel Aviv District Court The Phoenix Insurance and other insurance companies Approximately NIS 79 million from all defendants |
The subject matter of the claim, according to the plaintiffs, is that the defendants refuse to pay for the policyholders' expenses for the purchase of medical cannabis, contrary to the provisions of the policy to cover drugs excluded from the Healthcare Services Basket, and since medical cannabis is recognized for medical use in Western countries. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit; a hearing date has not yet been scheduled. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 64. | March 2021 Central District Court The Phoenix Insurance No estimate was provided for the claim amount, but it was stated that the damage exceeds NIS 2.5 million. |
The subject matter of the claim, according to the plaintiff, is that The Phoenix Insurance allegedly unlawfully rejects claims by its policyholders in "personal accident" policies to pay for hospitalization at a "non-general hospital", claiming that a "hospital", as defined in the policy, is a medical institution whose underlying meaning is a "general hospital only". |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A pre-trial hearing is scheduled for December 21 2021. |
| 65. | April 2021 Central District Court The Phoenix Insurance Approximately NIS 36.25 million. |
The subject matter of the claim, according to the plaintiff, is failure to reduce management fees for a savings policy, contrary to the agreement between the policyholders and The Phoenix Insurance. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A pre-trial hearing is scheduled for January 26 2022. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 66. | April 2021 Central District Court |
According to the plaintiffs, when using the defendants' digital services (while browsing their personal accounts), customers' private, personal and confidential information is transferred to third parties without the customers' consent, violating their privacy. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A hearing date has not yet been scheduled. |
| The Phoenix Insurance, banks, investment houses, credit card companies and other insurance companies |
|||
| The damage was not estimated but it was stated that it amounts to millions of shekels. |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 1. | May 2020 Tel Aviv District Court Excellence Gemel & Hishtalmut Ltd. (currently: Phoenix Excellence Pension and Provident Funds Ltd.) and additional insurance companies and management companies |
The claim is that the Law Enforcement and Collection Authority overcharges those who submit foreclosure applications in respect of financial instruments managed by the defendants; overcharging is allegedly carried out through an automated system and amounts overcharged are transferred to the defendants. |
On April 7 2021, the Court handed down a decision to strike the petition to approve the claim as a class action. |
| 2. | The amount of the claim was not estimated. May 2020 Tel Aviv District Court Halman Aldubi Provident and Pension Funds Ltd. and additional insurance companies and management companies The amount of the claim was not estimated. |
The claim is that the Law Enforcement and Collection Authority overcharges those who submit foreclosure applications in respect of financial instruments managed by the defendants; overcharging is allegedly carried out through an automated system and amounts overcharged are transferred to the defendants. |
On April 7 2021, the Court handed down a decision to strike the petition to approve the claim as a class action. It should be noted that a similar petition to approve a claim as class action was filed and withdrawn against Phoenix Excellence (see Section 1 above in the table). |
1 The date on which the petition for approval of the claim as a class action lawsuit was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plantiff(s) in the petition for approval of the claim as a class action lawsuit.
* For additional claims concluded between January 1 2021 and March 25 2021, please see Note 42(a)(2), Sections 10 and 11 of the table of concluded claims in the Company's financial statements as of December 31 2020, published on March 25 2021 (Ref. No. 2021-01-044709).

Set forth below is a description of legal and other proceedings against the Group. For proceedings where, in the opinion of management - which is based, among other things, on the legal opinion it has received - it is more likely than not that the Group's defense claims will be allowed and the proceeding will be dismissed, no provision was included in the financial statements.
For proceedings where it is more likely than not that the Group's defense claims will be dismissed, in whole or in part, the financial statements include provisions to cover the exposure estimated by the Group. In management's opinion, which is based, among other things, on legal opinions it received, the financial statements include adequate provisions, where provisions were required, to cover the exposure estimated by the Group.

In the statement of claim, the Court is requested to order the defendants, jointly and severally, to compensate the plaintiffs for the damage caused to them, according to the claim, due to the impairment of Pilat Group's value, in the total amount of NIS 35.9 million. The lawsuit continues to be heard in court.
Complaints are filed against the Group from time to time, including complaints to the Commissioner of the Capital Market, Insurance and Savings (hereinafter: the "Commissioner") in relation to policyholders' rights under insurance policies and/or the law. These complaints are handled on an ongoing basis by the Group's Public Complaints Department. The Commissioner's decisions with regard to these complaints, to the extent that a decision has been made in respect thereof, are sometimes issued as sweeping decisions relating to a group of policyholders. Before issuing a final version of his decisions, the Commissioner usually issues a draft decision.
Furthermore, as part of the Commissioner's inquiries with the group, following complaints and/or audits on his behalf, demands are made from time to time to receive various data regarding the Group's handling of insurance policies in the past and/or a demand to reimburse funds to groups of policyholders and/or other guidelines. ----

In addition, the Commissioner has the power, among other things, to impose monetary sanctions on the Group in accordance with the data that was and/or will be transferred thereto following inquiries as described above. In addition to the petitions to approve lawsuits as class actions filed against the Group and the legal and other proceedings, there is a general exposure, which cannot be assessed and/or quantified, due to, among other things, the complexity of the services provided by the Group to its policyholders. The complexity of these services inevitably leads to interpretive claims and other claims due to information gaps between the Group and third parties to the insurance contracts in connection with a long list of commercial and regulatory terms. This exposure is reflected, among other things, in the areas of pension savings and long-term insurance, including health and long-term care insurance, in which the Group operates. Insurance policies in these areas of activity are assessed over many years in which policies, regulation and legislation change and new court rulings are issued. These changes are implemented by automated systems that undergo frequent changes and adjustments. The complexity of these changes and the application of the changes over many years lead to an increased operational exposure. In addition, allowing new interpretations for the provisions of insurance policies and long-term pension products sometimes affects the Group's future profits in respect of its existing portfolio, in addition to the exposure embodied in claims for compensation for customers in respect of past activity.
It is impossible to anticipate the types of claims that will be raised in this area or the exposure arising from these and other claims in connection with insurance contracts - claims which are raised through, among other things, the procedural mechanism set forth in the Class Actions Law.
In addition, some of the Group's products have long terms and are particularly complex in light of the various legislative arrangements both in the field of product management and in the field of taxation, attribution of contributions, investment management, the policyholder's employment status, his contributions and more.
The Wage Protection Law, 1958 imposes a liability on the Group's institutional entities, in accordance with the circumstances specified in the law, in respect of employers' debts to the institutional bodies, where such debts have not been repaid on time. The Group is in the process of improving the data on employers' debts and policyholders' rights, during the course of which lawsuits were filed against employers and the debts of other employers were rescheduled. Once this process is completed, the Group will complete the handling of employers' debts in accordance with the provisions of the law.

The following table summarizes the amounts claimed in pending petitions to approve lawsuits as class actions, claims approved as class actions and other material claims against the Group, as noted by the plaintiffs in the statements of claim filed on their behalf. It is hereby clarified that the amounts claimed do not necessarily reflect the amounts of exposure assessed by the Group, since these are assessments on behalf of the plaintiffs which will be resolved as part of the legal proceedings. It is further clarified that the table below does not include proceedings that have been concluded, including proceedings that concluded after a compromise agreement was approved in respect thereof.
| Type | No. of claims |
Amount claimed in NIS thousand (unaudited) |
|---|---|---|
| Claims approved as a class actions: | ||
| A specific amount was attributed to the Company | 4 | 597,700 |
| The claim pertains to several companies and no specific amount was attributed to the Company |
1 | 225,200 |
| The amount of the claim was not specified | - | - |
| Pending petitions to approve lawsuits as class actions: | ||
| A specific amount was attributed to the Company | 27 | 4,503,654 |
| The claim pertains to several companies and no specific amount was attributed to the Company |
8 | 3,825,000 |
| The amount of the claim was not specified | 26 | - |
| Other material claims: | ||
| A specific amount was attributed to the Company | 1 | 5,167 |
| The claim pertains to several companies and no specific amount was attributed to the Company |
1 | 35,900 |
| The amount of the claim was not specified | - | - |
| Claims and other requirements | 26 | 27,895 |
The total provision amount in respect of class actions, legal proceedings and others, filed against the Group as specified above as of March 31 2021 and December 31 2020, amounted to approximately NIS 183,274 thousand (of which a total of approximately NIS 3,970 thousand is in respect of concluded class actions) and approximately NIS 185,444 thousand, respectively.

A decrease (increase) in long-term interest rates may increase (decrease) the paid pension reserve and the supplementary pension reserve is deferred due to the use of a lower (higher) discount rate, to the extent that a change in the discount rate is required due to changes in market interest rates.
In addition, the supplementary reserve for deferred pensions is affected by future income expectations (using K factor), so that the decrease (increase) in interest rates may decrease (increase) the expected future income, and if according to the new projection it will be impossible to continue funding the provisions to the reserve, the Company will increase the reserve in order to reduce future provision amounts (or vice versa).
| March 31 | |||
|---|---|---|---|
| 2021 | 2020 | 2020 | |
| Unaudited | |||
| % | |||
| In respect of yield-dependent insurance policies |
- | - | - |
| In respect of yield-dependent insurance policies |
0.85 | 0.58 | 0.85 |
For further details regarding changes in the K factor for the reporting periods, please see Section D below.
The Company tests the adequacy of the reserves for life insurance and LTC and where necessary, increases the reserves. Testing is performed according to the regulatory guidelines and on the basis of actuarial assumptions and a risk-free yield curve plus an illiquidity premium. To the extent that there are changes in these assumptions, the supplement required according to the test will change.
A decrease (increase) in the risk-free interest rate curve and/or in the rate of illiquidity premium will increase (decrease) the supplement for the reserves required according to the LAT test (to the extent that a supplement is required).
Regarding the retrospective application of Insurance Circular 2020-1-5, Amendment of the Provisions of the Consolidated Circular regarding Measurement of Liabilities - Liability Adequacy Test (LAT) (hereinafter – the "LAT Circular "- please see Note 2.DD to the Annual Financial Statements.

| For the 3 months ending March 31 |
For the year ended December 31 |
|||
|---|---|---|---|---|
| 2021 | 2020 | 2020 | ||
| Unaudited | In NIS million | Audited | ||
| Life insurance segment: | ||||
| Effect of updating other assumptions on the supplementary pension reserve and paid pensions |
(12) | |||
| Effect of updating of assumptions on the cancellation rates | - | - | - | |
| Effect of updating assumptions on the expense rates | - | 5 | (54) | |
| Effect of updating assumptions on the mortality rates | - | - | - | |
| Change in the discount rate used in the calculation of the supplementary retirement pension reserve and paid pensions. |
5 | 44 | 25 | |
| Change in K value | - | 94 | (261) | |
| Total increase (decrease) in liabilities on retention in the life insurance segment |
5 | 143 | (302) | |
| Health insurance segment: Effect of updating of assumptions on the cancellation rates: |
||||
| LAT Other |
- - |
- - |
(24) (43) |
|
| Effect of updating assumptions on the expense rates: | ||||
| LAT Other |
- - |
(46) (17) |
(54) (12) |
|
| Effect of updating assumptions on the mortality and morbidity rates: |
||||
| LAT Other |
- - |
- - |
- - |
|
| Change in reserve (LAT) following a change in the discount rate | 24 | 97(*) | 173(*) | |
| Change in reserve (LAT) following re-application of illiquidity premium |
- | - | (110) | |
| Total increase (decrease) in liabilities on retention in | ||||
| health insurance segment | 24 | 34 | (70) | |
| P&C insurance segment: | ||||
| Change in discount rate Effect of the discount rate applied to National Insurance allowances |
- - |
(11) - |
1 (74) |
|
| Total decrease in liabilities on retention in P&C insurance | ||||
| segment | - | (11) | (73) | |
| Total increase (decrease) in liabilities on retention before tax |
29 | 166 | (445) | |
| Total increase (decrease) in liabilities on retention, after tax | 19 | 109 | (293) | |
(*) This effect includes the effect of classifying the excess value of assets from the life insurance segment to the health insurance segment in the amount of approximately NIS 121 million, with the addition of approximately NIS 47 million from excess value of other non-marketable assets as a result of the first-time application of the LAT Circular and the amendment of the Circular on Allocation of Non-Marketable Assets. For further details, please see the Annual Financial Statements, Note 2.DD.


Assuming that all options exercisable under this outline are to be exercised, immediately after exercise thereof and taking into account the issued and paid-up capital of the Company to date, the shares arising from the exercise of the options shall constitute approximately 2.6% of the issued and paid-up capital of the Company and approximately 2.5% of its voting rights (and approximately 1.6% and 1.5%, respectively, on a fully diluted basis). In practice, no allotment will be made to the offerees who will realize the full stock options arising from them, but only shares in an amount that reflects the amount of the monetary benefit inherent in the options.
In accordance with the Board of Directors' decision, out of the amount of 3,937,000 options offered to offerees a total of 88,000 options will be allotted to the Company's CEO. The fair value at the Award Date is calculated based on a appraisal received from an external appraiser who used the binomial model. The average value of one option was estimated at approximately NIS 3.24, and the total value of the options allotted was estimated at that date at approximately NIS 12.8 million.

Details of assets for assets and other financial investments
| As of March 31 2021 | ||||
|---|---|---|---|---|
| Presented at fair value through profit and loss |
Available for-sale |
Loans and receivable s |
Total | |
| Unaudited | ||||
| In NIS thousand | ||||
| Marketable debt assets (A.1) | 119,151 | 7,271,495 | - | 7,390,646 |
| Non-marketable debt assets | - | - | 13,524,006 | 13,524,006 |
| Shares (A.2) | 7,791 | 2,048,579 | - | 2,056,370 |
| Other (A.3) | 581,679 | 2,908,999 | - | 3,490,678 |
| Total | 708,621 | 12,229,073 | 13,524,006 | 26,461,700 |
| As of March 31 2020 | ||||
|---|---|---|---|---|
| Presented at fair value through profit and loss |
Available for-sale |
Loans and receivables |
Total | |
| Unaudited | ||||
| In NIS thousand | ||||
| Marketable debt assets (A.1) | 56,770 | 7,401,994 | - | 7,458,764 |
| Non-marketable debt assets | - | - | 13,213,841 | 13,213,841 |
| Shares (A.2) | 2,691 | 1,381,887 | - | 1,384,578 |
| Other (A.3) | 396,502 | 2,071,970 | - | 2,468,472 |

Details of assets for assets and other financial investments (cont.)
| As of December 31 2020 | ||||
|---|---|---|---|---|
| Presented at fair value through profit and loss |
Available for-sale |
Loans and receivables |
Total | |
| Audited | ||||
| In NIS thousand | ||||
| Marketable debt assets (A.1) | 108,809 | 7,942,457 | - | 8,051,266 |
| Non-marketable debt assets | - | - | 13,231,897 | 13,231,897 |
| Shares (A.2) | 5,860 | 1,854,613 | - | 1,860,473 |
| Other (A.3) | 604,573 | 2,595,491 | - | 3,200,064 |
| Total | 719,242 | 12,392,561 | 13,231,897 | 26,343,700 |
| As of March 31 2021 | ||
|---|---|---|
| Carrying amount |
Amortized cost |
|
| Unaudited | ||
| In NIS thousand | ||
| Government bonds | 4,308,126 | 4,294,987 |
| Other debt assets: | ||
| Other non-convertible debt assets | 2,994,773 | 2,768,550 |
| Other convertible debt assets | 87,747 | 82,677 |
| Total marketable debt assets | 7,390,646 | 7,146,214 |
| Impairments carried to profit and loss (cumulative) | 93,385 |
| As of March 31 2020 | |||
|---|---|---|---|
| Carrying amount |
Amortized cost |
||
| Unaudited | |||
| In NIS thousand | |||
| Government bonds | 4,343,238 | 4,346,161 | |
| Other debt assets: | |||
| Other non-convertible debt assets | 3,097,633 | 3,142,198 | |
| Other convertible debt assets | 17,893 | 19,790 | |
| Total marketable debt assets | 7,458,764 | 7,508,149 | |
| Impairments carried to profit and loss (cumulative) | 196,544 |

Details of assets for assets and other financial investments (cont.)
| As of December 31 2020 | ||
|---|---|---|
| Carrying amount |
Amortized cost |
|
| Audited In NIS thousand |
||
| Government bonds | 4,974,270 | 4,817,279 |
| Other debt assets: | ||
| Other non-convertible debt assets | 3,008,147 | 2,597,370 |
| Other convertible debt assets | 68,849 | 49,863 |
| Total marketable debt assets | 8,051,266 | 7,464,512 |
| Impairments carried to profit and loss (cumulative) | 98,984 |
| As of March 31 2021 | |||
|---|---|---|---|
| Carrying amount |
Cost | ||
| Unaudited | |||
| In NIS thousand | |||
| Marketable shares | 1,738,462 | 1,308,569 | |
| Non-marketable shares | 317,908 | 201,263 | |
| Total shares | 2,056,370 | 1,509,832 | |
| Impairments carried to profit and loss (cumulative) | 186,848 |

Details of assets for assets and other financial investments (cont.)
| As of March 31 2020 | |||
|---|---|---|---|
| Carrying amount |
Cost | ||
| Unaudited | |||
| In NIS thousand | |||
| Marketable shares | 1,133,724 | 1,097,592 | |
| Non-marketable shares | 250,854 | 155,157 | |
| Total shares | 1,384,578 | 1,252,749 | |
| Impairments carried to profit and loss (cumulative) | 319,849 |
| As of December 31 2020 | ||
|---|---|---|
| Carrying amount |
Cost | |
| Audited | ||
| In NIS thousand | ||
| Marketable shares | 1,545,485 | 1,177,687 |
| Non-marketable shares | 314,988 | 185,520 |
| Total shares | 1,860,473 | 1,363,207 |
| Impairments carried to profit and loss (cumulative) | 213,115 |

| As of March 31 2021 | |||
|---|---|---|---|
| Carrying amount |
Cost | ||
| Unaudited | |||
| In NIS thousand | |||
| Total marketable financial investments | 815,655 | 753,094 | |
| Total non-marketable financial investments | 2,675,023 | 2,124,970 | |
| Total other financial investments | 3,490,678 | 2,878,064 | |
| Impairments carried to profit and loss (cumulative) | 121,315 |
| As of March 31 2020 | ||
|---|---|---|
| Carrying amount |
Cost | |
| Unaudited | ||
| In NIS thousand | ||
| Total marketable financial investments | 462,075 | 440,383 |
| Total non-marketable financial investments | 2,006,397 | 1,714,853 |
| Total other financial investments | 2,468,472 | 2,155,236 |
| Impairments carried to profit and loss (cumulative) | 105,246 |
| As of December 31 2020 | |||
|---|---|---|---|
| Carrying amount |
Cost | ||
| Audited In NIS thousand |
|||
| Total marketable financial investments | 660,178 | 503,235 | |
| Total non-marketable financial investments | 2,539,886 | 1,880,737 | |
| Total other financial investments | 3,200,064 | 2,383,972 | |
| Impairments carried to profit and loss (cumulative) | 116,453 |
Part 3
Data from the Consolidated Interim Financial Statements
As of March 31 2021 (Unaudited)

| Auditors' Review Report2 | |
|---|---|
| Condensed Interim Data on Financial Position3 | |
| Condensed Interim Data about Profit and Loss 4 |
|
| Condensed Interim Data about Comprehensive Income5 | |
| Condensed Interim data about Changes in Equity 6-8 |
|
| Condensed Interim data about Changes in Cash Flows 9-10 |
|
| Additional Information regarding the Condensed Interim Standalone Financial Information11 |

Kost Forer Gabbay & Kasierer Menachem Begin Road 144A, Tel Aviv 6492102
Tel. +972-3-6232525 Fax +972-3-5622555 ey.com
To the Shareholders of The Phoenix Holdings Ltd.
Dear Sir/Madam,
We have reviewed the separate interim financial information disclosed in accordance with Regulation 38D to the Securities Regulations (Periodic and Immediate Reports), 1970 of The Phoenix Holdings Ltd. ("the Company") as of March 31 2021 and for the three months period then ended. The Company's board of directors and management are responsible for the separate interim financial information. Our responsibility is to express a conclusion on the separate interim financial information based on our review.
We did not review the separate interim financial information taken from the interim financial information of investees, the total investment in which amounted to approximately NIS 1,602,529 thousand as of March 31 2021, and the Company's share in of their earnings amounted to approximately NIS 27,467 thousand for the three months period then ended, respectively. The separate interim financial information of those companies was reviewed by other auditors, whose review reports have been furnished to us, and our conclusion, insofar as it relates to the financial information in respect of those companies, is based on the review reports of the other auditors.
We conducted our review in accordance with Review Standard (Israel) 2410 of the Institute of Certified Public Accountants in Israel, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted pursuant to Israeli GAAP and, as a result, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review and the review reports of other auditors, nothing has come to our attention that causes us to believe that the accompanying separate interim financial information is not prepared, in all material respects, in accordance with Regulation 38D to the Securities Regulations (Periodic and Immediate Reports), 1970.
Tel Aviv, May 26, 2021 Kost Forer Gabbay & Kasierer Certified Public Accountants

| As of | |||||
|---|---|---|---|---|---|
| Mar. 31 2021 |
Mar. 31 2020 |
Dec. 31 2020 |
|||
| Unaudited | Audited | ||||
| In NIS thousand | |||||
| Assets | |||||
| Investments in investees | 8,159,355 | 5,885,860 | 7,861,266 | ||
| Loans and capital notes to investees | 1,286,069 | 1,192,756 | 1,192,107 | ||
| Total non-current assets | 9,445,424 | 7,078,616 | 9,053,373 | ||
| Other financial investments | 31,856 | 37,854 | 22,986 | ||
| Current tax assets | 1,159 | 1,163 | 1,159 | ||
| Dividend receivable from investees (see Note 2(b)) | 338,000 | - | - | ||
| Receivables and debit balances | 1,479 | 841 | 14,482 | ||
| Cash and cash equivalents | 33,233 | 71,188 | 40,270 | ||
| Total current assets | 405,727 | 111,046 | 78,897 | ||
| Total assets | 9,851,151 | 7,189,662 | 9,132,270 | ||
| Equity attributed to Company's shareholders | |||||
| Share capital | 309,961 | 309,951 | 309,951 | ||
| Premium on shares and capital reserves | 837,324 | 826,991 | 833,592 | ||
| Treasury shares | (26,411) | - | (26,411) | ||
| Capital reserves | 955,191 | 316,490 | 913,036 | ||
| Retained earnings | 5,875,712 | 4,602,739 | 5,939,754 | ||
| Total equity | 7,951,777 | 6,056,171 | 7,969,922 | ||
| Liabilities | |||||
| Non-current liabilities | 0 | 0 | 0 | ||
| Bonds | 1,414,279 | 1,004,080 | 1,082,538 | ||
| Current liabilities | |||||
| Bonds | 53,371 | 123,485 | 36,000 | ||
| Payables and credit balances | 13,869 | 5,926 | 5,955 | ||
| Dividend payable (see Note 2(c)) | 380,000 | - | - | ||
| Liabilities in respect of deferred taxes | 37,855 | - | 37,855 | ||
| Total current liabilities | 485,095 | 129,411 | 79,810 | ||
| Total liabilities | 1,899,374 | 1,133,491 | 1,162,348 | ||
| Total capital and liabilities | 9,851,151 | 7,189,662 | 9,132,270 |
(*) For further details, please see Note 4 to the consolidated financial statements.
The attached additional information is an integral part of the Company's standalone interim financial information.
Eli Schwartz Eyal Ben Simon Benjamin Gabbay
Executive Vice President, CFO Chief Executive Officer Chairman of the Board of Directors
Date of approval of the financial statements - May 26, 2021

| For the three months ended March 31 |
For the year ended December 31 |
||||
|---|---|---|---|---|---|
| 2021 | 2020 | 2020 | |||
| Unaudited | |||||
| In NIS thousand | |||||
| Company's share in the profits of investees, net of tax | 308,171 | (167,584) | 1,210,661 | ||
| Investment income, net and finance income | 12,562 | 7,999 | 42,353 | ||
| Income from management fees of investees | 750 | 750 | 3,000 | ||
| Total revenue | 321,483 | (158,835) | 1,256,014 | ||
| General and administrative expenses | 1,997 | 2,304 | 8,164 | ||
| Finance expenses | 4,082 | 4,928 | 40,972 | ||
| Total expenses | 6,079 | 7,232 | 49,136 | ||
| Profit before taxes on income | 315,404 | (166,067) | 1,206,878 | ||
| Taxes on income | - | - | 37,855 | ||
| Profit (loss) for the period attributed to the Company's owners | 315,404 | (166,067) | 1,169,023 |

| For the three months ended March 31 |
For the year ended December 31 |
||
|---|---|---|---|
| 2021 | 2020 | 2020 | |
| Unaudited | Audited | ||
| In NIS thousand | |||
| Profit (loss) for the period | 315,404 | (166,067) | 1,169,023 |
| Other comprehensive income (loss): | |||
| Amounts that will be or that have been reclassified to profit or | |||
| loss when specific conditions are met | |||
| Net change in fair value of financial assets classified as available for sale, carried to capital reserves |
|||
| 1,663 | (4,058) | (1,307) | |
| Net change in fair value of financial assets classified as available for sale, carried to the income statement |
|||
| - | 573 | 585 | |
| Gain on impairment of financial assets classified as available for sale, carried to the income statement |
- | - | 937 |
| The Group's share in other comprehensive income (loss) of investees | 38,839 | (408,349) | 169,838 |
| Total components of income (loss) items, subsequently | |||
| reclassified to profit or loss | 40,502 | (411,834) | 170,053 |
| Amounts that shall not be subsequently reclassified to profit or loss |
|||
| The Group's share in other comprehensive income of equity-accounted | |||
| investees | - | 1,248 | 13,621 |
| Other comprehensive income (loss) for the period, net | 40,502 | (410,586) | 183,674 |
| Total comprehensive income (loss) for the period | 355,906 | (576,653) | 1,352,697 |

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Reserve from transaction with controlling shareholder |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| In NIS thousand | |||||||||||
| Balance as of January 1 2021 (audited) Loss for the period |
309,951 - |
833,592 - |
(26,411) - |
5,939,754 315,404 |
(43,622) - |
11,000 - |
44,943 - |
114,614 - |
(23,338) - |
809,439 - |
7,969,922 315,404 |
| Other comprehensive income (loss) |
- | - | - | - | - | - | - | - | 1,057 | 39,445 | 40,502 |
| Total comprehensive income (loss) |
- | - | - | 315,404 | - | - | - | - | 1,057 | 39,445 | 355,906 |
| Share-based payment Transfer from revaluation reserve in respect of revaluation of property, plant, and equipment, at the depreciation amount |
- | 3,635 - |
- - |
- 554 |
- - |
- - |
2,314 - |
- (554) |
- - |
- - |
5,949 - |
| Exercise of employee options |
10 | 97 | - | - | - | - | (107) | - | - | - | - |
| Dividend | - | - | - | (380,000) | - | - | - | - | - | - | (380,000) |
| As of March 31 2021 (unaudited) |
309,961 | 837,324 | (26,411) | 5,875,712 | (43,622) | 11,000 | 47,150 | 114,060 | (22,281) | 848,884 | 7,951,777 |

| Share capital |
Premium and capital reserves in respect of shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Reserve from transaction with controlling shareholder In NIS thousand |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Balance as of January 1 2020 (audited) |
309,951 | 830,437 | 4,768,261 | (43,622) | 11,000 | 40,047 | 103,463 | (19,926) | 635,974 | 6,635,585 |
| Net income for the period | - | - | (166,067) | - | - | - | - | - | (166,067) | |
| Other comprehensive income (loss) | - | - | - | - | - | - | 1,248 | 5,185 | (417,019) | (410,586) |
| Total comprehensive income (loss) | - | - | (166,067) | - | - | - | 1,248 | 5,185 | (417,019) | (576,653) |
| Share-based payment | - | (3,446) | - | - | - | 685 | - | - | - | (2,761) |
| Transfer from revaluation reserve in respect of revaluation of property, plant, and equipment, at the depreciation amount |
- | - | 545 | - | - | - | (545) | - | - | - |
| As of March 31 2020 (unaudited) | 309,951 | 826,991 | 4,602,739 | (43,622) | 11,000 | 40,732 | 104,166 | (14,741) | 218,955 | 6,056,171 |

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Reserve from transaction with controlling shareholder |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| In NIS thousand | |||||||||||
| Balance as of January 1 2020 (audited) Net income for the year Other |
309,951 - |
830,437 - |
- - |
4,768,261 1,169,023 |
(43,622) - |
11,000 - |
40,047 - |
103,463 - |
(19,926) - |
635,974 - |
6,635,585 1,169,023 |
| comprehensive income (loss) |
- | - | - | 290 | - | - | - | 13,331 | (3,412) | 173,465 | 183,674 |
| Total comprehensive income (loss) for the year Transfer from revaluation reserve in respect of revaluation of property, plant, and equipment, at the depreciation |
- | - | - | 1,169,313 | - | - | - | 13,331 | (3,412) | 173,465 | 1,352,697 |
| amount | - | - | - | 2,180 | - | - | - | (2,180) | - | - | - |
| Share-based payment Acquisition of treasury shares |
- - |
3,155 - |
- (26,411) |
- - |
- - |
- - |
4,896 - |
- - |
- - |
- - |
8,051 (26,411) |
| Balance as of December 31 2020 (audited) |
309,951 | 833,592 | (26,411) | 5,939,754 | (43,622) | 11,000 | 44,943 | 114,614 | (23,338) | 809,439 | 7,969,922 |

| For the three months ended March 31 |
For the year ended December 31 |
||||
|---|---|---|---|---|---|
| 2021 | 2020 | 2020 | |||
| Appendix | Unaudited | Audited | |||
| In NIS thousand | |||||
| Cash flows for operating activities | |||||
| Profit (loss) | 315,404 | (166,067) | 1,169,023 | ||
| Adjustments required to present cash flows (for) from operating activities: |
(a) | (295,339) | 172,401 | (1,163,853) | |
| Net cash from operating activities of the Company | 20,065 | 6,334 | 5,170 | ||
| Cash flows from investing activities | |||||
| Net cash used in investing activities in investees | - | 12,000 | 12,000 | ||
| Investment in a capital note of an investee | - | (220,000) | (220,000) | ||
| Sales (acquisitions) of financial investments by the Company, net | (6,925) | 65,540 | 83,085 | ||
| Acquisition of a subsidiary (*) | (275,000) | - | - | ||
| Loan to subsidiary (*) | (93,633) | - | - | ||
| Net cash used in investing activities | (375,558) | (142,460) | (124,915) | ||
| Cash flows for financing activities | |||||
| Issuance of a bond, less issuance expenses | 348,457 | 217,511 | 585,433 | ||
| Repayment of bonds | - | (88,291) | (477,101) | ||
| Share buyback by the Company | - | - | (26,411) | ||
| Net cash from financing activities | 348,457 | 129,220 | 81,921 | ||
| Decrease in cash and cash equivalents | (7,037) | (6,906) | (37,824) | ||
| Balance of cash and cash equivalents at beginning of | |||||
| period | 40,270 | 78,094 | 78,094 | ||
| Balance of cash and cash equivalents at end of period | 33,233 | 71,188 | 40,270 |
(*) For further details, please see Note 4 to the consolidated financial statements.

| For the three months ended March 31 |
For the year ended December 31 2020 Audited |
||||
|---|---|---|---|---|---|
| 2021 2020 |
|||||
| Unaudited | |||||
| In NIS thousand | |||||
| Adjustments required to present cash flows (for) from | |||||
| (a) | operating activities: | ||||
| Items not involving cash flows: | |||||
| Net (gains) losses on financial investments | (282) | 323 | 1,346 | ||
| Income and expense items not involving cash flows: | |||||
| Accrued interest and appreciation of bonds | 655 | (573) | 11,289 | ||
| Income tax expenses | - | - | 37,859 | ||
| Company's share in the (profits) losses of investees, net | (308,171) | 167,584 | (1,210,661) | ||
| Changes in other balance sheet line items, net: | |||||
| Change in receivables and debit balances | 4,871 | 8,869 | (562) | ||
| Change in payables and credit balances | 7,914 | (5,572) | (5,543) | ||
| Changes in loans to investees | (326) | 1,770 | 2,419 | ||
| Total cash flows from (for) operating activities | (295,339) | 172,401 | (1,163,853) | ||
| (b) | Material non-cash activities | ||||
| Dividend declared and not yet paid (*) | (380,000) | - | - | ||
| Dividend receivable from subsidiaries (**) | 338,000 | - | - |
(*) For further details, please see Note 2.C below.
(**) Does not include repayment of a capital note from The Phoenix Investments; for further details, please see Note 3.A below.

The Interim Standalone Financial Information is presented in accordance with Regulation 38D of the Securities Regulations (Periodic and Immediate Reports), 1970 and does not include all the information required under Regulation 9C and the Tenth Addendum to the Securities Regulation (Periodic and Immediate Reports), 1970, "Standalone Financial Information of the Corporation". This standalone financial information should be read in conjunction with the standalone financial information as of the date and year ended December 31 2019 and in conjuction with the consolidated condensed interim financial statements as of March 31 2020 (hereinafter: the "Consolidated Financial Statements").
The Company - The Phoenix Holdings Ltd.
"Investee companies" - Consolidated companies and companies the Company's investment in which is included, whether directly or indirectly, in the financial statements based on the equity method.


May 26, 2021
To: The Board of Directors of The Phoenix Holdings Ltd. (hereinafter: the "Company") Dear Madam/Sir,
We hereby inform you that we agree to the inclusion (including by way of reference) of our reports outlined below in a shelf offering based on the Shelf Prospectus:
Kost Forer Gabbay & Kasierer Certified Public Accountants
Report and Statements regarding the Internal Controls over Financial Reporting and Disclosure


Management, under the supervision of the Board of Directors of The Phoenix Holdings Ltd. (hereinafter: the "Corporation") is responsible for establishing and maintaining adequate internal control over financial reporting and disclosure in the Corporation.
For this matter, the members of management are as follows:

The internal control over financial reporting and disclosure consists of the Corporation's existing controls and procedures that have been planned by the chief executive officer and the most senior financial officer or under their supervision, or by the equivalent acting officers, under the supervision of the Corporation's Board of Directors, designed to provide reasonable assurance about the reliability of financial reporting and the preparation of the financial statements in compliance with applicable laws, and ensure that all information that the Company is required to disclose in the financial statements its publishes pursuant to law is collected, processed, summarized and reported in a timely manner and according to the format prescribed by law.
Among other things, internal controls include controls and procedures planned to ensure that all information that the Corporation is required to disclose as aforesaid is collected and transferred to the Corporation's management, including the chief executive officer and the most senior financial officer, or the equivalent acting officers, in order to allow decision making on a timely basis with respect to the disclosure requirements.

Due to its inherent limitations, internal control over financial reporting and disclosure is not designed to provide absolute assurance that misstatements or omissions of information in the financial statements shall be prevented or detected.
The Phoenix Insurance Ltd., a subsidiary of the Corporation, is an institutional entity which is subject to the directives of the Commissioner of the Capital Market, Insurance and Savings in the Ministry of Finance regarding the assessment of the effectiveness of internal controls over financial reporting.
With respect to the internal control of the said subsidiary, the Corporation implements the following provisions:
Institutional Entities Circular 2009-9-10, "Management's Responsibility for Internal Controls over Financial Reporting"; Institutional Entities Circular 2010-9-6, "Management's Responsibility for internal control over financial reporting - Amendment"; Circular 2010-9-7, "internal control over financial reporting - Statements, Reports and Disclosures"; Circular 2012-9-5, "internal control over financial reporting - Statements, Reports, Disclosures and Management's Responsibility for internal control over financial reporting - Amendments"; and Circular 2015-9-15, "internal control over financial reporting - Statements, Reports, Disclosures and Management's Responsibility for internal control over financial reporting - Amendments".
In the quarterly Report on the Effectiveness of Internal Control over Financial Reporting and Disclosure attached to the quarterly report for the period ended December 31 2020 (hereinafter - the "Most Recent Annual Report Over Internal Control"), the Board of Directors and management assessed the internal control in the corporation. Based on this assessment, the Corporation's Board of Directors and management have concluded that the said internal control, as of March 31 2021, is effective.
As of the report date, the Board of Directors and management have not been informed of any event or matter that may alter the assessment of the effectiveness of internal control, as presented in the Most Recent Annual Report Over Internal Control.
As of the report date, based on the Most Recent Quarterly Report over Internal Control and based on information brought to the attention of management and the Board of Directors as stated above, the internal control is effective.
I, Eyal Ben Simon, hereby certify that:
Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.
May 26, 2021 ___________________________________________
Eyal Ben Simon, Chief Executive Officer
Nothing in the foregoing shall detract from my responsibility or the responsibility of any other person, under any law.
May 26, 2021 ___________________________________________
Statements regarding Controls and Procedures over Financial Reporting and Disclosure of The Phoenix Insurance Company Ltd.

I, Eyal Ben Simon, hereby certify that:


Nothing in the foregoing shall detract from my responsibility or the responsibility of any other person, under any law.
______________________________________
May 26, 2021
Eyal Ben Simon, Chief Executive Officer
I, Eli Schwartz, hereby certify that:
1As defined in the provisions of the institutional entities circular titled "Internal Control over Financial Reporting - Statements, Reports and Disclosures".
May 26, 2021
______________________________________________ Eli Schwartz, Executive VP, Chief Financial Officer
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.